BLASTOCYSTIS: INVESTIGATION OF PARASITE ADHESION AND ITS ROLE IN MEDIATING INTESTINAL BARRIER COMPROMISE by WU ZHAONA
BLASTOCYSTIS: INVESTIGATION OF PARASITE 
ADHESION AND ITS ROLE IN MEDIATING 





(Bachelor of Sciences) 
 
A THESIS SUBMITTED FOR THE DEGREE OF 
DOCTOR OF PHILOSOPHY 
 
DEPARTMENT OF MICROBIOLOGY 











DEDICATED WITH LOVE TO MY PARENTS & 
FAMILY 
 





Firstly, I would like to extend my deepest gratitude to my supervisor A/Prof 
Kevin Tan, who has been highly supportive all along my PhD journey. He was 
a strict professor, holding onto guidelines when training students or staff in the 
way they should go. Sometimes I did not understand why he was strict, but 
soon it turned out to be extremely beneficial to me as a research student being 
trained.  It would have been impossible for the completion of this project 
without his patient, timely, and kind help and encouragements, as well as 
wisdom which could not be understood in the beginning, but always speaks 
for itself later on. He encourages us to pursue projects we are passionate about, 
on condition that it comes with a good theoretical basis. It is such a blessing to 
pursue my PhD with his guidance.  
We are very blessed to have a very good lab environment to work in and enjoy. 
All the kind help has been given selflessly to me from my loving labmates, 
including past and present members of the Tan Lab. Specially, I would give 
thanks to Junhong, a brother-in-Christ, who has helped with every step of 
those experiments I used to have trouble with. His patient help has also been a 
great support.  Also, for Chuu Ling, for her love which is not often verbally 
expressed but always abundantly given; Joshua, for his selfless support in 
experimental materials and devices; Yan Quan, for sharing lots of insights on 
projects in our discussions. My mentor, Haris, who is now at Yale University, 
has always been a good model for me in doing research. His passion towards 
research has been inspiring to me as a young research student. He also has 
ii 
 
shared a lot about his professional knowledge and insights in medicine which 
lends the research work clinical relevance.  
I would also like to thank A/Prof Lee Yuan Kun for his kind help with the 
adhesion project, not only in knowledge input but also in advising on future 
directions; Dr Zhang Yongliang, for his valuable suggestions on various 
aspects of my project. His resourceful mind has provided new insights and 
approaches to tackle difficult questions. I highly appreciate their time and help 
given to me during the TAC meetings.   
Many thanks be to Geok Choo, for her constant support and kindness which 
has made me feel at home in a foreign land; Mr. Rama, for his “harsh” words 
which urged me to have a good habit in experiment; Auntie Zina, for the so 
much love from her in treating us like her own children. I would like to thank 
Mdm Siti Masnor for her patient and professional administrative assistance. I 
also want to thank all the lecturers of the Yong Loo Ling School of Medicine, 
for making the four-year PhD study a truly memorable journey. Speical thanks 
to Shuying and Wei an from Confocal Microscopy Unit, NUS, for their kind 
and timely assistance in my numerous bioimaging experiments.  
I would like to thank National University of Singapore for granting me the 
scholarship to pursue this project. 
Lastly, I extend my deepest gratitude to my dear Mommy and Daddy, 







ACKNOWLEDGEMENTS                                                                                          i  
TABLE OF CONTENTS                                                                                         iii 
SUMMARY                                                                                         ix 
LIST OF TABLES                                                                                        xii 
LIST OF FIGURES                                                                                         xiii 
LIST OF SYMBOLS                                                                                        xvii 
LIST OF PUBLICATIONS                                                                                        xxii 
  
CHAPTER 1: INTRODUCTION                                                                            1-34 
1.1 Introduction 
1.2 Classification 
1.3 Cell biology 
1.4 Life cycle 
1.5 Clinical presentation 
1.6 Laboratory diagnosis 
1.7 Epidemiology and prevalence 
1.8 High risk population 
1.9 Treatment 
1.10 Pathogenesis 
1.11 Objectives of the present study 
 
CHAPTER 2: ADHESION OF BLASTOCYSTIS TO 
ENTEROCYTES AND DEVELOPMENT OF AN 
ADHESION ASSAY 
        35-53 
2.1 Introduction  
2.2 Materials and methods  
 2.2.1 Culture of Caco-2 colonic epithelial cell line  
iv 
 
 2.2.2 Parasite culture  
 2.2.3 Confocal microscopy  
 2.2.4 Scanning electron microscopy  
 2.2.5 Fluorescent labeling of live Blastocystis parasites 
with CFSE 
 
2.3 Results  
 2.3.1 Apical attachment of Blastocystis to epithelial cells  
 2.3.2 Determination of Blastocystis attachment to Caco-
2 cell monolayer by Scanning Electron Microscopy 
 
 2.3.3 Development of an adhesion assay with CFSE 
staining for Blastocystis 
 
2.4 Discussion  
 
CHAPTER 3: FACTORS INVOLVED IN BLASTOCYSTIS      
ADHESION TO ENTEROCYTES                                                       
           54-81 
3.1 Introduction  
3.2 Materials and methods  
 3.2.1 Culture of Caco-2 colonic epithelial cell line  
 3.2.2 Parasite culture  
 3.2.3 Coincubation with different modulators and 
attachment assay 
 
 3.2.4 Statistical analysis  
3.3 Results  
 3.3.1 Time dependent variations in attachment  
 3.3.2 Dose response studies  
 3.3.3 Effects of temperature, rotational shaking, 
fixation and trypsinization on Blastocystis 
attachment 
 
 3.3.4 Effects of inhibition of cytoskeletal 
components, parasite cysteine proteases and 
lipid raft on attachment 
 
 3.3.5 Effects of saccharides on Blastocystis 




3.4 Discussion  
 
CHAPTER 4: HOST RESPONSES PART I: EFFECTS OF     
BLASTOCYSTIS ON APICAL JUNCTIONAL 
COMPLEX AND EPITHELIAL BARRIER 
FUNCTION 
         82-111 
4.1 Introduction  
4.2 Materials and methods  
 4.2.1 Culture of Caco-2 colonic epithelial cell line  
 4.2.2 Parasite culture  
 4.2.3 Epithelial permeability  
 4.2.4 Western blot and cellular fractionation   
 4.2.5 Confocal microscopy  
4.3 Results  
 4.3.1  Blastocystis induced time- and dose-
dependent permeability increase in Caco-2 
 
 4.3.2 Effect of Blastocystis on the overall expression 
of the apical junctional complexes 
 
 4.3.3 Effect of Blastocystis on the distribution of the 
tight junction proteins by cellular fractionation   
 
 4.3.4 Effect of Blastocystis on the distribution of the 
tight junction proteins 
 
 4.3.5 Loss of co-localization between tight junction 
proteins and F-actin after exposure to 
Blastocystis 
 
 4.3.6 Possible association of host tight junction 
protein Claudin-1 with adhering Blastocystis 
parasites 
 
4.4 Discussion  
 
CHAPTER 5: HOST RESPONSES PART II: ROLE OF          
BLASTOCYSTIS-INDUCED HUMAN 
ENTEROCYTE APOPTOSIS IN MEDIATING 
BARRIER DYSFUNCTION 
        112-133 
5.1 Introduction  
vi 
 
5.2 Materials and methods  
 5.2.1 Culture of Caco-2 colonic epithelial cell line  
 5.2.2 Parasite culture and lysate  
 5.2.3 Epithelial permeability  
 5.2.4 Flow cytometry  
 5.2.5 Confocal microscopy  
 5.2.6 Western blot  
 5.2.7 Statistical analysis  
5.3 Results  
 5.3.1 ST-4 (WR-1) strain could not establish 
enteroadhesion and cause disruption of tight 
junction, in contrast to the enteroadhesive 
strain of Blastocystis ST-7 (B) 
 
 5.3.2 Blatocystis ST-7 (B) induces characteristics of 
apoptosis in Caco-2 cells; ST-4 (WR-1) does 
not 
 
 5.3.3 Blastocystis ST-7 (B) induces increase in 
permeability to FITC-conjugated Dextran; ST-
4 (WR-1) does not   
 
 5.3.4 Inhibition of caspase prevented Blastocystis 
ST-7-induced ZO-1 rearrangement and 
epithelial barrier dysfunction in Caco-2 
 
5.4 Discussion  
 
CHAPTER 6: STRAIN-DEPENDENT VARIATIONS IN 
ADHESION AND ITS POSSIBLE ROLE IN 
MEDIATING BARRIER DYSFUNCTION                                                      
         134-176 
6.1 Introduction  
6.2 Materials and methods  
 6.2.1 Parasite culture  
 6.2.2 Culture of Caco-2 colonic epithelial cell line  
 6.2.3 Parasite viability assay  
 6.2.4 Growth curve  
vii 
 
 6.2.5 Azocasein assay for cysteine protease activity  
 6.2.6 Adhesion assay  
 6.2.7 Epithelial permeability  
 6.2.8 Western blot  
 6.2.9 Confocal microscopy  
 6.2.10 Drug preparation  
 6.2.11 Statistical analysis  
6.3 Results  
 6.3.1 Blastocystis exhibits intra-and inter- subtype 
variation in ability to induce epithelial 
permeability increase in human epithelium 
 
 6.3.2 Blastocystis exhibits intra-and inter-subtype 
variability in ability to disrupt epithelial tight 
junction proteins 
 
 6.3.3 Blastocystis isolates exhibit strain-to-strain 
variation in attachment to human enterocytes 
 
 6.3.4 Blastocystis exhibits extensive intra- and 
inter-subtype variation in cysteine protease 
activity 
 
 6.3.5 Blastocystis ST-7 isolates exhibit extensive 
variations in resistance to Mz and the level of 
Mz resistance is inversely correlated with an 
ability to attach and induce a permeability 
increase 
 
 6.3.6 Mz resistance in Blastocystis does not lead to 
decrease in cell proliferation in Blastocystis 
ST-7 
 
 6.3.7 Blastocystis ST-7 isolates exhibit extensive 
variations in resistance to nitrosative stress 
 
6.4 Discussion  
 
CHAPTER 7: APPLICATION OF THE ADHESION 
MODULATOR IN BLASTOCYSTIS INFECTION 
        177-194 
7.1 Introduction  
7.2 Materials and methods  
viii 
 
 7.2.1 Parasite culture  
 7.2.2 Culture of Caco-2 colonic epithelial cell line  
 7.2.3 Attachment assay  
 7.2.4 Western blot  
 7.2.5 Statistical analysis  
7.3 Results  
 7.3.1 Displacing effect of galactose on Blastocystis 
adhesion to Caco-2 cells 
 
 7.3.2 Effect of the cytadherence inhibitor galactose 
on prevention of Blastocystis–induced tight 
junction degradation in Caco-2 cell 
monolayers 
 
 7.3.3 Evaluation of galactose on the adhesion of the 
highly adhesive Blastocystis ST-7 (H) isolate 
to Caco-2 cells: interference with adhesion, 
displacing effects as well as rescue of tight 
junction degradation   
 
7.4 Discussion  
 
CHAPTER 8: GENERAL DISCUSSIONS                    195-202 
8.1 Discussion  
 








Blastocystis is an emerging enteric protistan pathogen that induces intestinal 
disorders in a range of hosts including humans. Despite being discovered more 
than 100 years ago, it is difficult to argue the clinical significance and 
pathogenic potential of Blastocystis. Recent studies have shed light on its 
potential virulence factors and host-pathogen interactions; however, there have 
been major gaps in our understanding of its basic biology. Adhesion of 
Blastocystis to host cells, as the first step to establish and maintain colonic 
infection, has never been studied. As an extracellular parasite, Blastocystis 
need to attach to avoid clearance by peristalsis. It would be important to 
investigate the ability of Blastocystis to attach and the factors that influence 
the attachment.   
The aim of this study was to investigate the pathobiology of Blastocystis 
adhesion and study the role of adhesion in initiating pathogenesis. Here the 
study reports that a metronidazole resistant (Mzr) strain of Blastocystis 
was able to attach to human intestinal epithelial cells and attachment was relat
ed to time, dose and temperature. By establishing an adhesion assay, this study 
made an extensive analysis of extrinsic and intrinsic factors influencing host-
parasite adhesion and revealed that galactose-binding protein on the surface of 
the parasite was important in mediating parasite attachment. 
Following attachment to the enterocytes, Blastocystis produces pathogenic 
effects on the host cells. The host responses upon adhesion were also 
characterized. A comprehensive analysis of the apical junctional complexes 
showed that the parasite altered the integrity of the tight junctions and 
x 
 
transferred Blastocystis legumain to the apical side of enterocytes. Cleavage of 
tight junction proteins caused a disruption in the colonic epithelial barrier and 
increased intestinal permeability, which might be related to the characteristic 
diarrhea observed in patients suffering from Blastocystis infections. The 
parasites could also induce host cell apoptosis in a caspase 3- and 9- 
dependent manner, and interestingly, pretreatment of Caco-2 monolayers with 
a pan-caspase inhibitor z-VAD-fmk, significantly inhibited the changes in 
tight junction protein and intestinal permeability increase. This suggested a 
role for enterocyte apoptosis in Blastocystis-mediated epithelial barrier 
compromise in the human intestine.  
Diverse intestinal symptoms with Blastocystis infections have confused 
clinicians and microbiologists alike. While a large number of infected 
individuals present with clinical symptoms, asymptomatic carriage of the 
parasite is also common. Moreover, in symptomatic patients, the duration and 
severity of symptoms vary from acute enteritis to chronic, mild diarrhea. 
Strain-to-strain variations in parasite pathogenicity have been proposed to 
contribute to this inconsistency. The study tested whether strain-to-strain 
variations in enteroadhesion may account for the differences in pathogenicity, 
and subsequently different outcomes of infection. The study showed that intra- 
and inter-subtype variations in cytopathogenicity were largely dependent on 
their adhesive properties, highlighting a major role of adhesion in 
pathogenesis. The study also showed impairment of parasite adhesion and 
consequently virulence as a possible fitness cost of drug resistance in 
Blastocystis strains. Metronidazole resistant (Mzr) strains were found to be 
less pathogenic owing to compromised adhesion. In addition, enhanced 
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tolerance of nitrosative stress was found in adhesive strains, suggesting 
parasites evolved for better survival fitness in adhesion as well as the defence 
against host immunity.   
Another issue complicating the pathogenic potential of Blastocystis is reports 
of treatment failure. Although metronidazole is considered first-line therapy, 
physicians are often skeptical about prescribing antibiotics for Blastocystis 
infections due to frequent reports of non-responsiveness to chemotherapy. 
There is a need to design alternative or adjunctive treatment options against 
antibiotic resistant Blastocystis infections. As attachment is crucial for 
Blastocystis survival and important for its pathogenicity, and thus it would be 
an appealing drug target. Modulators that prevent robust attachment may 
allow Blastocystis to be flushed from the intestinal lumen by host peristalsis, 
and ultimately result in reduction in infection. The inhibition studies with the 
adhesion assay revealed that galactose significantly interfered with attachment 
and when applied in barrier dysfunction study, galactose was shown to rescue 
the degradation of tight junction protein ZO-1 induced by Blastocystis. 
Interestingly, galactose was also able to dislodge adhered parasites from the 
host cells, suggesting potential application of galactose-based therapy in 
Blastocystis infections.  
Altogether, the findings from the study identified the importance of adhesion 
in Blastocystis pathogenesis, and provided a possible explanation for the 
cellular basis of strain-to-strain variations in pathogenicity, advanced our 
understanding of the mechanism of attachment and also pointed towards new 
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Blastocystis is a unicellular, genetically diverse protist, phylogenetically 
placed within the Stramenopiles (Scanlan, 2012) and it is the only member of 
this group associated with human pathology (Tan, 2008, Tan et al., 2010). It is 
a species complex comprising of 17 subtypes (STs) of which at least 9 are 
found in humans (Alfellani et al., 2013b). The prevalence of this parasite 
ranges from 1.5% to 15% in developed countries, and from 30% to 50% in 
developing countries (Tan, 2008). It is frequently reported in human fecal 
samples of symptomatic patients as well as healthy individuals (Stenzel et al., 
1996, Tan, 2004). The parasite induces general symptoms of intestinal 
inflammation such as mucous and watery diarrhea, bloating, abdominal pain 
and vomiting (Tan et al., 2010). Clinical studies also associate Blastocystis 
with intestinal and dermatological inflammatory disorders such as irritable 
bowel syndrome and urticaria (Garavelli et al., 1988, Kurniawan et al., 2009, 
Llibre et al., 1989, Tasova et al., 2000), suggesting Blastocystis may be an 
opportunistic pathogen. 
Despite being discovered more than 100 years ago (Alexeieff, 1911, Brumpt, 
1912), it is difficult to argue the clinical significance and pathogenic potential 
of Blastocystis (Clark et al., 2013). Limitations of diagnostic techniques, 
variable phenotypes and genotypes of Blastocystis, large number of 
asymptomatic carriers, and frequent reports of treatment failure are blamed for 
most of the controversies surrounding the clinical management of the parasite 
infection (Tan et al., 2010). In recent years, significant advances have been 
made in the knowledge of its molecular and cellular biology (Clark et al., 
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2013, Denoeud et al., 2011, Tan et al., 2010, Wu et al., 2010), as well as 
pathogenic mechanisms (Mirza et al., 2011b, Mirza et al., 2012b). However, 
many controversies remain unresolved regarding the life cycle, molecular 





Blastocystis has been a taxonomic enigma since its initial description more 
than 100 years ago. The organism was initially classified as the cyst of a 
flagellate, vegetable, yeast, and fungus (Zierdt, 1991). The genus name 
“Blastocystis” was coined by Alexeieff while Brumpt provided the species 
name, “hominis” (Zierdt, 1991). It was subsequently reclassified as a protist by 
Zierdt and colleagues based on its morphology and phenotypic properties such 
as the presence of one or more nuclei, cellular organelles like mitochondria, 
Golgi apparatus and endoplasmic reticulum, as well as its inabilty to grow on 
fungal medium, resistance to antifungal agents and susceptibility to 
antiprotozoal drugs (Zierdt et al., 1967). Blastocystis was later classified as a 
sporozoan and then as a sarcodine (Zierdt, 1991).  
An earlier analysis of Blastocystis partial small-subunit rRNA (ssrRNA) 
showed that Blastocystis sp. is not monophyletic with the yeasts, fungi, 
sarcodines, or sporozoans or even yeast and fungi (Johnson et al., 1989). 
Later, the complete Blastocystis ssrRNA gene was sequenced and 
phylogenetic analysis suggested that the parasite should be classified within 
the Stramenopiles (also known as Heterokonta) (Silberman et al., 1996). 
Further analysis of Blastocystis ssrRNA, cytosolic-type 70-kDA heat shock 
protein, translation elongation factor 2, and the non-catalytic ‘B’ subunit of 
vacuolar ATPase confirmed that it is indeed a Stramenopile (Arisue et al., 
2002). In general, the stramenophiles have flagella surrounded by lateral hair 
like mastigonemes, but Blastocystis lacks a flagella and is non-motile 
(Silberman et al., 1996, Boorom et al., 2008).  
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In the past, the species name of Blastocystis was given based on the host from 
which it was isolated such as B. hominis from humans, B. ratti from rats etc.. 
This outdated classification may have resulted in confusion regarding 
specificity, cell biology and pathogenicity of the parasite. Based on published 
ssrRNA sequence analysis (Noel et al., 2005), it was proposed Blastocystis 
isolates should be characterized by molecular subtyping of ssrRNA and 
designated as Blastocystis sp. (Stensvold et al., 2007b). More recently, 17 




1.3 CELL BIOLOGY  
Blastocystis is a polymorphic protist, and four major forms have been reported 
from in vitro culture and fecal samples (vacuolar, granular, amoeboid and 
cyst) (Fig. 1.1). The extensive heterogeneity of various forms of Blastocystis 
has led to the misinterpretation of findings from different studies (Tan, 2008). 
There is limited information available on the physiological relevance of these 
forms. Mechanisms involved in transition of the parasite from one form to 
other are not known either.  
1.3.1 Vacuolar form 
The central vacuole form, also referred to as vacuolated or central body form, 
is the most frequently observed form in laboratory culture and in stool 
samples. It is spherical and may display large size variations, ranging from 2 
to 200 μm (average of 4 to 15 μm) (Stenzel et al., 1996). The vacuolar form is 
characterized by a large central vacuole that occupies approximately 90% of 
the cell’s volume (Fig. 1.1) (MacPherson et al., 1994, Stenzel et al., 1996). In 
electron micrographs the peripheral cytoplasm appears to contain cellular 
organelles like nucleus, mitochondria-like organelle, endoplasmic-reticulum 
and Golgi bodies (Zierdt, 1973). Multiple nuclei can be seen in Blastocystis 
and an average of four nuclei is common  (Zierdt, 1973). A surface coat or 
fibrillar layer of varying thickness often surrounds the organism. The exact 
role of the surface coat is not understood but it has been suggested to play a 
role in trapping and degrading bacteria for nutrition (Zaman et al., 1997, 
Zaman et al., 1999) and protecting against osmotic shock (Cassidy et al., 
1994). The surface coat appears to be thicker in parasite freshly isolated from 
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stools, but it reduces with prolonged in vitro culturing (Cassidy et al., 1994). 
For the central vacuole in Blastocystis, its exact function is currently unclear 
but it appears to act as a storage organelle (Puthia et al., 2008, Tan, 2008). It 
was suggested that the central vacuole may act as a repository for 
carbohydrates and lipids required for cell growth (Yoshikawa et al., 1996). A 
few studies also suggest the role of central vacuole as a depository for 
apoptotic bodies during Blastocystis programmed cell death (Tan et al., 2005, 
Yin et al., 2010). Recently, the Blastocystis central vacuole was found to 
contain cysteine proteases (Puthia et al., 2008), which play an important role 
in parasites virulence and cell survival (Puthia et al., 2005, Puthia et al., 2008, 
Mirza et al., 2011a, Mirza et al., 2012b).  
1.3.2 Granular form 
The granular form of Blastocystis is morphologically identical to the vacuolar 
form. The only differentiating characteristic is the presence of multiple 
granules, especially within the central vacuole (Fig 1.1). The granules might 
differ considerably in appearance and described as myelin-like inclusions, 
droplets of lipid, tiny vesicles or crystalline granules (Dunn et al., 1989). The 
size of this form ranges from 3-80 μm in diameter. Granular form is more 
frequently observed in nonaxenized, older, and antibiotic-treated cultures. The 
physiological role of this form is not clear, but it is suggested to play a role in 
parasite programmed cell death as well as storage (Tan, 2004). 
1.3.3 Ameboid form 
The amoeboid form (Fig 1.1) is the most infrequently observed Blastocystis 
form. These forms have been observed in antibiotic treated cultures, old 
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cultures or in fecal samples (Zierdt, 1973). The size is considerably smaller, 
ranging from 2.6-7.8 μm in diameter. There are conflicting reports about its 
description (Dunn et al., 1989, McClure et al., 1980). Amoeboid forms were 
also observed from Blastocystis colonies grown in soft agar (Chen et al., 
1997b, Tan et al., 1996b, Tan et al., 1996c), with a central vacuole, numerous 
Golgi bodies and mitochondria. In contrast, Dunn et al. described amoeboid 
cells with extended pseudopodia and lysosome-like compartments containing 
ingested bacteria, yet lacked a central vacuole, a Golgi complex, a surface 
coat, and mitochondria (Dunn et al., 1989). The presence of bacteria and 
bacterial remnants within the amoeboid form suggested that this form may be 
phagocytic in nature. 
1.3.4 Cyst form 
The cyst form (Fig 1.1) is the most recently described form of the parasite. 
The size ranges between 2-5 μm in diameter (Moe et al., 1996). It is protected 
by a multi-layered cyst wall which is sometimes covered with a loose surface 
coat (Moe et al., 1996). Unlike vacuolar and granular forms, It can survive up 
to 19 days in water at normal temperature, up to 1 month at 25°C (Moe et al., 
1996) and as long as 2 months at 4°C (Yoshikawa et al., 2004). A report of 
Blastocystis cysts also suggests its resistance to common antiprotozoal agent 
metronidazole (Zaman et al., 1996). Therefore, this form is environmentally 
resistant and considered significant for the fecal-oral transmission of infection 












Fig. 1.1 Phase contrast micrographs representing four morphological 
forms of Blastocystis. Vacuolar form (V), and Multivacuolar forms (MV), 
Scale bar = 10 μm; Granular form (G), Scale bar = 10 μm; Amoeboid form 
(arrow). Scale bar = 10 μm; Cyst (arrow), Scale bar = 5 μm 
 




1.4 LIFE CYCLE 
There have been discrepancies over the life cycle of Blastocystis, which are 
due largely to the belief that Blastocystis exhibits multiple reproductive 
processes (Govind et al., 2002, Singh et al., 1995, Zhang et al., 2007). Modes 
of reproduction proposed such as schizogony, plasmotomy (budding) (Tan et 
al., 2007), endodyogeny (Zhang et al., 2007), and sac-like pouches (Govind et 
al., 2002, Suresh et al., 1997) are more likely due to the pleomorphic nature of 
the organism and not true modes of reproduction. Until proven otherwise, the 
only accepted mode of reproduction is binary fission (Tan, 2008). 
Apart from humans, several animal hosts have been described for Blastocystis 
including rats, pigs, birds, reptiles and even insects. Blastocystis commonly 
exhibits zoonoses and to complete its life cycle through the fecal-oral route, 
the parasite appears to involve one of more host species (Tan, 2008). A 
modified life cycle (Fig. 1.2) must take into consideration the large reservoir 
of Blastocystis among various animal populations and that humans are 
potential hosts to numerous zoonotic genotypes (subtypes). Ingested cysts 
develop into vacuolar forms in the large intestine and later reproduce by 
binary fission. Encystation occurs during passage along the large intestines 
and is deposited in the feces (Chen et al., 1997a). Apart from a few studies, 
the transitions from one of the classically described forms to another are not 








Fig. 1.2 Proposed life cycle for Blastocystis suggesting the existence of 
zoonotic genotypes (subtypes 1 to 7) with various host specificities. 
Subtype 1 is cross infective among mammalian and avian isolates; subtypes 2, 
3, 4, and 5 comprise primate/pig, human, cattle/pig, and rodent isolates, 
respectively; and subtypes 6 and 7 include avian isolates. The proposed 
scheme suggests that humans are potentially infected by seven or more species 
of Blastocystis and that certain animals represent reservoirs for transmission to 
humans. Recent studies have identified more subtypes. 
 
Reproduced from Tan (2008).  
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1.5 CLINICAL PRESENTATION 
Symptomatic infections with Blastocystis are called blastocystoses, which 
present with a variety of signs and symptoms (Tan et al., 2010), such as non-
specific intestinal symptoms (Mirza and Tan, 2012). Extraintestinal 
manifestations of Blastocystis infection including arthritis or skin disorders 
have also been described (Tejera et al., 2012, Vogelberg et al., 2010).  
Intestinal Symptoms: 
The most common symptom of blastocystosis is diarrhea with abdominal pain, 
with varying severity (Tan et al., 2010). Other nonspecific gastrointestinal 
symptoms include nausea, vomiting, constipation, dysentery, flatulence, 
bloating, anorexia and weight loss (Nagel et al., 2012, Stensvold et al., 2009c, 
Tan et al., 2010). The duration and severity of symptoms are reported to be 
variable, ranging from mild and chronic diarrhea to acute gastroenteritis 
(Mirza and Tan, 2012).  
Although the parasite is frequently associated with intestinal symptoms, an 
unequivocal causal relationship between Blastocystis and gastrointestinal 
disorders has not been established thus far primarily because of a large number 
of asymptomatic carriers. Consequently, Koch’s postulates have not been 
fulfilled for Blastocystis (Coyle et al., 2012).  
No consensus has been reached regarding the possible reasons for variation in 
intestinal symptoms. Some studies associate the severity of disease with 
parasite density (Tan et al., 2010). Significantly higher concentrations of 
Blastocystis were found in symptomatic patients than in asymptomatic ones 
13 
 
(Kaya et al., 2007). More than 5 Blastocystis on every 40x magnification field 
in fecal samples was accepted as pathogenity criterion (Stenzel et al., 1996). 
In a recent case of life-threatening toxic megacolon, >10 Blastocystis/field 
were observed (Salvi et al., 2012).  
Extraintestinal Symptoms: 
Interestingly, various reports associate Blastocystis infections with cutaneous 
lesions particularly urticaria (Katsarou-Katsari et al., 2008, Vogelberg et al., 
2010), suggesting host allergic response to some unknown parasitic factors. 
Treatment of the parasite leads to resolution of both the infection and 
cutaneous lesions. These cutaneous manifestations are likely immune-
mediated although the exact mechanism is presently unclear. Recently, a 
specific association has been found between acute urticaria and the amoeboid 
forms of Blastocystis subtype 3 (Katsarou-Katsari et al., 2008). The authors 
suggested several possible modes through which Blastocystis may give rise to 
such cutaneous symptoms, namely through a disruption to immune 
homeostasis as the host mounts an inflammatory response against the 
amoeboid forms of Blastocystis. Possible antigens might include 
carbohydrates found on its surface coat, leading to inflammatory cell 
recruitment, which release histamine-activating factors that prime mast cells 
and basophils. IgE might also be a possible mediator in urticaria through mast 
cell activation and degranulation, and subsequent release of inflammatory 
mediators. However, the mechanism by which a Blastocystis infection gives 
rise to such symptoms remains to be elucidated. The identification of 
Blastocystis-specific IgEs in patients with urticaria would be useful in defining 
the mechanism by which the parasite causes these lesions.  
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1.6 LABORATORY DIAGNOSIS 
One of the reasons for the controversial pathogenic potential of Blastocystis is 
lack of standardized diagnostic techniques. Therefore, establishing authentic 
methods for diagnosis would be crucial for the field to properly evaluate the 
clinical significance of the parasite. 
As reviewed in the previous sections, Blastocystis is an extremely diverse 
complex and it should be taken into consideration during laboratory 
investigations (Tan et al., 2010). Information on the density, morphology, 
subtype, as well as antibiotic susceptibility is important for appropriate 
management of Blastocystis infections. Technical advances in recent years 
have made it possible to assess these parameters. However, a number of 
Blastocystis infections go unreported or ignored owing to its controversial 
pathogenesis. Another challenge for diagnosis of Blastocystis is the presence 
of diverse morphological forms, making it one of the most difficult organisms 
to identify in stool samples. Diagnostic staff should be trained to identify 
various stages of the parasite, especially for cyst form because of their small 
size.   
Conventional diagnostic methods to identify the parasite in stools include 
FECT and XIVC, while tests based on serology and molecular biology are 
being used increasingly. Blastocystis antibiotic susceptibility testing is yet to 





1.6.1 FECT  
The formol ether concentration technique (FECT), though commonly 
employed to detect parasite ova and cysts, is not recommended for laboratory 
identification of Blastocystis, due to extremely poor sensitivity (Rene et al., 
2009, Stensvold et al., 2007a). Using only FECT to isolate Blastocystis might 
probably contributes to the underestimation of parasite burden in 
epidemiological studies (Tan et al., 2010). 
1.6.2 XIVC  
Trichrome-stained fecal smears following short-term xenic in vitro culture 
(XIVC) exhibits superior sensitivity in parasite detection. However, it should 
be noted that due to difference in generation time between Blastocystis strains 
(Zierdt et al., 1981), slower growing subtypes and mixed infections of slower- 
and faster growing subtypes may be missed by this technique. Another 
consideration for better diagnosis of Blastocystis infections is to take multiple 
stool samples over a period of time since the parasite shedding by humans is 
irregular (Suresh et al., 2004).  
1.6.3 Molecular Diagnostics  
A quantitative TaqMan PCR was developed for the detection of Blastocystis 
and shown to be applicable to genomic DNAs extracted directly from feces 
(Stensvold et al., 2012a). Emerging data suggests association of certain 
Blastocystis subtypes or strains with pathogenicity and antibiotic resistance 
(Stensvold et al., 2009c, Stensvold et al., 2010). Therefore, it’s important to 
determine which subtype is present in the specimen for better clinical 
management of blastocystosis. For subtyping, most epidemiological studies 
used a 600 bp barcoding region within the 18S small subunit ribosomal DNA 
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(18S rDNA) (Scicluna et al., 2006). The amplification of this 18S rDNA 
region is followed by sequencing of the PCR product to assign isolates to 
specific STs. A real-time quantitative PCR approach based on SYBR green 
detection of double-stranded DNA was reported (Poirier et al., 2011) and was 
designed as a genus-specific PCR targeting the SSU rRNA gene, enabling 
amplification of DNAs from Blastocystis strains. A recent study identified a 
single-copy subtyping rDNA marker in the genome of the mitochondria-like 
organelles (MLOs) and showed that it could be used not only for subtyping, 
but also to discriminate different isolates within a same ST (Poirier et al., 
2014). 
1.6.4 Serology 
There have only been a handful of reports employing serological techniques in 
identification of Blastocystis infections. Some studies involving enzyme-
linked immunosorbent assay for Blastocystis correlate antibody titers with 
symptoms (Hussain et al., 1997, Mahmoud et al., 2003). Since serological 
approaches provide rapid, sensitive and quantitative detection of microbe-
specific antibodies, they could be powerful tools for diagnosis of the parasite 
(Tan et al., 2010). Development of such assays however should take into 
consideration the genetic diversity of Blastocystis. A panel of monoclonal 
antibodies against specific subtypes would be useful for diagnosis of 
Blastocystis from stool specimens (Tan et al., 2010). 
1.6.5 Antibiotic Susceptibility Testing 
Chronic Blastocystis infections are often nonresponsive to conventional 
antibiotic regimens (Stensvold et al., 2010). Antibiotic susceptibility data, 
therefore, would be useful to manage such infections. Classical Blastocystis 
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antibiotic susceptibility evaluation utilized serial dilution or radioisotope 
inclusion methods (Dunn et al., 1991, Yakoob et al., 2004, Zierdt et al., 1983). 
These techniques were expensive, time consuming, and often injurious to 
health. Recent development of redox-based assays (Mirza et al., 2011a), as 
well as improvements in anaerobic microculture methods, have made it 
possible to efficiently evaluate Blastocystis antibiotic susceptibilities within 
24h (Mirza et al., 2011a). Redox-based assays are cheap, require a small 
parasite density, and could be adapted on high-throughput platforms. 
Furthermore, these assays do not require sophisticated equipment and are ideal 
for use in resource-poor healthcare facilities (Mirza et al., 2011a). However, 
most of these assays were adapted for the vacuolar morphological form of the 
parasite, which is the most commonly reported form (Dunn et al., 2012, Mirza 
et al., 2011a). It is believed that cysts, which are resistant to metronidazole 
(Zaman et al., 1996), and not the vacuolar form represent the infectious 
phenotype of the parasite (Tan, 2008). For more accurate assessment and 
management of the parasite antibiotic resistance, future studies should focus 
on adapting antibiotic susceptibility assays for non-vacuolar morphological 





1.7 EPIDEMIOLOGY AND PREVALENCE 
Despite the discrepancy in diagnostic methods used, there has been a renewed 
interest in Blastocystis epidemiology (Tan, 2008), and considerable numbers 
of the reports are now available for geographical and demographic distribution 
of Blastocystis infection in human (Yoshikawa, 2012). 
1.7.1 Geographic distribution 
Prevalence of human Blastocystis infection is different among countries or 
among different regions in the same countries. In general, prevalence of 
Blastocystis is closely related to socio-economic development and higher in 
developing countries than in developed countries (Yoshikawa, 2012). The 
higher prevalence in developing countries is due to the poor sanitary 
infrastructure and/or low level of care to environmental hygiene in developing 
countries, because this parasite is known to be infected by the ingestion of the 
cyst form via fecal–oral route (Tan, 2008). High prevalence in human 
infection of the parasite was observed in developing countries, even using 
routine diagnostic technique in epidemiological survey. These results indicate 
that real prevalence of these countries is higher than that of reported data. 
Although the prevalence in developed countries is generally lower than 
developing countries, several countries such as Turkey (32.5%) and USA 
(22.9%) show relatively high prevalence. In contrast, the prevalence in 
Singapore (3.3%) and Japan (2.5%) is very low among developed countries 




1.7.2 Genotype distribution  
Genotyping studies have highlighted the diversity in Blastocystis in humans 
and other animal hosts (Parkar et al., 2007, Stensvold et al., 2009a). Of the 
nine definite STs detected in humans, only four are common – ST1, ST2, ST3, 
and ST4. Together, these make up around 90% of all human Blastocystis in 
surveys that involve subtyping (Alfellani et al., 2013b). ST3 is the most 
common ST in humans worldwide, and its occurrence is a frequent finding in 
analyses of ST distribution, irrespective of the geographic origin of the 
population (Forsell et al., 2012, Malheiros et al., 2011, Meloni et al., 2011, 
Nagel et al., 2012), supporting the idea that subtype distribution does not vary 
much between human populations from different geographical locations (Tan, 
2008). The other STs are only sporadically reported in humans and may well 
prove to be the result of zoonotic transmission, as they are mostly much more 
common in nonhuman hosts. Though rare in humans, ST5 seems to be 
frequently found in livestock, particularly cattle, pigs, sheep, and camels 
(Stensvold et al., 2009a). STs 6 and 7 have been detected primarily in ground-
dwelling birds, with only single ST7 samples from a goat and an NHP having 
been found in nonhuman mammalian hosts (Alfellani et al., 2013a). Other 
than in humans, ST8 appears to be restricted to arboreal NHPs from Asia and 
South America—it has not been reported from African NHPs (Alfellani et al., 
2013a). The STs with numbers above 9 are, as far as is known at present, 
confined to nonhuman hosts (Clark et al., 2013). 
In the recent literature, it is still matter of debate whether disease is ST related. 
There have been reports suggesting that pathogenic strains belong to subtypes 
1, 4 and 7 (Dominguez-Marquez et al., 2009, Eroglu et al., 2009, Stensvold et 
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al., 2009c, Stensvold et al., 2009b) while subtypes 2 and 3 are likely to be 
non-pathogenic (Eroglu et al., 2009, Stensvold et al., 2009b). However, mixed 
subtype infections (Nagel et al., 2012) and high degree of genetic (Stensvold 
et al., 2012b) and pathobiological diversity within subtypes (Mirza and Tan, 
2009) complicate the subtype-dependent pathogenecity hypothesis. Numerous 
studies suggested the existence of pathogenic and non-pathogenic variants in 
different STs (Dogruman-Al et al., 2009, Hussein et al., 2008, Souppart et al., 
2009). All these observations suggested that Blastocystis infection is likely not 
due to a particular ST even if some STs are frequently dominant in 
epidemiologic studies but rather to a conjunction of factors in the course of 
infection including environmental risk (transmission routes and contamination 
sources) and parasite (pathogenic and zoonotic potential) and host factors 
(genotype, immunity, and age) (Souppart et al., 2010). Further studies should 





1.8 HIGH RISK POPULATION 
Blastocystis was considered to be an opportunistic pathogen and a number of 
reports suggested that certain populations might be more susceptible to 
Blastocystis infections. 
1.8.1 Patientswith HIV/AIDS  
Patients immunocompromised due to HIV have been reported to have frequent 
Blastocystis infections (Garavelli et al., 1988, Kurniawan et al., 2009, Llibre 
et al., 1989). Blastocystis was found in the stools in significantly pathogenic 
amounts in AIDS patients and induced intestinal disorders such as diarrhoea, 
abdominal pain. Blastocystis had disappeared from the stools with resolution 
of symptoms after metronidazole treatment (Garavelli et al., 1988). A serious 
complication of HIV-related Blastocystis infections is disseminated disease, 
not frequently observed in otherwise healthy individuals (Kurniawan et al., 
2009). These studies illustrate the possible role of Blastocystis in causing 
diarrhoea observed in AIDS and related conditions. 
1.8.2 Cancer Patients  
Blastocystis is one of the most frequently isolated from stools of cancer 
patients (Tasova et al., 2000). Infections present with abdominal pain, 
diarrhea, and flatulence (Tasova et al., 2000). Multiple reports suggest that the 
parasite thrives in cancer patients (Horiki et al., 1999, Patino et al., 2008). 
Moreover, Blastocystis infections have also been reported in breast and 
colorectal cancer patients undergoing anticancer chemotherapy suggesting that 
the parasite is capable of surviving highly cytotoxic drugs, while debilitating 
immunosuppressive state induced by chemotherapy promotes its colonization 
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(Chandramathi et al., 2012). Therefore, Blastocystis colonization, particularly 
in patients undergoing anticancer therapy might contribute to post-
chemotherapy intestinal inflammation and increased permeability (Tsuji et al., 
2003).  
1.8.3 Pediatric Infections 
Children are reported to be highly susceptible to Blastocystis infections 
(Londono et al., 2009). High incidence of the parasite colonization is observed 
in immunocompetent (Londono et al., 2009) as well as immunocompromised 
(Noureldin et al., 1999). Children receiving corticosteroid therapy for 
nephrotic syndrome were also reported to be susceptible to Blastocystis 
infections (Noureldin et al., 1999). Associations of low socioeconomic status 
(Mehraj et al., 2008) and HIV positivity (Idris et al., 2010) with Blastocystis 
infections are also observed in pediatric patients. 
1.8.4 Animal Exposure 
Zoonosis is well reported in Blastocystis (Stensvold et al., 2009c, Yoshikawa 
et al., 2009). Blastocystis also has a higher prevalence in occupations 
frequently exposed to animals or animal products (Stensvold et al., 2009c). 
Contact with pigs, poultry, primates, and canines increases the risk of 
Blastocystis infections (Nagel et al., 2012, Navarro et al., 2008, Stensvold et 
al., 2009c, Yoshikawa et al., 2009). A recent study of symptomatic patients 
and their pets identified a concordance of parasite subtypes recovered from 
their stool samples suggesting a possible transmission of the parasite between 




Due to the lack of knowledge of Blastocystis pathogenicity, treatments are not 
often offered (Mirza and Tan, 2012). The mild nature of the disease and self-
limitation of symptoms also made clinicians skeptical of antibiotic 
prescription for Blastocystis infections (Stensvold et al., 2010), which may 
result in ongoing symptoms. Metronidazole, a position 1,5 nitroimidazole is 
the most commonly prescribed drug for the treatment of Blastocystis in which 
all other etiologies have been excluded (Tan et al., 2010). However, Multiple 
studies have suggested a large variation in the efficacy of metronidazole 
against Blastocystis has been reported ranging from 0%- 100% (Moghaddam 
et al., 2005, Nigro et al., 2003, Stensvold et al., 2008). Factors that might 
influence treatment outcomes include infection density, acquisition of 
mutations, resistance of certain developmental stages to metronidazole, and, 
most importantly, strain-to-strain variation in antibiotic susceptibility (Tan et 
al., 2010). Recent studies have identified metronidazole resistance in various 
Blastocystis isolates (Mirza et al., 2011a). Other antimicrobial agents which 
have been used to treat Blastocystis infection include co-trimoxazole and 
Paromomycin with varying results (Stensvold et al., 2010). Unfortunately, 
resistance to these drugs has also been reported (Stensvold et al., 2010). 
Though prudent use and appropriate management may be able to slow the 
selection of resistant strains, there is a pressing need to identify alternative 
therapeutic strategies targeting Blastocystis infections. Table 1.1 summarizes 












    




ST-1, ST-4 and ST-6 
 ·     500 mg TDS for 10 days 
  ·     1.5 g OD for 7 days 
    
 TMP-SMX ·     320 mg TMP and  
          1600 mg SMX  





ST-1, ST-4 and ST-6 
Nitazoxanide ·     500 mg BD for 3 days Intestinal 
symptoms 
                      __ 
Paromomycin ·     25 mg/kg TDS for 10 days Cutaneous 
symptoms 
                      __ 
Tinidazole     ·     2 g OD for 5 days            __                       __ 
Ketoconazole     ·     200 mg OD for 7 days            __                       __ 
 
TDS three times per day, BD twice daily, OD once daily 
 






Most studies advocating a lack of association between Blastocystis infections 
and intestinal disease focus on the distribution of the parasite between 
asymptomatic and symptomatic groups (Tan, 2008). They either indicate no 
significant difference between the prevalence of the parasite between the two 
groups or a higher incidence in the asymptomatic group. Such studies 
wrongfully assume that Blastocystis infections are biologically and 
pathogenically homogeneous. Clinical outcomes of parasitic infections are 
multi-factorial and are influenced by diverse host and parasite factors; 
therefore such studies may not truly reflect the pathogenic potential of the 
parasite (Tan et al., 2010). A recent study highlighted the fact that Blastocystis 
should be considered a potential pathogen as all patients noted severe symptoms 
in the absence of any other infectious agents (Roberts et al., 2013). However, 
evidence is still limited. Results of placebo-controlled treatment trials involving 
symptomatic patients infected solely with Blastocystis would better reflect 
Blastocystis pathogenic potential. There have been only two such reports and 
both concluding that chemotherapy successfully eradicated parasite with 
concomitant resolution of symptoms (Nigro et al., 2003, Rossignol et al., 
2005). One of these studies used metronidazole and reported clinical cure in 
88% of the patients in the treatment group with parasitological clearance in 
80% of the cases (Nigro et al., 2003). Similar outcomes were observed in 
studies using nitazoxanide (Rossignol et al., 2005) as a chemotherapeutic 
agent. Symptoms however persisted in patients whom Blastocystis infection 
could not be eradicated, suggesting that these patients were harboring 
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Blastocystis subtypes that are resistant or less responsive to the anti-protozoal 
agents used. Resolution of symptoms with concomitant parasite clearance in 
symptomatic patients with Blastocystis infection provides compelling 
evidence for the parasite’s pathogenic potential. However, the outcomes of 
such studies are also influenced by several factors (Tan, 2008). The drugs used 
in these studies are all broad-spectrum antibiotics and clinical cure could thus 
be attributed to the clearance of some unidentified enteric pathogen or due to 
lack of comprehensive exclusion of other possible enteric pathogens, 
especially viruses or bacterial toxins. 
1.10.2 Animal infection studies 
An absence of a good animal model to study has hindered our understanding 
of the pathobiology of the parasite and its pathogenic potential. Several 
experimental infection studies involving rats, mice, guinea pigs, and chickens 
have been reported (Tan, 2008). Animal surveys have reported that laboratory 
mice generally do not harbor Blastocystis suggesting that these are not suitable 
animal models for Blastocystis infections. Additionally, experimental 
infections in mice are generally mild and self-limiting.  Rats and domestic 
fowl, particularly chickens, are often infected with the parasite. Due to this 
reason, animal infection studies in recent years have focused particularly on 
rats and chickens as potential animal models for Blastocystis infections. More 
recently, the infectivity of various zoonotic Blastocystis genotypes from 
humans was tested in rats and chickens (Iguchi et al., 2007). Variability in the 
infectivity of rodent subtype 4 and avian subtype 6 isolates was observed. 
Curiously, isolates of subtype 3, the most common subtype found in humans 
could not infect chickens and rats, whereas avian subtype 7 isolates could only 
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infect chickens, suggesting that these subtypes exhibit some level of host 
specificity. In another study, Blastocystis isolates from symptomatic and 
asymptomatic individuals were used to experimentally infect rats (Hussein et 
al., 2008). Isolates from symptomatic patients induced moderate to severe 
pathological changes in infected rats, whereas parasites from asymptomatic 
individuals induced only mild pathology. Authors concluded that the subtype 
1 isolate, that induced mortality in 25% of rats, was pathogenic, and 
pathogenic potential for subtypes 3 and 4 was variable. A recent Blastocystis 
animal infection study, using rat as host reported up-regulation of pro-
inflammatory cytokine interferon-gamma, interleukin (IL)-12 and tumor 
necrosis factor alpha 2-3 weeks post infection (Iguchi et al., 2009). Despite 
significant up-regulation of pro-inflammatory cytokines, local tissue pathology 
was moderate and the authors suggested that the subtype 4 isolate used in their 
study was a weak pathogen. 
The results of recent animal infection studies are encouraging. However, the 
observation that rodents do not naturally harbor subtypes other than subtype 4 
while birds harbor mostly subtypes 6 and 7 may limit the usefulness of these 
animals in infection studies (Stensvold et al., 2009a). The lack of pathology 
might therefore reflect resistance to colonization in rats or chickens rather than 
avirulence of the parasite. 
1.10.3 In vitro, host-pathogen interaction models 
In the absence of a relevant animal model to study Blastocystis infections, in 
vitro culture systems provide useful alternatives to study Blastocystis–host 
interactions. These in vitro studies have shed lights on many aspects of 
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Blastocystis pathogenesis, such as induction of intestinal barrier compromise, 
immune evasion, immune response and virulence factors. 
Evidence for Blastocystis-mediated barrier compromise has been reported 
(Puthia et al., 2006, Mirza et al., 2012b). Using transwell systems, it was 
reported that a rat isolate of Blastocystis (ST4) mediated barrier dysfunction 
evidenced by decrease in transepithelial resistance and increase in 
transepithelial flux in IEC-6 cells. Pretreatment with caspase inhibitors failed 
to rescue Blastocystis-induced changes, suggesting that apoptosis was not a 
major factor contributing to the loss of barrier function (Puthia et al., 2006). It 
has been recently observed that cysteine proteases of Blastocystis disrupt 
Caco-2 monolayer tight junctions in a Rho-kinase (ROCK)-mediated fashion 
resulting in colonic epithelial barrier compromise and that the pathological 
outcomes are mitigated when components of the Rho/ROCK pathways are 
blocked by the inhibitors Fasudil and Simvastatin (Mirza et al., 2012b).  
Recent studies have provided evidence that the parasite is capable of 
modulating host immune response to its own advantage. At mucosal surfaces 
of the gastrointestinal tract, secretory immunoglobulin A (sIgA) is the major 
immune defense against microbial pathogens and their toxins. In the 
Blastocystis study, both spent media and cell lysates from subtypes 4 and 7 
parasites were able to degrade human sIgA (Puthia et al., 2005). A recent 
study observed that Blastocystis ST-7 (B) modulates host anti-microbial nitric 
oxide (NO) response (Mirza et al., 2011b). ST-7 (B) was found to be highly 
susceptible to nitrosative stress compared to an isolate of ST-4. In order to 
contain NO to a tolerable concentration in its microenvironment, it was found 
that ST-7 (B) down-regulated epithelial inducible nitric oxide synthase and 
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reduced epithelial, anti-parasitic NO secretion, suggesting suppression of the 
innate immune response of human enterocytes by Blastocystis. Nitrosative 
stress generated by enterocytes in the gut lumen keeps luminal colonization of 
pathogens in check (Eckmann et al., 2000). Suppression of enterocyte NO 
production not only helps Blastocystis to survive and reproduce, but it might 
also facilitate the survival of pathogenic microorganisms in the immediate 
vicinity. Frequent reports of Blastocysits co-infection with other pathogens 
support this idea (Hu et al., 2008, Kurniawan et al., 2009, Rayan et al., 2007).  
Although reports of obvious mucosal inflammatory changes in human gut are 
inconclusive (Zuckerman et al., 1994), Blastocystis infections do induce host 
immune responses (Chandramathi et al., 2012, Iguchi et al., 2009, Puthia et al., 
2008). Recent studies have shown that the parasite causes up-regulation of 
pro-inflammatory cytokines IL-8 in human T-84 colonic epithelium mediated 
by NF-kB (Puthia et al., 2008). Similarly, up-regulation of IL-8 and GM-CSF 
has also been reported in the parasite-infected HT-29 colonic cells (Long et al., 
2001). 
Collectively, in vitro studies in recent years have advanced our understanding 
in Blastocystis pathogenic mechanisms as well as virulence factors. However, 
many gaps remained unfilled. For example, one important aspect of the 
parasite pathogenesis, adhesion, has never been investigated. Another 
challenge for characterizing specific virulence factor is the lack of a workable 
transfection system for Blastocystis to facilitate gene knock-out and 
expression studies (Tan and Mirza, 2012) . The advances in such in 
experimental technologies will help elucidate pathogenic factors of 
Blastocystis in the future.   
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1.11 OBJECTIVES OF THE PRESENT STUDY 
Significant progress has been achieved in the field of Blastocystis research 
since its discovery as far back as the early 1910s. However, knowledge of its 
cell biology and virulence factors is still limited, which has impeded our 
understanding of its pathogenic potential and clinical relevance (Tan and 
Mirza, 2012). Major gaps remain to be filled in the basic biology of 
Blastocystis to gain deeper insights into its pathogenesis. So far, Blastocystis 
adhesion to epithelial cells, an important aspect of its pathogenesis, has never 
been studied. The current study will focus on the pathobiology of Blastocystis 
adhesion to host cells and investigate its role in mediating pathogenesis. Using 
in vitro approaches, the study will first identify a metronidazole resistant strain 
of Blastocystis capable of attaching to human intestinal epithelial cells and 
inducing direct pathological changes. The study will then establish a 
convenient adhesion assay for an in-depth analysis of the physiochemical 
factors involved in Blastocystis adhesion to Caco-2 cells. Following adhesion, 
the parasites produced several aspects of pathology in the host cells. The study 
will also characterize the host responses in the aspects of intestinal barrier 
defect and apoptotic effects induced by the parasite. Strain-to-strain variations 
in pathogenicity have been proposed to contribute to the clinical controversies 
concerning the parasite pathogenic potential (Mirza and Tan, 2012). As 
attachment is generally an important aspect of virulence factor affecting the 
infection outcomes (Twu et al., 2013), using a range of various strains, the 
study will address the question whether the attachment properties affect their 
pathogenicity. In light of treatment failures in Blastocystis infections with 
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commonly used antiprotozoal agents (Roberts et al., 2013), the study will also 
evaluate alternative treatment options by targeting adhesion, and apply the 
adhesion inhibitor to see its protective effects against Blastocystis-induced 
pathology. 
Blastocystis adhesion to epithelial cells, which plays an integral role not only 
for parasite survival, but also for establishing and maintaining infections, has 
received little attention. An understanding of the basic pathobiology of 
Blastocystis adhesion and factors involved in it is necessary to evaluate the 
virulence as well as clinical relevance of Blastocystis. Using a clinically 
important strain isolated from a symptomatic patient, the study will first test 
whether Blastocystis is able to attach to human intestinal epithelial cells and 
induce subsequent pathological changes in the host cells. The study will 
develop a convenient and easily-manipulated adhesion assay to investigate the 
molecular mechanisms involved in Blastocystis adhesion to Caco-2 cells and 
elucidate possible molecules mediating the attachment. Such an understanding 
will provide targets for therapeutic treatment and prevention of Blastocystis 
infections. The information acquired here will be also used for further 
investigation of the role of adhesion in mediating pathogenesis.  
After establishing contact with the intestinal epithelium, the parasites survive 
and thrive in the gut and may lead to intestinal symptoms such as diarrhea, 
which indicates a functional disturbance of the intestine. How Blastocystis 
infection leads to the diseases is largely unknown. Host responses upon 
parasite adhesion in the changes of intestinal barrier function and enterocyte 
apoptosis will be characterized. The molecular basis for Blastocystis–induced 
epithelium injury is largely unknown. The study will provide for the first time 
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a comprehensive analysis of the changes in the apical junctional complexes 
and especially the tight junction proteins. As a role of apoptosis in barrier 
perturbation has been proposed in several studies, the effects of Blastocystis 
on enterocyte apoptosis will be evaluated. Besides, the study will also address 
the question whether apoptosis contributes to Blastocystis–induced barrier 
compromise. 
Asymptomatic carriage and inconsistent outcomes of infection continue to 
contibute to the pathogenic potential of the parasite (Stensvold et al., 2010). 
Several studies in recent years suggest that strain-dependent variations in 
Blastocystis pathogenicity might have contributed to the controversy (Mirza 
and Tan, 2012). However, direct evidence of strain-to-strain variations in 
pathogenicity with a convincing infection model is still limited. Identification 
of virulent and avirulent strains of the parasite might provide an explanation 
for the inconsistencies in the clinical outcome of Blastocystis infections. As 
attachment of the parasite to host cells is a critical step for the 
pathophysiological events in infection and might be an important 
characteristic of virulence, the study will evaluate the attachment properties of 
various strains from different subtypes, and compare whether they differ in 
their capability in attachment and how these variations would affect their 
pathogenicity. 
Another issue concerning the pathogenic potential of Blastocystis is treatment 
failure (Moghaddam et al., 2005, Roberts et al., 2013, Stensvold et al., 2008). 
Metronidazole is the treatment of choice, but physicians are often skeptical 
about prescribing antibiotics for Blastocystis infections (Mirza et al., 2011a). 
Recent studies have provided evidences of drug resistance of clinical isolates 
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(Mirza et al., 2011a). The lack of efficacy of commonly used antimicrobial 
regiments in the treatment of Blastocystis demonstrates the need for further 
research into alternative treatment options for Blastocystis infection. Since 
parasite attachment to the epithelial lining of the small intestine is a 
prerequisite in initiating and maintaining an infection, adhesion would serve as 
an appealing target. The study will utilize the knowledge acquired regarding 
the molecular mechanisms in the adhesion process of a metronidazole-
resistant isolate of Blastocystis and select the effective adhesion modulator and 
apply it in host-pathogen interaction to see whether the pathogenic effects 
exerted by Blastocystis could be ameliorated. The study will provide basis for 
evaluating the therapeutic potential of antiadhesives in Blastocystis infections 
and might facilitate future design of preventative and interventional strategies 
against this disease. 
Additionally, studies have implicated impaired attachment and compromised 
virulence as a possible fitness cost of drug resistance (Ben-Ami et al., 2012). 
The interplay between drug resistance, fitness and virulence in Blastocystis 
has never been investigated. Using various strains which exhibit different 
levels of adhesion, the possible association of attachment with drug 
susceptibility will be tested. This knowledge will yield new insights into 
parasite biology from an evolutionary point of view. 
In summary, the objectives of the current proposal focus on unraveling the 
role of adhesion in pathobiology of Blastocystis and determining the molecular 
mechanisms involved in adhesion. Thus, the specific aims for this study are: 
1. To provide evidence of adhesion of Blastocystis to human intestinal 
epithelial cells and develop an easily-manipulated adhesion assay. 
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2. To determine extrinsic and intrinsic factors involved in Blastocystis 
adhesion to Caco-2 cells, from both Blastocystis and host cells perspectives. 
3.  To screen for effective adhesion modulator. 
4. To characterize host responses upon adhesion leading to functional 
disturbance of the intestinal barrier: 
a. To identify the molecular alterations of the apical junctional complex. 
b. To evaluate Blastocystis–induced enterocyte apoptosis and its role in 
mediating barrier compromise. 
5. To determine whether adhesion is important in mediating Blastocystis–
induced barrier dysfunction by characterizing the intra- and inter-subtype 
variations in Blastocystis adhesion and investigating how it would affect their 
virulence. 
6. To evaluate the therapeutic potential of adhesion inhibitors by applying the 
adhesion modulator in a pathogenesis study.  










ADHESION OF BLASTOCYSTIS TO 
ENTEROCYTES AND DEVELOPMENT OF 







After introduction of Blastocystis to the gastrointestinal tract by faecal-oral 
route (Tan, 2008), a specific adherence event is required for the parasite to 
establish and maintain itself to resist shear stresses resulting from peristaltic 
flow, as it remains extracellular throughout infection (Boorom et al., 2008). 
Besides, initial attachment of parasites to host cells is a prerequisite for the 
pathophysiological events in infection (Joe et al., 1998). Yet nothing is known 
about Blastocystis adhesion to host cells. The study firstly investigated 
whether Blastocystis could adhere to intestinal epithelial cells and 
characterized the basic features of Blastocystis adhesion.  
A thorough examination of the mechanism of host-parasite adhesion will be 
important for our understanding of its pathogenesis, and also will help us 
design therapeutic options targeting adhesion in the future (Chen et al., 1998). 
Identification of molecular mechanisms involved in adhesion between host 
and parasite requires a robust, easy-to-manipulate assay for quantifying 
adhesion. This in vitro assay will provide the stepping stone for more detailed 
investigation of parasite pathogenic mechanisms. 
Adhesion of Giardia, Trichomonas and Acathomoeba has been measured 
qualitatively (discriminate cell types) and quantitatively by metabolic 
radiolabeling of parasites (Fichorova et al., 2006, McCabe et al., 1991, 
Morton et al., 1991) or counting with a haemocytometer or under microscopy 
(Magne et al., 1991). But these methods are laborious, time-consuming and 
therefore not suitable for extensive analysis with various conditions. More 
importantly, for Blastocystis–host interaction, it would not provide a good 
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resolution between the two cell types, as the morphological distinction was not 
obvious especially after co-incubation and washing steps. Thus, to accurately 
visualize and count the number of parasites in a mixed cell population, a cell 
tracker dye is required to label the parasites. 
CFSE, carboxyfluorescein diacetate, succinimidyl ester, is a well-retained cell-
tracing reagent (Lyons et al., 1994). CFSE passively diffuses into cells. It is 
colorless and nonfluorescent until the acetate groups are cleaved by 
intracellular esterases to yield highly fluorescent carboxyfluorescein 
succinimidyl ester. The succinimidyl ester group reacts with intracellular 
amines, forming fluorescent conjugates that are well retained. Excess 
unconjugated reagent and by-products passively diffuse to the extracellular 
medium, where they can be washed away.Therefore, CFSE would be suitable 
for staining Blastocystis to discriminate host cells and parasites. 
Caco-2 cells, derived from a human colon adenocarcinoma, has been used 
extensively over the past couple of decades as an in vitro model system to 
study various biological interactions of parasitic pathogens and host cells, such 
as the adhesion, invasion, and cytotoxicity of pathogens (Humen et al., 2011, 
Joe et al., 1998, Katelaris et al., 1995, Li et al., 1994, Magne et al., 1991, 
Sambuy et al., 2005). Caco-2 cells are physiologically closer to the natural 
targets of Blastocystis, as in culture, they exhibit the differentiated features of 
enterocytes, such as cell polarity, apical brush border (Rigothier et al., 1991). 
Caco-2 model has been shown to be well suited to investigations of the 
mechanisms involved in Blastocystis–induced intestinal barrier function 
(Mirza et al., 2012b). Thus, this study would also use Caco-2 cell line for 
investigations of Blastocystis adhesion.  
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Using Caco-2 epithelial monolayers and ST-7 (B), a metronidazole-resistant 
(Mzr) Blastocystis isolate recovered from a symptomatic patient (Mirza et al., 
2011b), the current study was designed to determine whether Blastocystis 
could adhere to intestinal epithelial cells and investigated whether adhesion of 
Blastocystis causes lesions in the cells upon adhesion. In this chapter, various 
microscopic techniques, including differential interference microscopy, 
confocal microscopy, scanning electron microscopy, would be used to 
visualize adhesion of the parasite to host cells, to examine the features of 
adhesion and characterize the pathogenic effects it exerts on Caco-2 cells. 
Also, by CFSE labelling of the parasites, an in vitro adhesion assay would be 
established to facilitate further study of the factors involved in adhesion 




2.2 MATERIALS AND METHODS 
2.2.1 Culture of Caco-2 colonic epithelial cell line 
All Blastocystis-host interaction experiments were performed using Caco-2 
human colonic cell line (ATCC). Caco-2 stock cultures were maintained in T-
75 flasks in a humidified incubator with 5% CO2 at 37°C. Cell cultures were 
grown in Dulbecco’s modified Eagle’s medium (HyClone) supplemented with 
10% heat-inactivated fetal bovine serum (HyClone) and 1% each of sodium 
pyruvate, MEM and antibiotic Penicillin-Streptomycin (Gibco; final 
concentrations are 100 units/mL of penicillin and 100 µg/mL of streptomycin). 
Culture health was evaluated using trypan blue assay and only cultures with 
>95% viability, were used for the experiments. Cells were trypsinzed with 
0.25% trypsin-EDTA. For immunofluorescence, confocal microscopy and 
scanning microscopy experiments, Caco-2 monolayers were cultured on Poly-
L-lysine-treated 15mm glass coverslips placed in standard 24-well culture 
plates.  
2.2.2 Parasite culture 
Axenized Blastocystis isolate B was previously recovered from a symptomatic 
patient at Singapore General Hospital (Ho et al., 1993). It belonged to ST-7 
according to recent classification system (Stensvold et al., 2007b). Stock 
cultures were maintained as described previously (Mirza et al., 2011a). In 
brief, the parasites were maintained in 10 ml of prereduced Iscove's modified 
Dulbecco's medium (IMDM) containing 10% heat-inactivated horse serum in 
an anaerobic jar (Oxoid) with an AnaeroGen gas pack (Oxoid) at 37°C. 
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2.2.3 Confocal microscopy 
To visualize the spatial relationship between Blastocystis and Caco-2 
monolayers after attachment, Caco-2 monolayers were grown to confluency 
on glass converslips and were then conincubated for 1 h with Blastocystis live 
cells. After 1h incubation, cells were washed 5 times with sterile PBS and 
fixed with 2% formaldehyde for 30 min, blocked with 10% FBS for 2 hours at 
room temperature and then incubated with legumain antibody-mAb1D5 (Wu 
et al., 2010), a murine IgM monoclonal antibody produced in this laboratory 
(Tan et al., 1996a) and secondary Alexa Fluor® 594 goat anti-mouse IgM 
(red). Phalloidin-FITC (green) was used to label F-actin of Caco-2 cells and 
DAPI (blue) for nuclei. All monolayers were mounted onto glass slides using 
fluorescence mounting media (VECTASHIELD) before being observed using 
confocal microscope (Olympus FLUOVIEW-FV100; Olympus, Japan).  
2.2.4 Scanning electron microscopy 
For SEM, Caco-2 monolayers were grown to confluency on glass converslips 
and were then conincubated with Blastocystis live cells. After 1h incubation, 
cells were washed 5 times with sterile PBS and fixed with 2% Glutaradehyde 
(double-strength fixative) for 1 h at 4°C; after three times of washing with 
sterile PBS, cells were post-fixed with 1 % Osmium Textroxide for 2 h at 
room temperature (RT) followed by another 3 times of washing with sterile 
PBS. Dehydration was performed with 25%, 50%, 75% and 95% ethanol 
sequentially, for 5, 10, 10 and 10min, respectively; and with 100% ethanol for 
three rounds, 20min each. Samples were transferred to critical point dryer for 
infiltration with CO2 then the dried specimen were mounted on SEM stub and 
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transfer stubs to sputter-coater to coat sample with a thin layer of gold. The 
samples were then viewed under SEM.  
2.2.5 Fluorescent labeling of live Blastocystis parasites with CFSE  
1-day-old Blastocystis ST-7 (B) isolate culture was used for CFSE labeling. 
Blastocystis pellets were collected and CFSE stain was added at a final 
concentration of 20μM. After 15min incubation at 37°C, pre-warmed sterile 
PBS was added and spun down at 3,000 rpm for 10min to get rid of the 
excessive reagent. With wet mount, the stained parasites were then for 






2.3.1 Apical attachment of Blastocystis to epithelial cells 
When applied apically onto Caco-2 monolayers, attachment of Blastocystis to 
the epithelial monolayer could be readily seen under confocal microscopy. 
Differential interference contrast image clearly illustrated individual ring-
shaped Blastocystis cells with diameters about 10μm (Fig. 2.1), distinct from 
the Caco-2 cells. From the corresponding z-projections of the XY view, 
numerous parasites were shown to adhere closely to the apical regions of 
epithelial cells.  
Double fluorescence labelling of Blastocystis with 1D5 antibody targeting 
parasite surface-localized legumain, and host cells with Phalloidin-FITC more 
clearly demonstrated their spatial relationship. The close contact at the 
interface between the host cell and the parasites could be seen (Fig. 2.2A). 
Notably from the 3-D reconstruction of image slices from apical to basal of 
the speciment, parasites were found to preferentially adhere to the junctional 








Fig. 2.1 Confocal differential interference contrast micrographs of 
Blastocystis in contact with Caco-2 cells. Typical Blastocystis cells (yellow 
arrows) are seen among larger Caco-2 epithelial cells. The micrograph 
corresponds to an optical plane at the top of the epithelial monolayer. In XZ 
and YZ transverse sections, the parasites are shown in close proximity (black 
arrowheads) to the apical regions of the epithelial cells.  
 







Fig. 2.2 Fluorescence confocal micrographs of Blastocystis in contact with 
Caco-2 cells. (A) The micrograph corresponds to an optical plane at the top of 
the epithelial monolayer Blastocystis ST-7 (B) is labeled with Blastocystis 
legumain antibody-mAb1D5, a murine IgM monoclonal antibody and 
visualized with secondary Alexa Fluor® 594 goat anti-mouse IgM (red). 
Caco-2 cells are stained with actin-specific Phalloidin-FITC (green) and DAPI 
(blue). Scale bar = 10 μm (B) Representative confocal micrographs illustrating 
Blastocystis ST-7 (B) preferentially adhered to the junctional area of Caco-2 
monolayers. Attachment of Blastocystis ST-7 to Caco-2 apical side could be 
seen clearly. Parasites could be seen intimately adhering to the epithelium and 
preferentially to the cell-cell junction site. The percentage of Blastocystis that 
located at the junctional area was 78% ± 4.6% of all attached cells (values are 
means ± SE). Scale bar = 10 μm  
 
Fig. 2.2A was adapted from Tan and Mirza, (2012)  
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2.3.2 Determination of Blastocystis attachment to Caco-2 cell monolayer 
by Scanning Electron Microscopy 
The untreated Caco-2 was shown to be a confluent monolayer under scanning 
electron microscopy, healthy and intact with clear borders between the cells. 
In contrast, significant changes were noticed in the monolayers attached with 
Blastocystis parasites. The cells appeared flat and exhibited a number of holes 
on the surface, indicating cell leisions (Fig. 2.3A, red arrows). Quite a few 
parasites could be seen adhering on top and again, they appeared to mainly 
bind along the regions reassembling the junctional areas (Fig. 2.3A).  
At a higher magnification, dense brush border were found on the surface of 
Caco-2 cell, which is a characteristic of mature intestinal epithelial cells. 
However, this could not be seen in the infected monolayer with Blastocystis 
(Fig. 2.3B). The parasites established close contact with the epithelium and 
caused lesions at the interface (Fig. 2.3B). Interestingly, membrane extensions 
were found between the parasite and the host. With methylene blue staining, 
examination of semi-thin sections of monolayers also revealed loss of brush 





Fig. 2.3 Scanning electron micrographs of Blastocysitis attached to Caco-2 
monolayers. Caco-2 cells were incubated with parasites for 10 h, normal 
culture media was used as a negative control. After 10 hours, unbound 
parasites were washed away and samples were fixed with 2% Glutaradehyde 
and processed for SEM. Compared to negative control, attachment of 
Blastocysitis to Caco-2 cells caused significant changes in the monolayer at 10 
h post-infection. In (A), parasites attached to the monolayer intimately and 
preferentially to the junctional area (red arrows). The affected epithelial cells 
appeared to be damaged and exhibited holes on the cell surface and leisions 
especially at the junctional area. In (B), cells in the negative control have 
dense brush borders on the surface, Blastocysitis treatment seemed to distort 
microvilli on the cell surface. It also could be noted that filipod-like structures, 
with lengths ranging from 2-6 μm, extended at the host-parasite interface. 
Scale bar for (A) =20 μm, Scale bar for (B) = 5 μm 
 
Fig. 2.4 TEM semi-thin sections illustrating Blastocystis on top of the 
epithelium. Light micrographs of a 1 μm section of Caco-2 monolayers 
without parasites (Control) and after incubation with ST-7 (B). A typical 
Blastocystis cell was found to adhere on top of the epithelium. The treated 
monolayer showed loss of brush borders at the apical regions compared to 
untreated control. Methylene blue stain. Scale bar = 20 μm 
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2.3.3 Development of an adhesion assay with CFSE staining for 
Blastocystis isolate ST-7 (B) 
The results above have shown that Blastocystis readily adhered to human 
epithelium. To develop a simple and fast adhesion assay to quantify the 
number of parasites adhered, the first step is to label the parasites and the host. 
CFSE is a well-retained cell-tracing reagent widely used for live cell imaging 
and in vivo tracing and was therefore tested for Blastocystis labelling. The 
results showed that Blastocystis well retained the stain and light up brightly 
when probed with CFSE (Fig. 2.5). Most of the healthy cells were stained in 
round shape by the green fluorescence; some debris or dead cells also got 
stained but their irregular shapes could be distinguished from the healthy and 
intact cells based on the DIC images and thus be excluded (Fig. 2.5, red 
arrows). Therefore, CFSE labeling could be used to trace Blastocystis live 
cells. Also, CFSE at the concentration used to label the parasites was not toxic 
to the cells and did not alter the metabolic activity of Blastocystis (Results not 
shown). 
The pre-stained parasites were then co-incubated with Caco-2 cells for 
attachment assay. After washing and fixing, the host cells were stained with 
DAPI. When viewed under the green fluorescence channel, no green staining 
was detected for the negative control; in monolayers treated with ST-7 (B) 
isolate, bright green was detected on top of the host cells, indicating adherent 
parasites, as could be seen in the DIC image (Fig. 2.6). Interestingly again, it 
could be noted that parasites preferred to adhere at the sites of pericellular 
junctions (Fig. 2.6).  
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As shown in Fig. 2.6, in a particular field, the number of host cells could be 
counted from DAPI staining, the number of attached parasites visualized by 
green was also countable. Therefore a ratio of attached parasites with host 
cells could be calculated and thus quantitiated. In order to include a larger 
sample size, images were taken under 200× magnification (Fig. 2.7), so that 
more host cells could be captured for better statistical strength of the image 





Fig. 2.5 Representative confocal micrograghs showing live Blastocystis 
parasites after CFSE staining. 1-day-old Blastocystis ST-7 (B) isolate 
cultures were stained with CFSE and viewed under confocal microscope. The 
parasite could retain the stain and light up brightly when probed with CFSE. 
Most of the healthy cells were stained by the green fluorescence in round 
shape; some debris or dead cells also got stained but their irregular shapes 
could be distinguished from the DIC images (red arrows). Therefore, CFSE 
labeling could be used to trace Blastocystis live cells. Images were taken at a 









Fig. 2.6 Representative confocal micrograghs showing CFSE-labeled 
Blastocystis parasites adhering to Caco-2 cells. 1-day-old Blastocystis ST-7 
(B) isolate cultures were stained with CFSE and co-incubated with Caco-2 
cells, washed, and fixed for viewing under confocal microscope 
(maginification 1500×). From both the DIC images and the merged images, 
ST-7 (B) were found to adhere at the junctional area of Caco-2 cells, as shown 
the bright green staining (red arrows), whereas negative control did not show 





Fig. 2.7 Representative confocal micrograghs showing CFSE-labeled 
Blastocystis parasites adhering to Caco-2 cells at a lower magnification. 
One-day-old Blastocystis ST-7 (B) isolate cultures were stained with CFSE 
and co-incubated with Caco-2 cells, washed, and fixed for viewing under 
confocal microscope (maginification 200×).  Green dots represented adherent 
parasites on top of Caco-2 cells. Absence of parasites was noticed in zones of 





Attachment of Blastocystis, though being a crucial step to establish 
colonization and infections for an extracellular parasite, has never been 
studied (Tan and Mirza, 2012). By using a Blastocystis isolate from a 
symptomatic human patient, this isolate was found to readily adhere to the 
Caco-2 human intestinal epithelial cell line, and induce various aspects of 
pathological changes. The current study provided the first visual evidences of 
Blastocystis adhesion and that adherent parasites induced direct cell damage. 
By TEM and SEM, Caco-2 cells exposed to Blastocystis underwent a series of 
changes. The features of cell lesions were readily seen, including 
accumulation of actin at the cell junctions, loss of microvilli, and disruption of 
the cell membrane. These morphological and structural alterations induced by 
the adhesion of parasites may be involved in pathological processes of 
diarrhea by affecting intestinal cell function (Puthia et al., 2006). For example, 
loss of apical brush borders might lead to malabsorption and thus might be 
related to diarrhea in some patients infected with Blastocystis. The 
morphological data with SEM and confocal microscopy clearly demonstrated 
the intimate contact between the parasite and the host cells, suggesting that 
there might be molecules of both host and parasite origins mediating their 
contact. This will be investigated in detail in Chapter 3. Besides, surface 
features of membrane extensions were observed. The function of this structure 
is unknown yet. In Entamoeba, pseudopods, filipods have also been observed 
and involved in trophozoite adhesion (Rigothier et al., 1991). 
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Another notable observation from the SEM and confocal images was the 
preferential attachment of the parasites at or near the intercellular junction. 
Similar observations have also been made in other pathogens. Campylobacter 
concisus UNSWCD strain was shown to preferentially attach to intercellular 
junctional spaces (Man et al., 2010). Such spatial distribution was 
concomitantly associated with a striking barrier disruption, and a loss of tight 
junction proteins ZO-1 and occludin in Caco-2 monolayers after C. concisus 
UNSWCD infection. It was suggested that the observed preferential 
attachment may allow rapid disruption of tight junctions, either by direct C. 
concisus–host contact or by release of secretory proteins directly to the target 
sites, resulting in damage to the structural integrity and function of intestinal 
epithelial cells. Naegleria fowleri also exhibited a tropism for cell junction 
regions and led to disruption of tight junctions (Shibayama et al., 2013). The 
same pattern of attachment at the cell junction has been seen in Brachyspira 
pilosicoli infection both in vitro and in vivo and it was suggested that this 
distribution may facilitate penetration of the epithelial layer (Naresh et al., 
2009). Blastocystis has not been shown to be invasive, but it is reasonable to 
speculate that preferential adherence of cytopathic Blastocystis strains to 
intercellular junctions might facilitate tight junction disruption leading to 
barrier dysfunction. The effects of Blastocystis on TJ changes have received 
little attention so far and will be described in detail in Chapter 4. 
Altogether, these observations strongly suggest that Blastocystis is directly 
cytopathic. These data not only provide insights into the features and 
consequences of microbial interactions with human intestinal epithelia, but 
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may also be relevant to the mechanisms by which Blastocystis causes 
diarrhoeal disease in human infections. 
Moreover, the study also developed an easy and fast adhesion assay for future 
investigations of possible factors involved in adhesion. Labeling the parasites 
is a necessary step in adhesion experiments to differentiate the parasite from 
the cell monolayer employed. Generally, radioactive labeling of the parasites 
is done with thymidine (Alderete et al., 1985, McCabe et al., 1991) or 
methionine (Krieger et al., 1990). This type of labeling requires radioisotopes 
and specialized and expensive equipment, like a cell harvester and scintillation 
counter; and there is a hazard in the handling of ‘‘hot’’ scintillation fluids 
(Rojas et al., 2004). These problems led to the search for non-radioactive 
alternatives for adhesion assays. In the current study, the CFSE staining was 
found to be suitable for Blastocystis labeling and can be used to discriminate 
the parasite from Caco-2 cells, and therefore allowed the detection and 
quantification of parasites adhering to the intestinal cell monolayer. This 
process for labeling and detection is safer than a radioactive label, and much 
easier to be assayed. This convenient method would be suitable for detailed 
investigations of molecular mechanisms of host-parasite interactions. 
It should be noted that ST-7 (B) is not only adhesive, but also Mz resistant. It 
will be particularly difficult to manage infections with such strains, 
demonstrating the need for new treatments. It is hoped that the use or 
adaptation of this adherence assay will prove useful in screening potential 
therapeutic or prophylactic compounds aimed at inhibiting parasite adherence 












FACTORS INVOLVED IN 
BLASTOCYSTIS ADHESION TO 




Adherence of microorganisms to the intestinal cells is a prerequisite for 
colonization and infection of the intestinal epithelium (Twu et al., 2013). A 
thorough understanding of mechanisms of parasite-epithelial cell association 
requires study of this process under defined conditions. The in vitro adhesion 
assay developed in Chapter 2 would enable the study of various parameters 
influencing in the adherence of Blastocystis to this highly differentiated, Caco-
2 cell line.  
Studies carried out in recent years on the process of parasite-host cell 
interaction in common protozoas such as Giardia, Entamoeba and 
Trichomonas have indicated that adherence is time, temperature, and dose 
dependent (Katelaris et al., 1995, Li et al., 1994, Mendoza-Lopez et al., 2000) 
and that it is a multi-factorial process in which microtubules, microfilaments, 
different adhesins (Arroyo et al., 1992), cysteine proteinases (Arroyo et al., 
1989). A comprehensive summary of common structures or molecules 
mediating the attachment of protozoan parasites to host cells was listed in 
Table 3.1. Among these factors investigated, recognition of host cell 
glycolipids and/or glycoproteins by a variety of microbial pathogens appears 
to be significant in adherence of organisms to their target tissues and in 
determination of tissue tropism, species specificity, and genetic specificity of 
pathogens (Hashim et al., 2006).  
However, none of these factors mentioned above has been investigated in 
Blastocystis adhesion to host cells. To mimic some in-vivo conditions in the 
colon, where Blastocystis usually colonize, it’s important to investigate 
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possible effects of physicochemical factors on attachment, i.e. temperature, 
rocking conditions. The above adhesion assay could be done with 
physiological manipulation for different experiment conditions.  
An understanding of factors controlling these primary interactions between the 
pathogen and the enteric cell surface not only will shed new light on the 
pathogenesis of Blastocystis, but also will be crucial for developing new 
therapeutic strategies aimed at preventing the initial colonic establishment of 
this pathogen. Compounds that appear to specifically inhibit attachment will 
serve as promising tools for future identification of the cellular machinery 
involved in Blastocystis attachment. 
To get a more comprehensive understanding about Blastocystis adhesion to 
host cells as well as to screen for effective adhesion modulators, in this chapter, 
the in vitro adherence assay developed in Chapter 2 would be used to 
characterize conditions for Blastocystis adherence to intestinal epithelium, to 
determine whether the binding is time-, dose- and temperature-dependent, and 
whether recognition of carbohydrate moieties on the surface of the corneal 
epithelial cells may play a role in Blastocystis adhesion to Caco-2 cells. The 
respective roles of the cytoskeleton, cysteine proteases and lipid raft structures 




Table 3.1 Host or parasite structures or molecules mediating attachment in 
common protistan parasites 
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3.2 MATERIALS AND METHODS 
3.2.1 Culture of Caco-2 colonic epithelial cell line 
Caco-2 stock cultures were maintained as previously described in Chapter 2. 
For adhesion assay, Caco-2 monolayers were cultured on Poly-L-lysine-
treated 15mm glass coverslips placed in standard 24-well culture plates. In 
order to synchronize cells before experiments, all cultures were serum-starved 
overnight in antibiotic-free and serum-free DMEM. 
3.2.2 Parasite culture 
Axenized isolates of Blastocystis B was maintained as previously described in 
Chapter 2. 1-day-old healthy Blastocystis parasites were used in all 
experiment. 
3.2.3 Coincubation with different modulators and attachment assay 
1-day-old Blastocystis were collected and stained with CFSE at a final 
concentration of 20 M. Pellets were then added with PBS and centrifuged 
@3,000 rpm for 10min to get rid of the stain and were diluted with pre-
warmed PBS for inoculation onto Caco-2 cells. Attachment was assayed with 
coverslips in 24-well tissue culture plates. Unless stated otherwise, for each 
well, 1.25 × 107 parasites were added onto Caco-2 cell monolayer and 
incubated together for 1 hour at 37°C. Because at this time point and dosage 
for parasite-host incubation, Caco-2 cell monolayers remained confluent and 
appeared intact with normal morphology when examined by light microscopy.  
Parasites produced lesions in the cell monolayer and at a later time point of co- 
incubation, the cell monolayers usually would not stay intact and some areas 
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may be sloughed off and thus not suitable for evaluation of attachment. Also, 
Blastocystis remained viable after treatments and co-incubation as they could 
be successfully subcultured after recovery from culture wells.  
After the incubation, Caco-2 cell monolayers were washed 5 times with sterile 
PBS and fixed with 2% formaldehyde for 30 min. The monolayers were then 
washed and stained with DAPI for 10min and washed again. All monolayers 
were mounted on a glass slide using fluorescence mounting media 
(VECTASHIELD) before being observed using confocal microroscope 
(Olympus FLUOVIEW-FV100; Olympus, Japan). Attachment was quantified 
by image analysis. The factors that might be involved in host-parasite 
attachment are being investigated as follows:  
For time course studies, the parasites were incubated with Caco-2 for different 
periods of 10min, 30min, 1, 1.5, 2, 4, 6, 9 and 12 hours at 37°C. For dose 
response, different numbers of parasites at 0.04, 0.125, 0.4, 0.6, 0.8, 1.25, 1.6, 
2.5, 3.3 and 4.2 × 107 were added to each well and incubated with host cells 
for 1 hour at 37°C.   
An investigation of the impact of temperature on adherence was carried out 
concurrently at 4, 25 and 37°C. To assess the avidity of binding of Blastocystis 
to Caco-2 cells (McCabe et al., 1991),  monolayers were incubated for 1 h on 
a rotational shaker (Orbital shaker) at 75 rpm at 37°C. To determine whether 
cells need to be alive for parasite and host binding (McCabe et al., 1991), 
either Blastocystis ST-7 (B) or Caco-2 cells were fixed with 2% formaldehyde 
for 30min, washed once and then incubated for 1h at 37°C in 5% CO2 with 
viable Caco-2 cells or Blastocystis parasites. To see whether Blastocystis 
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surface molecules mediating attachment are sensentive to trypsin, parasites 
were trypsinized for different lengths of time (15min, 30min and 1h) at 37°C 
before interacting with epithelial cells. 
To determine the role of components of the host or parasite cytoskeleton in 
attachment, assays were done after 30 min of preincubation of hosts or 
parasites with the microfilament inhibitor cytochalasin D (1 μg/ml or 2 μg/ml; 
Sigma) at 37°C (Sousa et al., 2001). To investigate whether Rho/ROCK 
signaling or MLCK pathway-mediated actin polymerization (Mirza et al., 
2012b) is involved in attachment, host cells were pre-incubated with MLCK 
inhibitor ML-9 or Rho/ROCK signaling pathway inhibitors Simavastatin, 
Fasudil and Y-27632 (All were purchased from Sigma) before interaction with 
parasites (Table 3.2). 
To see whether Blastocystis cysteine proteases play a role in cytoadherence to 
host cells, protease inhibitors TLCK, TPCK and E64 (All were purchased 
from Sigma) were used to pre-treat the parasites for 1 hour before the 
attachment assay (Table 1) (Arroyo et al., 1989, Lauwaet et al., 2004a, Mirza 
et al., 2012b). Particularly, a special Blastocystis cysteine protease legumain 
was inhibited by either monoclonal antibody 1D5, or legumain specific 
inhibitor APE-RR (Table 3.2) (Wu et al., 2010). 
To investigate whether lipid raft structures are involved in Blastocystis 
adhesion (Humen et al., 2011, Laughlin et al., 2004), either parasites or Caco-
2 cells were pre-treated with MBCD (10 mM) for 1 hour, washed and then 
used for adhesion assay.  
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To define the possible role of surface glycoproteins in attachment, assays were 
done in the presence of monosaccharides (D-galactose, D-mannose, D-glucose 
and L-fucose) (5 to 100 mM). All monosaccharides were purchased from 
Sigma. To further study whether the parasite or the host has sugar-binding 
protein or sugar containing protein, either the parasites or the host cells were 
pre-incubated with sugar for 1 h at 37°C, washed and then used for the 
attachment assay. 
3.2.4 Statistical analysis 
Results are expressed as means ± standard errors. Differences between means 
were compared using Student's t tests or analysis of variance where 





3.3.1 Time dependent variations in attachment 
A time course of attachment was firstly conducted to analyze the kinetics of 
Blastocystis attachment to Caco-2 cells (Fig. 3.1). Parasites were able to attach 
as early as 10min after addition onto the Caco-2 monolayer (59.8 ± 18.3 
parasites for every 500 Caco-2 cells). The number of attached parasites 
increased steadily with maximal level reached at 4h post-infection (333.2 ± 
32.4 parasites for every 500 Caco-2 cells) and then began to decrease. 
Parasites remained bound to epithelial cells even at 12h post-infection (187.7 
± 27.4 parasites for every 500 Caco-2 cells).  
 
Fig. 3.1 Time course studies of Blastocystis adhesion to Caco-2 
monolayers. The same number of Blastocystis ST-7 (B) parasites (1.25 × 107 
parasites) interacted with Caco-2 cells for different lengths of incubation: 
10min, 30min, 1, 1.5, 2, 4, 6,9,12 hours at 37°C. The number of parasites 
attached at different time points were counted and calculated for every 500 
Caco-2 cells. Values are the means ± standard errors from data of three 
experiments. Error bars represent standard errors.  
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3.3.2 Dose-response studies  
The number of Blastocystis parasites attached to Caco-2 cells was directly 
related to the inoculum onto the monolayer and increased as more parasites 
were added (Fig. 3.2). 142.1 ± 31.4 parasites were observed for every 500 
Caco-2 cells at the standard dose of 1.25 × 107parasites/well. At the highest 
infection dose (4.2 x 107parasites/well) tested in our study, no saturation point 
of attachment was observed (294.2 ± 38.9 parasites for every 500 Caco-2 
cells).  
 
Fig. 3.2 Dose response of Blastocystis adhesion to Caco-2 monolayers. 
Different doses of Blastocystis ST-7 (B) parasites (0.04, 0.125, 0.4, 0.6, 0.8, 
1.25, 1.6, 2.5, 3.3, 4.2 × 107 parasites/ well respectively) were incubated with 
Caco-2 cells for the same length of incubation time of 1h at 37°C. The number 
of parasites attached at all doses were counted and calculated for every 500 
Caco-2 cells. Values are the means ± standard errors from data of three 




3.3.3 Effects of temperature, rotational shaking, fixation and 
trypsinization on Blastocystis attachment 
Blastocystis adhesion to Caco-2 cells was temperature dependent (Fig. 3.3).  
The number of parasite attachment at 37°C was assigned as a control value of 
100%. Adherence was significantly reduced to 55% ± 1.9% at 25°C (p<0.01), 
and was almost abrogated at 4°C (13.7% ± 2.9% of control) Interestingly, 
incubation at a higher temperature of 40°C significantly increased attachment 
to 130.4% ± 5.4% of control (p<0.01). 
With rotational shaking at 75rpm, no reduction in Blastocystis attachment to 
Caco-2 cells was observed as compared to assays conducted in non-shaking 
condition (102% ± 12%). 
Formaldehyde fixation of Caco-2 cells diminished the attachment to 57.6% ± 
15.3% of control (p<0.01) (Fig. 3.4), and when parasites were fixed, 
attachment was reduced to only 19.4% ± 7.97% of control (p<0.01) (Fig. 3.4). 
To see whether Blastocystis surface molecules mediating attachment are 
sensentive to trypsin, parasites were trypsinized for different lengths of time 
(15min, 30min and 1h) at 37°C before interacting with epithelial cells. 
Pretreatment of live parasites with trypsin reduced Blastocystis attachment to 
59.4% ± 9% of control (p<0.01) (Fig. 3.5), and decreased even more (39.8% ± 
10.6%) (p<0.01) if trypsinized for 30min. Similar level of diminished 
attachment (40.5% ± 5.3% of control) (p<0.01) was observed with 1h 




Fig. 3.3 Effect of temperature on Blastocystis adhesion to Caco-2 cells. 
1.25 × 107 Blastocystis ST-7 (B) parasites were incubated with Caco-2 cells 
for 1 hour at different temperatures (37°C, 25°C, 4°C). A value of 100% was 
assigned to the number of binding parasites incubated at 37°C. Blastocystis 
attachment for monolayers incubated at 25°C and 4°C are expressed as change 
in binding value with respect to control. *, p<0.01, versus control incubated at 
37°C. Values are the means ± standard errors from data of three experiments. 





Fig. 3.4 Effect of formaldehyde fixation on Blastocystis adhesion to Caco-2 
cells. Either Blastocystis ST-7 (B) or Caco-2 cells were fixed with 2% 
formaldehyde for 30min, washed once and then incubated at 37°C in 5% CO2 
with viable Caco-2 cells or Blastocystis parasites. Blastocystis ST-7 (B) or 
Caco-2 cells pretreated with PBS at the same time was used as control (100%), 
respectively. The numbers of attached parasites for all other treatments were 
normalized to control. *, p<0.01 versus control. Values are the means ± 
standard errors from data of three experiments. Error bars represent standard 
errors. 
 
Fig. 3.5 Effect of trypsinization on Blastocystis adhesion to Caco-2 cells. 
Blastocystis ST-7 (B) were pretreated with 0.15% trypsin at 37°C for 15min, 
30min and 1h respectively, washed and added onto epithelial cells. 
Blastocystis ST-7 (B) pretreated with PBS at the same time was used as 
control (100%). The numbers of attached parasites for all other treatments 
were normalized to control. *, p<0.01 versus control. Values are the means ± 




3.3.4 Effects of inhibition of cytoskeletal components, parasite cysteine 
proteases and lipid raft on attachment 
To investigate whether host or parasite cytoskeletal components participate in 
attachment, Caco-2 cells or parasites were treated with actin inhibitors prior to 
co-incubation (Table 1). No significant modification in attachment was 
observed when either host cells or parasites were pretreated with 
microfilament inhibitor cytochalasin D (1 and 2 μg/ml). ML-9, which inhibits 
host cell actin polymerization via myosin light chain kinase, did not affect 
cytoadherence levels (Table 3.2). Similarly, inhibition of ROCK/MLC-
mediated actomyosin contraction by Simvastatin, Fasudil or Y-27632, at 
concentrations which were able to prevent Blastocystis–induced barrier 
dysfunction (Mirza et al., 2012b). also did not produce any notable inhibitory 
effects on parasite attachment (Table 3.2). 
To evaluate whether cysteine proteases mediate Blastocystis attachment to 
epithelial cells, parasites were pretreated with various cysteine proteases 
inhibitors (TPCK, TLCK and E-64). The results showed that the extent of 
cytoadherence of parasites after cysteine proteases inhibition equaled those of 
control parasites (vehicle control) (Table 3.2). Particularly inhibiting a 
surface-localized cysteine protease-Blastocystis legumain, with either 
monoclonal antibody 1D5, or legumain specific inhibitor APE-RR, did not 
alter the attachment significantly from that of control, suggesting legumain 
might not play a direct role in Blastocystis adhesion to host cells.  
 Lipid rafts are submembrane domains enriched with cholesterol and 
sphingolipid (Chen et al., 2006) and have been shown to play a crucial role in 
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adhesion of Entamoeba and Giardia (Humen et al., 2011, Laughlin et al., 
2004). The study therefore also tested whether disruption of lipid raft structure 
on the host cell or the parasite would result in any change in Blastocystis 
adhesion. Interestingly. an about 20 %  inhibition (p<0.05) (Table 3.2) in 
adhesion was observed by preincubating Caco-2 cells with 10mM MBCD (a 
lipid raft disorganizing agent), but not when MBCD was used to treat parasites 




Table 3.2 Effects of different treatments on attachment of Blastocystis to 
Caco-2 cells (targeting host cells cytoskeleton, parasite proteases and lipid raft 
structure on both host and parasites)   
Agents and concn 
% Attachment after: 
Pretreatment of 
        Blastocystis Caco-2 
Cytochalasin Da      
1 μg/ml 96.3 ± 3 100.8 ± 2 
2 μg/ml  98.1 ± 5 
ML-9b (50 μM)  105 ± 4 
Simvastatinc    
5 μg/ml 
 
95.3 ± 6 
10 μg/ml 
 
91.2 ± 5 
Fasudild 
  5 μg/ml 
 
93.6 ± 9 
10 μg/ml 
 
96.4 ± 6 
Y-27632e 
  5 μM 
 




TPCKf (50 μM) 99.1 ± 10 
 TLCKg (50 μM) 98 ± 15 
 E64h (50 μM) 91.7 ± 12 
 APE-RRi (1mM) 
 
86.8  ± 13 
 mAb 1D5j (1.2 
μg/ml) 
 
97.1  ± 8 
 MBCDk (10mM) 91.9 ± 10 81.2 ± 6 
 
a  Cytochalasin D: actin microfilament destabilizer  
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b ML-9: a myosin light chain kinase (MLCK) inhibitor 
c  Simvastatin:  the HMG-CoA reductase inhibitor, which  prevents rho 
kinase-mediated intestinal epithelial barrier compromise induced by 
Blastocystis  
d  Fasudil: Rho kinase (ROCK) inhibitor  
e  Y-27632: Rho kinase (ROCK) inhibitor  
f  TPCK: N-Tosyl-Phenylalanine chloromethyl ketone, inhibitor of papain-like 
cysteine proteinases  
g  TLCK: N-Tosyl-L-Lysine chloromethyl ketone, cysteine protease inhibitor  
h  E-64: trans-epoxysuccinyl-L-leucylamido-(4-guanidino) butane, a broad-
spectrum cysteine protease inhibitor  
i  mAb 1D5: a murine IgM monoclonal antibody targeting Blastocystis 
legumain  
j APE-RR: legumain-specific inhibitor, carbobenzyloxy-Ala-Ala-AAsn-
epoxycarboxylate, ethyl ester (where AAsn is aza-asparagine)  




3.3.5 Effects of saccharides on Blastocystis adhesion to Caco-2 cells 
Surface glycoconjugates were described as important mediators in adhesion of 
various parasitic pathogens (de Araujo Jorge et al., 1984, Lu et al., 2001, 
Pegado et al., 1994). Therefore monosaccharides were used, i.e. D-Glucose 
(Glu), L-Fucose (Fuc), D-Mannose (Man) and D-Galacose (Gal) (Fig. 3.6A), 
to test the participation of glycoconjugates on the surface of either the parasite 
or the epithelial cell in the adhesion process. Differential inhibitory effects by 
these four saccharides were observed (Fig. 3.6B). Galactose (100 mM) was the 
most effective inhibitor and reduced Blastocystis adhesion to Caco-2 cells to 
13% ± 2% of control (p<0.01). Fucose and Mannose at the same concentration 
(100mM) reduced attachment to 81.4%  ± 6.6% and 76.9% ± 5.3% of control, 
respectively (p<0.01 for both values). Glucose, however, did not affect the 
attachment significantly compared with control (96.7% ± 4.7%). 
The inhibitory effect of galactose on the adhesion of Blastocystis to epithelial 
cells was dose dependent (Fig. 3.7). Even at the lowest concentration tested (5 
mM), Blastocystis binding to epithelium was inhibited by 41.2 % ± 9.5% 
(p<0.01). The inhibition values were even higher at 10, 25 and 50mM (51.5% 
± 12.1%, 63.1% ± 9.8%, 80% ± 2%, respectively) (p<0.01 for all values). 
Glucose, as a control sugar, had little effect on attachment at concentrations 
ranging from 5 to 100mM.  
The results above with galactose suggested the possible involvement of a 
galactosyl glycoconjugate in mediating adhesion. It was also of interest to 
determine whether the glycoconjugate is parasite or host cell origin. 
Preincubation of parasites with galactose (100mM) reduced Blastocystis 
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adhesion to 6.7% ± 2% of control values (p<0.01) (Fig. 3.8), compared to 13% 
± 2%, when galactose was added in the host-parasite coculture medium. 
Interestingly, attachment was significantly increased when Caco-2 cells were 
pretreated with galactose at 100mM for 1h (144% ± 15% of control values) 









Fig. 3.6 Effect of saccharides on adhesion of Blastocystis to Caco-2 cells. 
Blastocystis ST-7 (B) were incubated with epithelial cells in the presence of 
100 mM different glucose, fucose, mannose and galactose. A value of 100% 
was assigned to number of binding parasites without addition of sugars. The 
values of Blastocystis attachment to Caco-2 cells performed in other 
conditions are expressed as change in binding value with respect to control. *, 
p<0.01 versus control. Values are the means ± standard errors from data of 
four experiments. Error bars represent standard errors. Glu, glucose; Fuc, 










Fig. 3.7 Dose-dependent inhibiton of galactose on Blastocystis adhesion to 
Caco-2 monolayers. Blastocystis ST-7 (B) parasites were incubated with 
epithelial cells in the presence of different concentrations of galactose and 
glucose (5, 10, 25, 50 and 100mM, respectively). A value of 100% was 
assigned to number of binding parasites without addition of sugars. The values 
of Blastocystis attachment to Caco-2 cells performed in other conditions are 
expressed as change in binding value with respect to control. *, p<0.01 versus 
control. Values are the means ± standard errors from data of three 

















Fig. 3.8 Effects of pretreating either parasites or host cells with galactose 
on Blastocystis adhesion to Caco-2 cells. For pretreatments, either 
Blastocystis ST-7 (B) parasites or host cells were pre-incubated with 100mM 
galactose for 1h at 37°C, washed once with warm PBS, then used for adhesion 
assay. Also, another treatment was to add galactose upon the coincubation of 
Blastocystis and Caco-2 (First bar). A value of 100% was assigned to number 
of binding parasites pretreated with warm PBS at the same time. The values of 
Blastocystis attachment to Caco-2 cells performed in other conditions are 
expressed as change in binding value with respect to control. *, p<0.01 versus 
control. Values are the means ± standard errors from data of three 




As an immotile protist in the gut, attachment of Blastocystis would be critical 
for host parasitism and establishment of infection. Yet it has received little 
attention. Using the adhesion assay established in Chapter 2, this is the first 
study to investigate comprehensively the factors influencing Blastocystis 
attachment and the role of attachment in Blastocystis pathobiology. The study 
showed that, similar to Giardia, Entamoeba and Trichomonas (Katelaris et al., 
1995, Li et al., 1994, Mendoza-Lopez et al., 2000), Blastocystis adhesion is a 
multifactorial process and it is time-, temperature-, and dose-dependent. 
It was observed that parasite attachment decreased after 4h incubation with the 
host. One possible reason is that the experiments were conducted under 
aerobic conditions needed for viability of the Caco-2 cells (McCabe et al., 
1991), whereas Blastocystis are anaerobes (Silberman et al., 1996). Thus the 
non-optimal condition for the parasite might contribute to the decreased 
attachment. This observation might also be due to the dynamic interactions 
between host and parasite. Findings from other parasitic pathogens suggested 
host cells develop various anti-parasitic strategies which are likely to decrease 
parasite colonization (Eckmann et al., 2000, Gobert et al., 2001). It has been 
shown that Caco-2 cells actively produce nitric oxide upon Blastocystis 
infection (Mirza et al., 2011b), as an aspect of host innate immune response 
which could induce parasite cell death. Unpublished data from our laboratory 
suggested that host cells also synthesized antimicrobial peptides against 
parasite invasion. Thus complicated host-parasite interactions occurring during 
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prolonged coincubation might possibly lead to the reduction in Blastocystis 
attachment.   
The results of dose-response showed more parasites adhered to host cells as 
the infection dose increased. Similar trend has been shown in Giardia 
(Katelaris et al., 1995, McCabe et al., 1991). Studies have reported 
overgrowth of Blastocystis in response to illnesses and other 
immunosuppressive conditions (Dogruman-Al et al., 2009, Rao et al., 2003, 
Waghorn et al., 1991). Thus in the scenario of intestinal infestation with 
Blastocystis, the number of parasites which are able to adhere and colonize the 
gut may continue to increase, which might contribute to subsequent intestinal 
pathology. 
Lower temperature decreased adhesion. One reason might be, at low 
temperature, the alteration in the microenvironment of the cell surface might 
render the adhesins inaccessible to the binding partners from the host cells 
(Panjwani et al., 1997). The dependence of Blastocystis attachment on 
temperature has its clinical relevance. Blastocystis is regarded as an 
opportunistic pathogen associated with a number of inflammatory disorders 
such as IBS and was more prevalent especially when there are other infections 
occurring (Dogruman-Al et al., 2009, Llibre et al., 1989, Poirier et al., 2012). 
In a status of inflammation, the local temperature of infected sites might 
increase and thus the local microenvironment might facilitate the attachment 
of Blastocystis and leading to more severe pathology. Interestingly, the 
adherence was also significantly inhibited by formaldehyde, indicating that 
adherence is indeed a dynamic process, and both mammalian cells and 
Blastocystis must be metabolically active for the attachment process to occur.  
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Cytoskeletal components of either host cells or pathogens have been shown to 
participate in the adhesion process of various bacterial and parasitic pathogens 
(Katelaris et al., 1995, Knutton et al., 1989, McCabe et al., 1991), which 
include actin polymerization at sites of adhesion to tissue culture cells and 
reorganization of cytoskeleton (Knutton et al., 1989, Seigneur et al., 2005). 
Host cells microfilament inhibition by cytochalasin D has been shown to 
inhibit adherence of G. lamblia to Int-407 cells (Sousa et al., 2001). Other 
studies have shown preincubation of Giardia trophozoites with cytochalasins 
also decreased attachment (Katelaris et al., 1995, McCabe et al., 1991). In the 
current study, neither inhibiting host nor parasite cytoskeleton resulted in 
significant modifications in attachment, indicating attachment of Blastocystis 
to Caco-2 cells might be independent of microfilaments.  
Simvastatin, Fasudil and Y-27632 have been shown to effectively prevent 
Blastocystis–induced barrier compromise by blocking actin polymerization via 
Rho/ROCK signaling pathway (Mirza et al., 2012b). With the concentration 
that effectively prevented Blastocystis–induced barrier compromise, no change 
in attachment was observed, confirming that actin polymerization, though 
important in mediating barrier dysfunction, might not be crucial for parasite to 
establish initial contact with host cells.  
Cysteine proteases are suspected to be Blastocystis virulence factors (Mirza et 
al., 2012b, Puthia et al., 2005, Puthia et al., 2008). In Trichomonas, cysteine 
proteases are involved in cytoadherence and have been suggested to be 
prerequisite for recognition and binding to host cell surfaces (Arroyo et al., 
1989, Mendoza-Lopez et al., 2000). Also, one particular legumain-like 
cysteine proteases has been recently shown to be crucial for cytoadherence 
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(Rendon-Gandarilla et al., 2013). Interestingly, Blastocystis legumain, an 
unusual cysteine protease located on the cell surface of subtype 7 parasites, 
was suggested to be a potential virulence factor (Wu et al., 2010). It is of 
interest to evaluate their role in cytoadherence to host cells. However, neither 
cysteine proteases inhibition nor specifically legumain inhibition, resulted in 
significant changes in adhesion, suggesting unlike that in Trichomonas, 
cysteine proteases may be insignificant in Blastocystis cytoadherence.  
Lipid raft structures of Entamoeba and Giardia have been shown to play a 
crucial role in cytadherence (Humen et al., 2011, Laughlin et al., 2004, Mittal 
et al., 2008) and disruption of lipid rafts by MBCD treatment leads to the 
inhibition of adhesion and rescued parasite-induced pathology (Faust et al., 
2011, Humen et al., 2011). However, a reduction in attachment was observed 
only when host cells were treated with MBCD, but not when lipid raft of 
parasites were targeted, suggesting lipid raft structure in the host instead of the 
parasites might participate in adhesion. Indeed, lipid rafts in mammalian cells 
have been involved in several bacterial pathogens and was proposed to be the 
possible preferred entry points for Campylobacter (Chen et al., 2006, 
Wooldridge et al., 1996). How the lipid raft of the host mediates Blastocystis 
adhesion needs to be investigated further. Lipid raft is known to control 
numerous protein–protein and lipid–protein interactions at the cell surface 
(Manes et al., 2003). It is possible that some host proteins involved in 
adhesion are located in this structure and disruption of it might interfere with 
the binding to Blastocystis.  
Recognition of host cell glycolipids and/or glycoproteins by a variety of 
microbial pathogens appears to be significant in adherence of organisms to 
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their target tissues (Morton et al., 1991). In the current study, drastic inhibition 
of Blastocystis adhesion by galactose suggested that Blastocystis bind to the 
surface of the epithelial cells by a recognition system mainly mediated by 
galactosyl glycoconjugates, with galactose-binding protein probably residing 
on the surface of Blastocystis. Similar inhibitory effects of galactose have been 
well documented in Entamoeba adhesion (Faust et al., 2011, Li et al., 1988) 
and it has been shown that recognition of epithelial glycoconjugates to an 
amebic cell surface Gal/GalNAc lectin is involved in adherence of Entameba 
histolytica to the colon (Ravdin et al., 1981). Gal or Gal/GalNAc-specific 
lectins have also been identified in several other protozoan parasites. 
Trypanosoma cruzi expresses a 67-kDa surface-associated Gal-binding 
protein, which is implicated in mediating attachment to host cells (Silber et al., 
2002, Hashim et al., 2006). It would be important to characterize the 
galactose-binding protein on the surface membranes of Blastocystis as well as 
its reactive glycoprotein in epithelial cells, and investigate the role of their 
interaction in subsequent pathogenesis of the parasite. In Entamoeba, the 
virulence program was activated upon interaction of the lectin with host cells 
(Blazquez et al., 2007). Thus it will be interesting to investigate the function 
of the galactose-binding protein and see whether the specific binding could 
initiate the sequence of events leading to barrier dysfunction in the epithelial 
cells after adhesion. 
On the other hand, it should be noted that galactose did not abolish adhesion 
completely. This incomplete inhibition of adhesion may also suggest that 
additional galactose-glycoprotein-independent mechanisms are involved in 
adhesion to host cells. The observation that Mannose and Fucose could also 
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reduce adhesion, albeit to a much less significant extent, shows that there 
might be more than one type of glycoproteins mediating the process of 
adhesion. Previous studies on the identification of surface coat carbohydrates 
in Blastocystis indicate that the parasite has surface components containing D-
mannose (Lanuza et al., 1996). Carbohydrate binding studies on Caco-2 cells 
also showed that Caco-2 binds to oligomannose structures (Arndt et al., 2011). 
Thus it might explain why addition of mannose partially inhibited adhesion.  
The results with the adhesion modulators suggested that the pathogen 
possesses multiple mechanisms to mediate the initial contact with the host. It 
appears likely that one major mechanism of Blastocystis adhesion to the 
epithelial cell surface may involve interactions between the galactose-binding 
protein of Blastocystis and galactose-containing proteins on the surface of 
Caco-2 cells. Fucose-glycoproteins and mannose-glycoproteins and lipid raft 
of the host cell also seem to play a minor role in adhesion.  
Altogether, the in vitro attachment model has proven to be reliable and useful 
for investigating the mechanisms by which Blastocystis attach to intestinal 
cells and facilitating the evaluation of the efficacy of antiadhesives. This study 
also screened out a potent inhibitor of adhesion-galactose and confirmed its 
role in ameliorating Blastocystis–induced pathology. Although studies 
performed in vitro may not mirror events in vivo, and further in vivo validation 
is needed, these investigations provide important clues regarding the initial 
event of Blastocystis pathogenesis. Future work on the identification of the 
parasite and host molecules that mediate the initial host-parasite interactions is 










HOST RESPONSES-PART I: 
EFFECTS OF BLASTOCYSTIS ON 
APICAL JUNCTIONAL COMPLEX AND 




Chapter 2 revealed that Blastocystis readily attaches to the epithelium. Studies 
have shown that pathogen adhesion led to several alterations within the host 
cells (da Costa et al., 2005, Lauwaet et al., 2004b, Maia-Brigagao et al., 2012, 
Spitz et al., 1995). For luminal pathogens especially, this initial attachment 
between pathogen and intestinal epithelial cells triggers a series of events that 
culminate in the production of diarrhoea (Cotton et al., 2011, Peiffer et al., 
2000, Spitz et al., 1995). While the process leading to these abnormalities 
could be complicated, these pathophysiological stages are believed to involve 
heightened rates of enterocyte apoptosis and intestinal barrier dysfunction 
(Cotton et al., 2011). Blastocystis infections have been frequently associated 
with intestinal symptoms such as diarrhea (Tan et al., 2010). The post-
adhesion events leading to perturbations on host cell function, however, have 
not been determined. It would be important to characterize changes in 
epithelial-cell physiology after parasite infection. In Chapter 2, it was 
observed that adhesion of Blastocystis induced direct pathological changes in 
host cell. But these were mostly morphological observations. In the next two 
chapters, the functional and structural changes upon parasite adhesion would 
be characterized. Mainly, the study would focus on the intestinal barrier-
disrupting events as well as induction of host cell death by Blastocystis. In the 
first part of host responses, alterations in barrier function would be 
investigated; while the second part would address the question whether 
enterocyte apoptosis occurred upon Blastocystis infections. 
As the first line of defence, the main function of intestinal epithelial cells is to 
provide a physical and chemical barrier that keeps luminal contents separate 
from the interstitium (Turner, 2009). The functional integrity of the intestinal 
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epithelial barrier forms a major defense against unwelcome intrusion of 
pathogens (Cliffe et al., 2005). Therefore, an intact intestinal barrier is critical 
to normal physiological function and prevention of disease (Turner, 2006). In 
many intestinal diseases, such as inflammatory bowel disease, this barrier 
function can become compromised and a leaky barrier may result in 
gastrointestinal symptoms including diarrhea (Clayburgh et al., 2004). As 
reviewed in Chapter 1, there is ample evidence suggesting that Blastocystis 
causes intestinal epithelial barrier compromise in vitro and in vivo. However, 
the molecular alterations behind the functional disturbances have not yet been 
fully elucidated.  
In polarized epithelial cells, it is well established that the apical junctional 
complex (AJC) is responsible for maintenance of the integrity of intercellular 
contacts (Baranwal et al., 2012). AJC is mainly composed of tight junctions 
and adherens junctions (Vogelmann et al., 2005), the former being most 
critical (Turner, 2006). Tight junctions (TJ) are multi-protein complexes 
composed of transmembrane proteins, peripheral membrane (scaffolding) 
proteins and regulatory molecules that include kinases. Together they form the 
continuous intercellular barrier between epithelial cells, which are required to 
separate tissue spaces and regulate selective movement of solutes across the 
epithelium (Anderson et al., 2009). Claudins are transmembrane proteins and 
are the key components for the structure and function of TJs (Furuse, 2010, 
Itoh et al., 1999). Occludin is a transmembrane tight junction protein that 
interacts directly with claudins and actin, and plays a direct role in the 
paracellular permeability (Furuse et al., 1993). Peripheral membrane proteins, 
such as zonula occludens 1 (ZO-1) and ZO-2, are crucial to tight junction 
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assembly and maintenance (Turner, 2009) and these cytosolic adaptor proteins 
link tight junctions to a perijunctional actomyosin ring, which supports and 
regulates tight junction permeability (Steed et al., 2010). Adherens junctions 
(AJs) are cell–cell adhesion complexes that are important for solid tissues 
maintenance (Harris et al., 2010). Cadherin adhesion molecules, including E-
cadherin, are transmembrane proteins that are the core of AJ (Halbleib et al., 
2006). AJC provides a tight physical barrier that protects deeper tissues from 
external aggressions, including microbial infections. However, the first line of 
defense against infection has become one of the most exploited gates to access 
and invade epithelial cells, disrupt epithelial integrity, and colonize the 
organism (Bonazzi et al., 2011). Many enteropathogenic bacteria or parasitic 
pathogens disrupt the tight and adherence junctions to alter intestinal 
permeability (Groschwitz et al., 2009). The strategies to overcome the tight 
junction barrier employed by harmful microorganisms are diverse. Whereas 
some pathogens bind and modify junction components directly, others exert 
their effects through the actin cytoskeleton, which controls the integrity of 
tight junctions (O'Hara et al., 2008). The mechanisms of the pathogens 
reviewed are summarized in Table 4.1. 
An association of this functional disturbance of the intestinal barrier by 
Blastocystis with reorganization of ZO-1 tight junction protein was recently 
demonstrated (Mirza et al., 2012b), yet a comprehensive analysis of molecular 
alterations in the apical junctional complex for the barrier defects is still 
lacking. The aim of the current chapter was to conduct an in-depth analysis of 
molecular changes in apical junctional complex, which would facilitate our 
understanding of the pathogenesis of the understudied emerging organism. 
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The results showed that on direct contact with the apical side of the enteric 
cells, Blastocystis caused an increase in paracellular permeability as evidenced 
by an increase in Dextran-FITC probe flux. Protein expression profile by 
Western blot revealed degradation of Occludin, loss of ZO-1 and Claudin-1, 
but none of E-cadherin. Therefore, Blastocystis-induced increase in 
paracellular permeability of enteric cell layers might be ascribed to 
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4.2 MATERIALS AND METHODS 
4.2.1 Culture of Caco-2 colonic epithelial cell line 
Caco-2 stock cultures were maintained as previously described in Chapter 2. 
For cell fractionation and Western blot analysis, Caco-2 monolayers were 
grown on 6-well cell culture plates (corning) until 100% confluency. For 
immunofluorescence and confocal microscopy experiments, Caco-2 
monolayers were cultured on Poly-L-lysine-treated 24mm glass coverslips 
placed in standard 6-well culture plates. For epithelial permeability 
experiments cells were grown on Millipore transwell filters with PET 
membranes of 3μm pore-size, placed in 24-well tissue culture plates. In order 
to synchronize cells before experiments, all cultures were serum-starved 
overnight in antibiotic-free and serum-free DMEM. 
4.2.2 Parasite culture 
Axenized isolate of Blastocystis ST-7 (B) was maintained as previously 
described in Chapter 2. 1-day-old healthy Blastocystis parasites were used in 
all experiment. 
4.2.3 Epithelial permeability 
Caco-2 monolayers were grown on Millipore transwell system till they reach 
confluency and tight junction maturation on day 21. After confirmation of 
maturation by TER measurement, monolayers were co-incubated with parasite 
live cells for 24 h. Following co-incubation, epithelial and basolateral 
compartments were washed twice, followed by addition of 400 μl of warm 
HBSS at the basolateral compartments and 200 μl of 100 mg/ml FITC-
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conjugated Dextran 4000 (Sigma) solution in HBSS to apical compartments. 
After 1 h at 37°C, 300μl of HBSS was taken from basolateral compartments 
and was transferred to a black 96-well plate (NUNC) to estimate Dextran–
FITC flux across monolayers. Fluorescence was measured using an ELISA 
reader (Tecan Infinite M200) at excitation and emission wavelengths of 492 
and 518nm respectively. 
4.2.4 Western blot and cellular fractionation 
Caco-2 cells were plated at a density of 2 × 104 /cm2 on a 6-well culture plate 
and allowed to reach confluency. After treatments, monolayers of cells were 
then rinsed three times with chilled sterile PBS (pH 7·4) and then were lysed 
on ice for 40 min with 150l of ice-cold radioimmunoprecipitation assay 
(RIPA) buffer (150 mM NaCl, 1.0% Triton X-100, 0.5% sodium 
deoxycholate, 0.1% SDS, 50 mM Tris-HCl, pH 8.0), including protease and 
phosphotase inhibitors for protein extraction. After centrifugation at 16,000 × 
g for 30 min at 4°C, the supernatant was collected for further analysis. 
For cellular fractionation, Caco-2 monolayers were lysed with lysis buffer A 
(0.5% Triton X-100, 150 mM NaCl, 50 mM Tris-HCl, and protease inhibitors, 
pH 7.5) for 30 min on ice. After centrifugation of cell lysates (14,000 × g for 
10 min), the supernatant (“soluble fraction”) was separated from the pellet. 
The pellet was further incubated with in lysis buffer B (lysis buffer A with 
0.1% SDS) for 20 min, on ice, and centrifuged (14,000 × g for 30 min). The 
resulting supernatant was collected (“insoluble fraction”) for further analysis. 
Equal amounts of total protein were separated on 10% SDS-polyacrylamide 
gels and then transferred to a nitrocellulose membrane. After blocking for 2 h 
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in PBS containing 0.1% Tween and 5% dry powdered milk, membranes were 
incubated overnight at 4°C, in primary antibody (mouse anti-ZO-1, mouse 
anti-Occludin, rabbit anti-Claudin-1; Zymed). After five washes for 5 min 
each with PBS-T, the membranes were incubated for 1 h with corresponding 
horseradish peroxidase-conjugated secondary antibody. Following five washes 
with PBS-T, the membranes were developed for visualization of protein by 
addition of enhanced chemiluminescence reagent (Amersham, Princeton, NJ, 
USA). 
4.2.5 Confocal microscopy  
For visualization of tight junction proteins in Caco-2 cells, Caco-2 cells were 
grown on Poly-L-Lysine treated glass coverslips to 100% confluency. After 
treatments, monolayers of cells were then rinsed three times with chilled 
sterile PBS (pH 7·4), fixed with 2% formaldehyde for 30 min, permeabilized 
with 0.1% Triton X-100 for 10 min, blocked with 10% FBS for 2 hours at 
room temperature and then incubated with respective primary antibodies to 
ZO-1, occludin and Claudin-1 overnight 4°C. After five washes for 5 min each 
with PBS, the monolayer were then incubated with Cy3-conjugated secondary 
antibodies. Coverslips were then mounted onto clean glass slides using 
fluorescence mounting media (VECTASHIELD) and viewed under confocal 
laser microscopy using an Olympus Fluoview FV1000 (Japan). Images were 
captured using Olympus Fluoview version 1.6b. 
Legumain staining after coincubation of Caco-2 cells with Blastocystis was 





4.3.1 Blastocystis induced time- and dose-dependent permeability increase 
in Caco-2 monolayer 
Barrier function could be measured by intestinal permeability, thus the flux of 
Dextran–fluorescein isothiocyanate (FITC) probe across the Caco-2 
monolayer was measured. Blastocystis ST-7 (B) induced a time- and dose-
dependent drop in Caco-2 epithelial permeability (Fig. 4.1). A significant 
increase in Caco-2 permeability was observed as early as after 6h of co-
incubation (p<0.05; Fig. 4.1) and continued at 12 and 24h (p<0.01; Fig. 4.1). 
A minimum dose of 1.5 × 107 parasites induced a significant alteration in 
epithelial permeability after 24h of co-incubation (p<0.01, Fig. 4.2).  
 
Fig. 4.1 Time-dependent effect of Blastocystis ST-7 on epithelial 
permeability of Caco-2 cell monolayers. Confluent Caco-2 cells grown on 
24-well Millipore transwell inserts were coincubated with 2 × 107 Blastocystis 
ST-7 parasites or normal culture media as a negative control for the indicated 
lengths of time (3,6,12 and 24h). Permeability was determined by 
measurement of Dextran-FITC fluxes across the monolayer. ST-7 treatment, 
compared to negative control induced a significant increase in permeability 
from 6h onwards (p<0.05 for 6h; p<0.01 for 12 and 24h). Each value 
represents mean of twelve samples, taken from three independent experiments, 





Fig. 4.2 Dose-dependent effect of Blastocystis ST-7 on epithelial 
permeability of Caco-2 cell monolayers. Confluent monolayers grown on 
24-well Millipore transwell inserts were coincubated with varying doses of 
ST-7 for 24 h at 1, 1.5, and 2 × 107parasites. Compared to negative control 
Blastocystis ST-7 induced a significant permeability increase in Caco-2 at 1.5, 
and 2 × 107parasites (p<0.01). Each value represents mean of twelve samples, 
taken from three independent experiments, four samples from each. Error bars 
represents standard error. 
 
4.3.2 Effect of Blastocystis on the overall expression of the apical 
junctional complexes 
The functional disturbance by Blastocystis led us to further investigate the 
molecular changes. Western blot analyses were performed to determine the 
total protein expression levels of the apical junctional complex, including tight 
junction proteins Occludin, ZO-1 and claudin-1, as well as adherence junction 
protein E-Cadherin. An obvious reduction in the expression of tight junction 
proteins Occludin, ZO-1 and Claudin-1 was observed from the densitometry 
analysis (p<0.01; Fig. 4.3). However, no significant change was detected in 
the total amount of E-Cadherin, suggesting Blastocystis might induce 
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impairment of barrier function mainly via the tight junction proteins of the 
epithelial cells, instead of proteins at adherence junction. 
 
Fig. 4.3 Western blots showing distinct effects on tight junction and 
adherens junction proteins by apical application of Blastocystis ST-7 (B). 
Confluent Caco-2 monolayers were incubated with Blastocystis ST-7 (B) and 
normal culture media as a negative control. Total protein was extracted and 
run for Western Blot. Tight junction proteins Occludin, ZO-1 and Claudin-1, 
as well as adherence junction protein E-Cadherin were analyzed. The 
densitometry values revealed obvious reduction in the expression of all the 
tight junction proteins, but not for E-Cadherin. *, p<0.01 versus control for all 
tight junction proteins, but not for E-Cadherin. Values are the means ± 
standard errors from data of three experiments.  
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4.3.3 Effect of Blastocystis on the distribution of the tight junction 
proteins by cellular fractionation   
As tight junction is the most important regulator for barrier function, and there 
is no significant change observed in E-Cadherin, the study went on to make an 
in-depth analysis of the tight junction proteins by cellular fractionation. The 
proteins were analyzed in cytosolic (soluble) and membrane-associated 
(insoluble) fractions (Fig. 4.4). Occludin, ZO-1, Claudin-1 and β-actin in 
uninfected controls were detected as clear bands in both fractions. Our results 
showed Blastocystis treatment induced an obvious decrease in Occludin 
expression in the membrane-associated fraction compared with control 
(p<0.01; Fig. 4.4). ZO-1 protein level in both fractions were greatly affected 
and significantly reduced (p<0.01; Fig. 4.4). Interestingly, for Claudin-1, 
while the expression in the cytosol fraction was decreased, a prominent 
increase in membrane-associated fraction was observed concomitantly after 




Fig. 4.4 Representative Western blots showing the changes in tight 
junction proteins and densitometric analysis of protein expressions in the 
insoluble fraction and soluble fraction of Caco-2 cells after treatment by 
Blastocystis ST-7 (B). Confluent Caco-2 cells cultured on 6-well plates were 
exposed to Blastocystis ST-7 (B) for 6h or normal culture media as a negative 
control. Cells were prepared and analyzed in cytosolic (soluble; S) and 
membrane-associated (insoluble; IS) fractions, and also at the same time for 
total protein extraction after the same treatments. Western blots were probed 
with anti-Occludin, anti-ZO-1 and ani-Claudin-1 antibody. β-actin was used as 
a loading control. Data shown is representative of 3 separate experiments. 
Each experiment had duplicate cultures for each experimental condition. The 
measurements for each fraction were determined from the ratio of the 
integrated band intensity of the target proteins to that of β-actin in the same 
fraction of the same sample. *, p< 0.01 versus control. Values are the means ± 
standard errors from data of three experiments. 
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4.3.4 Effect of Blastocystis on the distribution of the tight junction 
proteins 
Meanwhile, to visualize the distribution and integrity of the tight junction 
proteins after exposure to Blastocystis ST-7 (B), indirect immunolabelling of 
occludin, ZO-1 and Claudin-1 were performed and analyzed by confocal 
microscopy. All three tight junction proteins were continuously distributed in 
a belt-like manner along membranes in the control Caco-2 intestinal 
monolayers. From the cross sectional view, tight junction proteins were 
present at the intercellular borders, encircling the cells and delineating the 
cellular borders with bright staining.  
Treatment of Blastocystis ST-7 (B) led to significant changes in the 
distribution of all three proteins. In contrast to the uniform membrane staining 
in controls, a drastic decrease in Occludin fluorescence intensity in Caco-2 cell 
line was observed (Fig. 4.5). ZO-1 proteins, instead of a sharp definitive 
localization at intercellular junction, became punctate and migrated from the 
apical region to the cytoplasm (Fig. 4.6) after apical infection with 
Blastocystis ST-7 (B). For Claudin-1, the amount of tight junction proteins 
was significantly decreased compared with that of the control (Fig. 4.7). 
Interestingly, the distribution of Claudin-1 was noticed to migrate from the 





Fig. 4.5 Representative confocal z-projections showing effects of 
Blastocystis exposure on the distribution of tight junction protein 
Occludin. Caco-2 cells were grown to confluency on 24mm glass coverslips 
in 6-well culture plates. After 6h coincubation with Blastocystis ST-7 (B) and 
normal culture media as a negative control, monolayers were fixed, 
permabilized, and labelled with DAPI (Blue) and an antibody targeting tight 
junction protein Occludin and Cy3® goat anti-mouse IgG (Red). Control 
monolayer (C) exhibited a typical occludin pericellular organization at the 
periphery of enterocytes. Monolayers incubated with ST-7 (B) exhibited a 






Fig. 4.6 Representative confocal micrographs illustrating ZO-1 integrity 
in Caco-2 monolayers. Monolayers were grown to confluency on glass 
converslips. Caco-2 cells were then conincubated for 6h with Blastocystis ST-
7. Normal culture media were used as a negative control. Control monolayers 
exhibited a clear and sharp ZO-1 staining at intercellular junctions, as well as 
uniform localization at the apical region (yellow arrows), whereas ST-7 
treatment resulted in focal disruption of ZO-1 tight junction protein (white 
arrows) and the apical localization of ZO-1 was also re-distributed in the 





Fig. 4.7 Representative confocal micrographs with z-projections showing 
the redistribution of Claudin-1 tight junction protein after 6h exposure to 
Blastocystis ST-7 (B). Representative confocal micrographs illustrating 
Claudin-1 distribution in Caco-2 monolayers. Caco-2 cells were grown to 
confluency on glass converslips. Monolayers were fixed, permealized and 
immunostained with rabbit polyclonal anti-Claudin-1 antibody and analyzed 
by confocal microscopy. Control monolayers showed strong staining at 
pericellular regions, the intensity in ST-7 (B)-treated cells, however, has 
decreased significantly. Besides, Instead of being localized basolaterally in 
untreated cells, Claudin-1 was re-distributed to the apical of the monolayer 




4.3.5 Loss of co-localization between tight junction proteins and F-actin 
after exposure to Blastocystis  
Double immunostaining was performed to see the interaction between tight 
junction proteins and cytoskeleton. The F-actin staining pattern of control 
Caco-2 cells showed a continuously lined distribution at the cell borders and 
cytoskeletal regions, with negligible stress fiber formation in the cytoplasmic 
area. Occludin and F-actin showed yellow merged patterns in the negative 
control; however, after treatments, a pronounced formation of stress fibers and 
actin condensation was noticed in the monolayers incubated with parasites 
(Fig. 4.8). With alteration of F-actin filaments as well as loss of Occludin 
protein at the pericellular regions, the colocalization also disappeared.  
ZO-1 and Claudin-1 showed a spatial overlap at regions of cell-to-cell contact, 
as seen in the merged view of control cells. After Blastocystis ST-7 (B) 
treatment, both ZO-1 and Claudin-1 staining have decreased drastically 




Fig. 4.8 Representative confocal micrographs illustrating Occludin and F-
actin double staining in Caco-2 monolayers. Caco-2 cells were grown to 
confluency on glass converslips. After 6h coincubation with Blastocystis ST-7 
(B) and normal culture media as a negative control, monolayers were fixed, 
permabilized, and labelled with DAPI (Blue) for nuclei, fluoresceinphalloidin 
(Green) for F-actin and an antibody targeting tight junction protein Occludin 
and Cy3® goat anti-mouse IgG (Red). The pericelluar colocalization of 









Fig. 4.9 Co-imunostaining of tight junction protein ZO-1 and Claudin-1 in 
Caco-2 cells after 6h exposure to Blastocystis ST-7 (B). Caco-2 cells were 
grown to confluency on glass converslips. Monolayers were fixed, 
permealized and immunostained with rabbit polyclonal anti-Claudin-1 
antibody and mouse monoclonal anti-ZO-1 antibody. Staining intensity has 
greatly decreased after treatments with ST-7 (B) for both proteins. The 
colocalization pattern seen in control monolayers also became ambiguous in 




4.3.6 Possible association of host tight junction protein Claudin-1 with 
adhering Blastocystis parasites 
As an increase in Claudin-1 protein in the membrane-associated fraction was 
observed, more experiment were performed to see the relationship of host tight 
junction protein Claudin-1 and the parasite using two methods of staining. One 
was to label the parasite with legumain antibody, targeting a surface-localized 
protease of Blastocystis; the other labeling was to stain the parasites with 
CFSE as described in Chapter 2. Both staining methods showed similar 
patterns regarding the relationship of the adhered parasites with host protein 
Claudin-1. Instead of being localized basolaterally, Claudin-1 was re-
distributed to the apical of the monolayer, some of which were found to 
colocalize with the parasites, indicating that parasites might interact with the 
host tight junction protein (Fig. 4.10 and Fig. 4.11).  Additionally, 1D5-
binding protein, Blastocystis legumain, was transferred to apical surface of 













Fig. 4.10 Representative confocal micrographs illustrating Claudin-1 
staining and deposit of Blastocystis legumain in Caco-2 monolayers after 
6h exposure to Blastocystis ST-7 (B). Caco-2 monolayers were grown to 
confluency on glass converslips and were then incubated with Blastocystis ST-
7 (B). Normal culture media was used as a negative control. Blastocysis ST-7 
was labeled with legumain antibody-mAb1D5, and secondary Alexa Fluor® 
594 goat anti-mouse IgM (red). Claudin-1 of Caco-2 cells was at the same 
time stained in green, and DAPI (blue) was used to counterstain nuclei. No 
1D5-binding legumain can be seen in the untreated monolayers. After 
infection, parasites were seen adhering to the monolayer. Besides, legumain 
deposit was found to bind to junctional area of Caco-2 cells (green arrow). 
White arrows indicate spatial overlap (colocalization) of the red-stained 






Fig. 4.11 Representative confocal micrographs illustrating the spatial 
relationship of Claudin-1 tight junction protein and Blastocystis in Caco-2 
monolayers after 6h exposure to Blastocystis ST-7 (B). Confluent Caco-2 
monolayers were incubated with Blastocystis ST-7 (B) pre-stained with CFSE 
(green). Normal culture media was used as a negative control. After co-
incubation, the non-attached parasites were washed away. The Caco-2 
monolayers were then stained with Claudin-1 (red) and DAPI (blue) and then 
were viewed using confocal microscope. Green in the field represents 
parasites attached to the monolayer, and some were found to colocalize the 
Claudin-1 protein which migrated from basolateral to the apical region of 





It was demonstrated here that after a close interaction with polarized intestinal 
epithelial cells, Blastocystis could directly alter the epithelial barrier evidenced 
by an increase of paracellular permeability, suggesting that Blastocystis 
induced a perturbation of the epithelial barrier that may lead to Blastocystis-
related gastrointestinal symptoms. 
As one of the major physiological functions of intestinal epithelium, barrier 
function is crucial to regulate the back and forth flow of contents between the 
gut lumen and sub-epithelial tissue (Turner, 2009). A breakdown of epithelial 
barrier function has been the cause of a wide range of gastrointestinal 
disorders particularly bacterial enteritis, celiac disease and inflammatory 
bowel disease (Bjarnason et al., 1995, Chin et al., 2002). Increased 
permeability of tight junctions may cause or contribute to diarrhea by 
exposing the sub-epithelial cells to parasitic virulence factors and to help the 
invasion of the organism (Spitz et al., 1995). Modulation of intestinal 
epithelial barrier function is one of the major mechanisms employed by 
pathogens to induce host pathology and several extracellular luminal parasites 
have evolved mechanisms to sabotage this gate function and cause bowel 
pathology by increasing intestinal epithelial permeability. There are a few 
reports of Blastocystis compromising intestinal epithelial barrier in rats, in-
vitro and in-vivo (Mirza et al., 2012b, Puthia et al., 2006). There is also one 
clinical study correlating increased intestinal absorption of Technetium-99m 
labeled diethyl triamine penta acetic acid (99mTc-DTPA), with Blastocystis 
infections in humans (Dagci et al., 2002). The cause of Blastocystis-associated 
diarrhea is so far unidentified, but an association between increase in epithelial 
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permeability and diarrhea has been described for other intestinal diseases 
(Madara, 1988). It is possible that Blastocystis-induced epithelial barrier 
function alteration might lead to electrolyte imbalance and thus diarrhea. 
It was found that the functional disturbance in intestinal barriers by 
Blastocystis was associated with molecular changes in the tight junction 
complex. These changes are coupled to disruption of ZO-1, degradation of 
Occludin in the membrane-associated fraction, Claudin-1 degradation as well 
as redistribution to the apical region. No obvious change was observed in 
adherens junctions. Tight junctions are key regulators of epithelial barrier 
function (Turner, 2006). Numerous enteric pathogens disrupt epithelial tight 
junctions and alter intestinal permeability (Berkes et al., 2003), or utilize tight 
junctions during the pathogenesis (O'Hara et al., 2008). The strategies to 
overcome the tight junction barrier employed by enteropathogens are diverse. 
Whereas some pathogens bind and modify junction components directly, by 
downregulating at translational or protein levels by degradation (Wan et al., 
1999, Wu et al., 2000) or at transcriptional level (Nazli et al., 2010), others 
exert their effects through the actin cytoskeleton (Scott et al., 2002), which 
controls the integrity of tight junctions. For example, Giardia intestinalis and 
Trichomonas vaginalis caused a defect in barrier function by altering the 
distribution of the ZO-1 and ZO-2 proteins (da Costa et al., 2005, Maia-
Brigagao et al., 2012). Entamoeba histolytica triggered disruption of the TJ 
proteins via the dephosphorylation and degradation of ZO-1 (Leroy et al., 
2000). Acathamoeba castellanii, a pathogenic free-living amoeba, releases 
secretory products (mainly proteases) into the culture medium, activates 
Rho/Rho-kinase pathway resulting in the degradation of ZO-1 and occludin in 
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human brain microvascular endothelial cells (HBMEC) (Khan et al., 2009). 
However, the reports are not always consistent even for one microorganism, 
which not only depends on the experimental conditions or models used (Maia-
Brigagao et al., 2012), but also because a single pathogen could engage 
diverse strategies to sabotage the TJ (Sakaguchi et al., 2002). For example, 
level of ZO-1 expression was affected in G. duodenalis infection (Buret et al., 
2002), but in another study, ZO-1 migration from the cellular margins into the 
cytoplasm was the mainly observed mechanism (Scott et al., 2002). reiterating 
the complexity of the mechanisms used by pathogens in disassembly of 
epithelial TJ. 
How adhesion leads to tight junction disruption should be investigated further. 
The adhesion of the parasites to the host cells may be activating or 
deactivating a signalling cascade (Maia-Brigagao et al., 2012), leading to the 
destabilisation of the junctional proteins with a loss of their functionality. 
These effects may be due to release of secreted products, like toxins or 
proteases by the parasite during adhesion on epithelial cells. However, further 
studies will be necessary to support these hypotheses in Blastocystis. 
The current study for the first time provided a comprehensive analysis with 
cellular fractionation, which enables us to see the distribution of specific 
proteins upon Blastocystis infection, as some microorganisms induced a 
partitioning of those proteins to induce permeability changes (Man et al., 2010, 
Scott et al., 2002). The results not only provided molecular basis for the 
epithelial functional disturbance, mediated mainly by degradation of tight 
junction protein, but also unraveled interesting events in parasite pathogenesis 
and revealed interesting patterns of changes in tight junction protein-Claudin-
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1. An overall reduction in protein expression was found in Claudin-1 after 
infection with Blastocystis. Interestingly enough, it also showed redistribution 
from the cytosol to the membrane-associated fractions. Immunofluorescence 
revealed that Claudin-1 migrated to the apical regions and was found to 
colocalize with the parasites, indicating interaction between the parasite and 
the host tight junction proteins. The redistribution of Claudin-1, however, was 
not without precedent. Similar observations have been found in 
Campylobacter jejuni infection (Chen et al., 2006), where Claudin-1 was 
shown to increase in raft-associated fraction. So far, the reason is not clear 
why parasites want to up-regulate Claudin-1 in the membrane-associated 
fraction. It is intriguing to think Claudin-1 could be a potential 
interacting partner of Blastocystis for it to stabilize and develop further 
pathogenesis. The imaging data also supported the association of parasite with 
host protein Claudin-1. Future work on the protein-protein interaction between 
parasite factors and host tight junction protein Claudin-1 will shed new light 
on the strategy the parasite uses to target the host cells. 
The study also implicates an unusual parasitic cysteine protease, 1D5-binding 
legumain in pathogenesis. The result showed that legumain was transferred 
onto the enterocytes upon interaction. Blastocystis legumains have been shown 
to localize on the cell surface as well as in the cytoplasm and central vacuole 
(Wu et al., 2010), and have also been found to be secreted. They were 
described as possible Blastocysistis virulence factors (Wawrzyniak et al., 
2012). Similar phenomena of antigen transfer have been reported in 
Entamoeba to host cells where Gal/GalNAc specific lectin as well as 
lipophosphopeptidoglycans (LPPG) were deposited by the trophozoites to the 
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enterocytes following adhesion and prior to dysfunction of tight junctions, 
suggesting antigen transfer could play a role also in the breakdown of target 
cell membrane integrity (Lauwaet et al., 2004b, Leroy et al., 1995). Besides, 
the deposited legumain in infected cells appeared to be most prominent in 
regions of epithelial cell-cell contact, indicating transfer site specificity. How 
it is specifically bound to the junctional area of enterocytes remains to be 
investigated. Legumain in cancer cells has been shown on the cell surface and 
colocalizes with β1 integrins (Liu et al., 2003). Although integrins are found 
generally associated with the basolateral cell surfaces of enterocytes (Beaulieu, 
1999, Hynes, 1992), data has indicated that β1 integrins are exposed also 
apically in the tight junction area in Caco-2 cells (Levy et al., 1998, Tafazoli 
et al., 2000). For example, Yersinia was shown to bind to apical β1 integrins, 
and consequently modified host F-actin organization and affected tight 
junction structure and function (Tafazoli et al., 2000). Another possibility is 
that when tight junction is disrupted and epithelial cells loose polarization, 
integrin molecules could migrate to the apical (Muza-Moons et al., 2003). 
Disruption of tight junctions after Blastocystis infection was clearly shown in 
the results above, whether integrin is redistributed from basolateral to apical, 
serving as a binding site for legumain would be interesting to investigate. 
Interestingly, integrin regulates the activity of several members of the Rho 
family of small GTPases, which control the contraction of filamentous actin 
fibers (DeMali et al., 2003, Huveneers et al., 2009). A recently study showed 
Blastocystis was able to induce reorganization of actin cytoskeleton in a 
Rho/ROCK-dependent fashion (Mirza et al., 2012b). Future study addressing 
whether Blastocystis legumain binds to integrin molecules on the enterocytes 
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and initiates integrin signaling leading to actin polymerization via Rho/ROCK 
pathway would help elucidate the role of Blastocystis legumain binding to 
human enterocytes. 
Altogether, these results demonstrate the functional disturbance as one 
significant resultant host cell effects by parasite attachment and also revealed 
the complexity of molecular events and quite a few molecules participating in 










HOST RESPONSES-PART II: 
ROLE OF BLASTOCYSTIS-INDUCED 
HUMAN ENTEROCYTE APOPTOSIS IN 




Chapter 4 characterized the molecular basis for barrier disruption following 
Blastocystis adhesion. Interestingly, recent evidence has suggested various 
luminal parasites sabotage this gate function by utilizing the apoptotic 
machinery of the host cell (Betanzos et al., 2013, Chin et al., 2002). It would 
be important to investigate if an increased incidence of cell death is a cellular 
basis contributing to the intestinal barrier defect upon parasite infection.  
Apoptosis, a regulated programmed cell death, is a physiological process 
which plays an important role in the normal turnover of cells, maintaining a 
correct cell number in organisms by balancing cell growth and death, and is 
also involved in various pathological processes (Earnshaw, 1995). 
Biochemically, apoptosis is the orderly, immunologically silent dismantling of 
a cell following the activation of a family of cysteine proteases known as 
caspases (Danial et al., 2004). There are two central pathways which activate 
caspases (Elmore, 2007). The extrinsic pathway is activated following the 
binding of a ligand to a death receptor on the cell surface (e.g. FasL/Fas, TNF-
α/TNFR), and activation of the receptor results in the formation of the death-
inducing signalling complex (DISC) (Muzio et al., 1996), which recruits and 
activates the initiator caspase, caspase 8 (Peter et al., 2003). Active caspase 8 
then cleaves and activates an executioner caspase, caspase 3, which is 
responsible for cleaving multiple proteins and the subsequent death of the cell 
(Peter et al., 2003). The intrinsic pathway, initiated by intracellular signals (e.g. 
DNA damage), relies on the release of cytochrome c from mitochondria to 
activate the initiator caspase, caspase 9, in a macromolecular complex called 
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the apoptosome (Green, 2005, Opferman et al., 2003). As with the extrinsic 
pathway, the initiator caspase then activates caspase 3 and the cell undergoes 
apoptosis (Green, 2005). The activation of caspase 8 can also lead to the 
release of cytochrome c due to the cleavage of the Bcl-2-family protein Bid – 
serving as a nexus between the intrinsic and extrinsic cascades (Kuwana et al., 
1998, Li et al., 1998). Apoptosis or programmed cell death is a mechanism of 
clearing up unwanted cells by the body while simultaneously limiting overt 
immune response (Gao et al., 1998). Recently, a variety of intestinal 
pathogens were found to induce apoptosis in intestinal epithelial cells, and 
their association with pathogenicity was suggested (Crane et al., 1999, Huston 
et al., 2003, McCole et al., 2000, Valenti et al., 1999). Entamoeba induces 
enterocyte apoptosis to facilitate the parasite infection of gut (Becker et al., 
2010), while Giardia induces epithelial barrier compromise by activating 
caspase 3-mediated enterocyte programmed cell death (Chin et al., 2002). A 
list of parasite-induced apoptosis and the role of apoptosis in mediating barrier 
function was listed in Table 5.1. Blastocystis was reported to induce caspase-
mediated apoptosis in vitro (Puthia et al., 2006), with no effect on the barrier 
function of rat intestinal epithelium, but this finding was limited to rodent 
models. An association of parasite-induced apoptosis with disruption of 
epithelial barrier function, as observed in Giardia and Entamoeba infections is 
not known in human intestinal epithelium.  
Using ST-7 (B) isolate, recovered from a symptomatic patient, which was 
demonstrated to adhere to intestinal cells and cause epithelial damage in 
Chapter 2, the study aimed to find whether Blastocystis treatment induces 
apoptosis in Caco-2 cells and whether apoptosis could contribute to the 
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observed impairment in barrier function. A control strain ST-4 (WR-1), which 
was recovered from a rat and not adhesive to Caco-2 cells, would also be used 
to test whether there exists a difference in adhesive strain and non-adhesive 
strain in their capability of inducing enterocyte aopotosis and barrier 
dysfunction. The study reported for the first time that Blastocystis ST-7 (B) 
induced caspase-3- and 9-mediated apoptosis, breakdown of epithelial barrier 
function, and rearrangement of the tight junction protein ZO-1. Caspase 
inhibition in human gut epithelium prevented the effect of parasite on barrier 
dysfunction. In contrast, WR-1, previously reported to induce rat epithelial 
injury (Puthia et al., 2006), did not cause any pathology in human epithelium.   
Table 5.1 Studies on induction of apoptosis in protistan parasites and their 









Huston et al, 
(2000) 
Caspase-3; independent 
of the upstream 
caspases 8 and 9 
-- 
Ragland et al., 
(1994) 
Independent of Bcl-2 -- 
Faust et al., 
(2011) 
-- -- 




Panaro et al., 
(2007) 
caspases -8, -9 and -3 -- 





Sasahara et al., 
(2003) 
-- -- 
Chen et al.,  
(2002) 
-- Yes 














5.2 MATERIALS AND METHODS 
5.2.1 Culture of Caco-2 colonic epithelial cell line 
Caco-2 stock cultures were maintained as previously described in Chapter 2. 
Cell cultures for Western blotting and flow cytometry experiments were 
grown on standard cell culture 24-well plates (Corning). For confocal imaging, 
cells were cultured on poly-L-lysine-treated 24-mm glass coverslips, placed in 
standard 6-well culture plates (Corning). For permeability experiments, cells 
were grown on Millipore transwell filters as previously described in Chapter 4. 
For caspase inhibition experiments, cell cultures were pretreated with 40 μM  
broad-spectrum caspase inhibitor, z-VAD-fmk (Sigma) for 4 h. Cytochalasin 
D (Sigma) was used as a positive control for permeability experiments at a 
concetration of 1 μg/ml. Staurosporine was used as a positive control for 
induction of apoptosis and ZO-1 rearrangement experiments at a concentration 
of 0.5 μM. 
5.2.2 Parasite culture and lysate 
Two axenized Blastocystis isolates belonging to different subtypes (ST) were 
used in this study. Axenized isolates of Blastocystis ST-7 (B) was maintained 
as previously described in Chapter 2. Isolate WR-1, belonging to ST-4, was 
isolated from a Wistar rat during an animal survey (Chen et al., 1997a). Both 
parasite cultures were maintained in the same conditions. One-day-old parasite 
cultures were harvested for lysate preparation. The cultures were washed twice 
in sterile PBS. Parasitic lysates were prepared by three freeze-thaw cycles in 




5.2.3 Epithelial permeability 
Epithelial permeability measurements after co-incubated with lysate of ST-7 
(B) and ST-4 (WR-1) were performed as described in Chapter 4.  
5.2.4 Flow cytometry 
Annexin-V binding assay was used to observe early apoptotic changes in 
Caco-2 cells. Caco-2 monolayers were grown in 24-well culture plates and 
coincubated with Blastocystis ST-7 or ST-4 for 3 h. Annexin-V-FITC 
apoptosis detection kit (BioVision) was used according to manufacturer's 
instructions. Propidium iodide (PI) was used to exclude necrotic cells. After 
cell staining, samples were analyzed using a flow cytometer (Dako 
Cytomation; Cyan LX) at 488-nm excitation wavelength, with a 515-nm band-
pass filter for fluorescein detection, and a 600-nm filter for PI detection. The 
lower right quadrant was defined to represent the apoptotic cells showing 
annexin-V-FITC-positive and PI-negative staining. 
5.2.5 Confocal microscopy 
Immunostaining for ZO-1 tight junction protein was performed as described in 
Chapter 4. The ImageJ software was used for intensity measurement.  
5.2.6 Western blot 
ZO-1 Western blot analysis was done as previously described in Chapter 4.  
5.2.7 Statistical analysis 





5.3.1 ST-4 (WR-1) strain could not establish enteroadhesion and cause 
disruption of tight junction, in contrast to the enteroadhesive strain of 
Blastocystis ST-7 (B) 
The ability of different Blastocystis strains in adhesion and causing leisions in 
tight junction protein was firstly investigated. Chapter 2 characterized ST-7 
(B) as an adhesive strain and Chapter 4 showed that it could cause degradation 
of ZO-1 tight junction proteins upon adhesion. Here with a strain isolated from 
rat, we demonstrated compared to ST-7 (B), ST-4 (WR-1) is not adhesive to 
Caco-2 cells and did not produce obvious changes in ZO-1. 
Similar to the changes shown in Chapter 4, ST-7 (B) disrupted integrity in ZO-
1 tight junction protein (Fig. 5.1), and caused focal disruption (white arrows) 
and obvious reduction in ZO-1 apical localization. The ZO-1 proteins in WR-
1-treated monolayers remained well preserved and apically localized in the 
monolayer, similar to that in the control monolayer. 
Therefore, by using a control strain, the results provide the first visual 
evidence that the ability in causing leisions in tight junction proteins of 






Fig. 5.1 Representative confocal micrographs illustrating attachment of 
Blastocystis to Caco-2 monolayers resulted in changes in ZO-1 tight 
junction protein.  Caco-2 monolayers were grown to confluency on glass 
converslips and were then co-incubated with the same number of Blastocystis 
ST-4 (WR-1) and ST-7 (B) parasites pre-stained with CFSE (green). Normal 
culture media was used as a negative control. After co-incubation, the non-
attached parasites were washed away. Caco-2 cells were then stained with 
DAPI and labeled with an antibody targeting tight junction protein ZO-1 and 
Cy3® goat anti-mouse IgG (Red). Blastocysis ST-7 (B) attached to Caco-2 to 
a greater extent than ST-4 (WR-1) as seen by more parasites stained with 
CFSE. Compared to negative control, ST-7 (B) treatment resulted in 
disruption of ZO-1 tight junction protein, as shown by the decreased intensity, 
focal disruption (white arrows) and obvious reduction in ZO-1 apical 
localization (yellow arrows) in Caco-2 cell monolayer. However, Blastocystis 
ST-4 (WR1) isolate, which could not adhere, did not produce obvious changes 
in ZO-1 tight junction protein. It could also be noted that parasites preferably 





5.3.2 Blatocystis ST-7 (B) induces characteristics of apoptosis in Caco-2 
cells; ST-4 (WR-1) does not  
(i) PS-flip indicated by annexin-FITC binding 
One of the early indicators of apoptosis is the flipping of phosphatidylserine 
(PS) molecules from the inner to outer leaflet of the plasma membrane. A 35- 
to 36-kDa molecule, Annexin-V, binds to PS with high specificity in the 
presence of calcium. Viable, apoptotic, and necrotic cells can be distinguished 
when FITC conjugated-annexin-V is used in conjunction with PI. The lower 
right quadrants of the dot plots represent the apoptotic cell population, positive 
for annexin binding but PI-negative (Fig. 5.2). Upper quadrants represent 
necrotic cells due to permeability to PI (Fig. 5.2). After treatment with 
Blastocystis ST-7, Caco-2 cells exhibited a significant rise in percentage of 
apoptotic cells compared to the negative control and ST-4 treatment (p<0.01) 
(Fig. 5.2). These findings are in agreement with a strain-dependent 




Fig. 5.2 Flow cytometry analysis of annexin V-FITC and propidium 
iodide staining. Representative dot plots of Caco-2 cells pre-incubated with 
culture media as negative control, Blastocystis ST-7, ST-4 and 0.5 μM 
staurosporin as positive control. 2 × 104 cells were analysed in each sample. 
Values represent mean ± standard error (error bars; n=3). Caco-2 cells treated 
with ST-7 exhibited significantly higher percentage of annexin V+ and PI- 
cells (lower right quadrant) compared to cells co-incubated with ST-4 or 
culture media only (*, p< 0.01 versus control and ST-4). Values are means ± 





(ii) Nuclear fragmentation indicated by DAPI staining 
One of the most distinctive features of apoptosis is morphological change in 
the nucleus, easily observed under florescence microscopy (Fig. 5.3). After 24 
hr treatment with Blastocystis ST-7, nuclei of the Caco-2 cells exhibited 
nuclear condensation and fragmentation (Fig. 5.3) typical of apoptotic cells. 
Significantly higher number of apoptotic cells was observed in ST-7-treated 
membranes compared to ST-4 (p<0.01) and control (p< 0.01) (Fig. 5.3).  
 
Fig. 5.3 Representative fluorescence micrographs after DAPI staining 
showing apoptosis of Caco-2 cells. Caco-2 cells were incubated for 24 h with 
culture media, ST-4, ST-7 or 0.5 μM staurosporine as positive control. Cells 
co-incubated with ST-7 and staurosporine exhibit nuclear fragmentation and 
condensation (arrow) typical of apoptotic cells. Histogram represents 
percentage of apoptotic cells after DAPI fluorescence assay. Caco-2 
monolayers coincubated with ST-7 exhibited significantly higher percentage 
of apoptosis (*, p<0.01) compared with ST-4 and the negative control. Values 
are means ± standard error (n=6 per group). For each sample, ~100 cells were 
counted at 1000× magnification. 
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 (iii) Caspase 3 and 9 activation  
Caspases are pro-enzymes, which are activated by being cleaved into active 
fragments in apoptotic cells. In this study, Western blot analysis revealed that 
Blastocystis ST-7 coincubation with Caco-2, resulted in cleavage of caspase 3 
and 9 (Fig. 5.4). No cleavage of caspase 8 was observed even after 12 h 
treatment with ST-7 (Fig. 5.4) suggesting that Blastocystis ST-7 induced 
Caco-2 programmed cell death by activation of the intrinsic apoptotic 
pathway. ST-4, as expected, did not activate any of the three caspases tested in 
this study (Fig. 5.4).    
 
Fig. 5.4 Western blot analysis of caspase activation (cleavage) in Caco-2 
cells. Caco-2 cells were grown on cell-culture plates and harvested after 
coincubation with Blastocystis ST-4 and ST-7 for 6 and 12 h, as described in 
Materials and methods. Treatment with ST-7 resulted in loss of Caspase 3 and 
9 bands suggesting activation, while caspase 8 remained unchanged. ST-4 did 




(iv) Ultrastructural changes  
Morphological changes were observed by transmission electron microscope in 
Caco-2 cells treated with Blastocysitis for 6h. The cells displayed obvious 
characteristic changes of apoptosis, including chromatin condensation and 
mitochondrial denaturation such as swelling and disappearance of 
mitochondrial cristae in the Blastocysitis-treated cells (Fig. 5.5, Fig. 5.6). 
 
Fig. 5.5 Transmission electron micrograph showing ultrastructural 
changes of Caco-2 cell monolayer induced by Blastocysitis treatment. 
Caco-2 cells were co-incubated with Blastocysitis for 6 hours and then 
prepared for viewing under a transmission electron microscope. One 
prominent feature is the changes in mitochondria. Compared to the condensed 
mitochondria in the normal control, abnormal mitochondria with swollen 
appearances were observed after Blastocysitis treatment (red aroow). The 
cristae structure in the mitochondria appeared to be dirsrupted. The surface 











Fig. 5.6 Transmission electron micrograph showing ultrastructural 
changes of Caco-2 cell monolayer induced by Blastocysitis treatment. 
Caco-2 cells were co-incubated with Blastocysitis for 6 hours and then 
prepared for viewing under a transmission electron microscope. The changes 
in mitochondria again were noticed, with swollen appearances and disrupted 
cristae (red arrow). Chromatin condensation as well as formation of vacuoels 




5.3.3 Blastocystis ST-7 (B) induces increase in permeability to FITC-
conjugated Dextran; ST-4 (WR-1) does not  
Chapter 4 demonstrated ST-7 (B) was able to induce a significant increase in 
epithelial permeability. For monolayers treated by ST-4 (WR-1), on the other 
hand, no significant flux of Dextran-FITC probe across Caco-2 monolayers 
was noticed (Fig. 5.9).  
5.3.4 Inhibition of caspase prevented Blastocystis ST-7-induced ZO-1 
rearrangement and epithelial barrier dysfunction in Caco-2  
It has been reported previously that tight junction disruption and host 
epithelial dysfunction induced by luminal parasites is caused by increased 
apoptosis in enterocytes (Chin et al., 2002). Confocal micrographs and 
Western blot analysis showed that inhibition of host caspases by z-VAD-fmk 
prevented ST-7-induced ZO-1 changes (Fig. 5.7, and Fig. 5.8). Also, the 
increase in permeability of Caco-2 monolayers induced by ST-7 (B) was 
significantly prevented (p<0.01) (Fig. 5.9). These findings suggest a role of 





Fig. 5.7 Representative confocal micrographs illustrating ZO-1 integrity 
in Caco-2 monolayers. Caco-2 monolayers were grown to confluency on 
poly-L-lysine treated converslips. Caco-2 cells were then conincubated for 12h 
with either Blastocystis ST-4 or ST-7. Some monolayers were treated with 
broad-spectrum caspase inhibitor z-VAD-fmk before coincubation with ST-7. 
Normal culture media and 0.5 μM staurosporine were used as negative and 
positive controls respectively. Compared to negative control, ST-7 treatment 
resulted in obvious reduction in ZO-1 apical localization in Caco-2 cell line. 
ST-4 did not alter ZO-1 integrity. Pretreatment with z-VAD-fmk rescued ST-7 
induced ZO-1 changes in the epithelium. (B) Quantification of ZO-1 staining 
shown as graphs. Each cell layer (1–25) corresponds to series of images from 
Z-stack sections taken at 1µm thickness through the cell monolayer shown in 
(A). X-axis illustrates cell layers from apical to basolateral. Y-axis illustrates 
the number of pixels present over the entire area of image. Monolayers treated 
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with ST-7 and staurosporine resulted in marked reduction in number of pixels 
in cell layers representing apical region, compared to ST-4 treated epithelium 
and normal control. Pre-treatment of epithelium with broad-spectrum caspase 
inhibitor, z-VAD-fmk resulted in inhibition of ST-7 induced ZO-1 changes in 





Fig. 5.8 Western blot analysis of ZO-1 integrity in Caco-2 epithelium. 
Caco-2 monolayers were cultured in cell-culture plates and harvested after 
coincubation with Blastocystis ST-4, ST-7, normal growth media and 0.5 μM 
staurosporine. Monolayers were also treated with broad-spectrum caspase 
inhibitor z-VAD-fmk before incubation with ST-7. After coincubation with 
ST-7 and staurosporine for 6 h, loss of ZO-1 band was observed. The ZO-1 
band remained unchanged in ST-4 treated and control Caco-2 cells. Caspase 







Fig. 5.9 Inhibition of Caco-2 caspases prevented Blastocystis ST-7-induced 
epithelial barrier dysfunction. Flux measurement with FITC-conjugated 
Dextran. Confluent monolayers of Caco-2 cells were co-incubated for 24 h 
with Blastocystis ST-4 or ST-7. Some monolayers were co-incubated with ST-
7 after pretreatment of cells with the broad-spectrum caspase inhibitor Z-
VAD-fmk. Permeability was determined by measurement of Dextran-FITC 
fluxes across the monolayer as described in Materials and Methods. A 
significant increase in the epithelial permeability can be noticed after 
incubation with ST-7, compared to negative control and ST-4 coincubation 
(p<0.01). Pretreatment of Caco-2 cells with caspase inhibitor significantly 
rescued these cells from Blastocystis-induced effect on permeability. Values 
are means ± standard error (error bars) (n=6). (*, p<0.01 vs. control and ST-4; 






The study reported that Blastocystis ST-7 (B) isolate recovered from a 
symptomatic patient adhered to the intestinal epithelium and induced caspase-
mediated enterocyte apotosis and epithelial barrier dysfunction in Caco-2 
human epithelial cell-line. Interestingly an ST-4 isolate, WR-1, recovered 
from an asymptomatic host did not adhere to the epithelium or induce 
enterocyte pathology. The study provides the evidence of a strain-to-strain 
variation in Blastocystis induced intestinal epithelial barrier compromise and 
suggests that this variation might be determined by enterocyte adhesion. 
This was also the first report that Blastocystis caused apoptosis in human 
epithelial cells. Apoptosis or programmed cell death is a pre-programmed 
method of clearing up unwanted cells by the body (Savill, 1997) without 
overtly stimulating a host immune response (Gao et al., 1998). Cells undergo 
apoptosis even under physiological conditions, but several pathogens 
including parasites have evolved mechanisms to disrupt this machinery, by 
either up-regulating (Chin et al., 2002, Huston et al., 2003) or down-regulating 
(Yamada et al., 2011) it for their survival in the host. Blastocystis ST-7 
induced both early and late hallmarks of apoptosis, i.e. PS-externalization and 
nuclear fragmentation respectively, in host enterocytes. Increased enterocyte 
apoptosis in some cases is also proposed to be a host response to infection by 
increasing the cell turnover in order to rid the body of the infected cells (Cliffe 
et al., 2005). Mucosal sloughing reported during Blastocystis infections (Chen 
et al., 1997a) might be a result of this increased turnover. Anti-inflammatory 
effects of apoptosis are also well recognized (Haslett, 1997). The relatively 
131 
 
moderate level of apoptosis induced by Blastocystis in intestinal epithelium, is 
similar to programmed cell death of enterocytes when exposed to 
Cryptosporidium (McCole et al., 2000) and Giardia (Chin et al., 2002). It is 
suggested that up-regulation of host cell apoptosis might be a reason for lack 
of overt host inflammatory response during parasitic infections (Chin et al., 
2002, McCole et al., 2000) and might assist them in colonizing the hostile host 
environment. Although further investigation is needed in this area, the absence 
of obvious gut inflammatory changes in Blastocystis infected hosts might be 
due to the ability of the parasite to down-regulate host inflammatory response 
by induction of enterocyte apoptosis. 
The first study also identified that Blastocystis induced epithelial apoptosis by 
activation of the intrinsic pathway. Caspase 3 activation lies at the center of 
the caspase-mediated apoptosis (Savill, 1997). It is preceded by activation of 
either intrinsic pathway, involving mitochondrial injury and capase 9 
activation or extrinsic pathway due to Fas/FasL receptor mediated caspase 8 
activation. Parasites have evolved complex mechanisms to activate epithelial 
caspase 3. Giardia activates extrinsic as well as intrinsic apoptotic pathways 
(Panaro et al., 2007). Entamoeba on the other hand does not require either 
caspase 8 or 9 for enterocyte caspase 3 activation (Huston et al., 2000). An 
earlier study reported that Blastocystis ST-4 induced rat epithelial apoptosis by 
caspase 3 activation (Puthia et al., 2006). There is no data available suggesting 
a similar outcome in human epithelium. Upstream pathways involved in 
caspase 3 activation by the parasite are not known either. In this study the 
rodent strain had no effect on Caco-2 cell line, but ST-7-induced caspase 3 
activation.  Blastocystis unlike Giardia or Entamoeba only activated caspase 
132 
 
9. A recent study suggested the involvement of Rho kinases in selective 
activation of caspase 9, leading to apoptosis (Del Re et al., 2007). A role of 
Rho kinase has been suggested in Blastocystis-induced breakdown of host 
epithelial barrier function, cytoskeletal rearrangement (Mirza et al., 2012b). 
Although more data is required, selective activation of caspase 9 by 
Blastocystis in this study might be a result of epithelial Rho kinase modulation 
by the parasite. Further understanding of the unique cellular mechanisms 
employed by Blastocystis to induce host-cell apoptosis might help us develop 
targeted therapeutics to prevent parasite induced host pathology.  
Apoptosis also plays a diverse role in the modulation of epithelial barrier 
function and tight junction reorganization. On one hand enterocyte apoptosis 
ensures that epithelial barrier remains sealed (Marchiando et al., 2011), while 
in other cases induction of apoptosis is employed by pathogens to increase 
epithelial permeability (Chin et al., 2002) and cause host pathology (Becker et 
al., 2010). Inhibition of host caspases resulted in prevention of Giardia-
induced modulation of epithelial permeability and ZO-1 organization (Chin et 
al., 2002) while, inhibition of caspase-mediated apoptosis in enteropathogenic 
E. coli (EPEC) infections did not prevent the epithelial ZO-1 alterations (Buret 
et al., 1998). In a recent study on rodent epithelium, pretreatment of host 
epithelium with pan-caspase inhibitor z-VAD-fmk did not rescue Blastocystis 
ST-4-induced epithelial barrier dysfunction (Puthia et al., 2006). In the current 
study, z-VAD-fmk treatment of epithelium significantly inhibited Blastocystis 
ST-7-induced epithelial barrier compromise. Parasite-induced ZO-1 alteration 
was also prevented significantly by host caspase inhibition, reiterating that 
role of enterocyte apoptosis in parasite-induced epithelial barrier dysfunction. 
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Interestingly, changes in ZO-1 were also shown to be prevented by Rho kinase 
(Mirza et al., 2012b), again raising the question of the role of Rho kinase in 
capase-mediated apoptosis.  
To conclude, this is the first study showing that enteroadhesive Blastocystis 
ST-7 (B), an isolate recovered from a symptomatic patient, induced enterocyte 
apoptosis by activating caspase 3 and 9, suggesting the involvement of the 
intrinsic apoptotic pathway in pathogenesis. Inhibition of host caspases 
prevented parasite induced epithelial barrier dysfunction as well as ZO-1 
rearrangement suggesting the role of caspase-dependent enterocyte apoptosis, 
induced by Blastocystis, in host epithelial barrier dysfunction. Furthermore, 
the inability of rodent subtype ST-4 to adhere and induce any changes in 
Caco-2 provides evidence of host-specificity and strain-dependency in 
Blastocystis-induced human epithelial pathology. The strain-to-strain variation 
in parasite virulence is a plausible explanation for the large number of 
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As reviewed in Chapter 1, it is difficult to argue the clinical significance and 
pathogenic potential of Blastocystis, since infections do not consistently lead 
to intestinal symptoms (Eroglu et al., 2009, Kaneda et al., 2000, Stensvold et 
al., 2009c). While a large number of infected individuals present with clinical 
symptoms (Eroglu et al., 2009), asymptomatic carriage of the parasite is also 
common (Boorom et al., 2008). Moreover, in symptomatic patients, the 
duration and severity of symptoms vary from acute enteritis to chronic mild 
diarrhea (Nagel et al., 2012, Stensvold et al., 2009c). There is no consensus on 
the possible reasons for the observed diverse intestinal symptoms. A number 
of reports have suggested a strain- or subtype-dependent variation in parasite 
pathogenicity (Dominguez-Marquez et al., 2009, Mirza et al., 2011b, Nagel et 
al., 2012, Scanlan, 2012, Stensvold et al., 2009b, Stensvold et al., 2009c). 
Studies have associated ST-1, -4 and -7 with pathological alterations in 
humans, as reviewed in Chapter 1. The presence of both pathogenic and 
nonpathogenic strains within one subtype has also been well reported (Hussein 
et al., 2008, Iguchi et al., 2007). Yet the factors determining this variation in 
pathogenicity across different Blastocystis strains have not been resolved. 
Attachment is a crucial step in the expression of the cytopathogenicity of 
extracellular parasites. Studies have suggested the level of adhesion is directly 
linked to the virulence properties of pathogens (Brooks et al., 2013, Park et al., 
2009). Highly adhesive strains of Giardia, Entamoeba, Trichomonas and other 
eukaryotes have been shown to result in more severe damage of the epithelium 
compared with less adherent strains (Flores-Romo et al., 1997, Muller et al., 
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2005, Rojas et al., 2004). Chapter 2 identified a strain which adhered and 
caused pathological changes. Chapter 4 and 5 investigated in-depth the 
structural and functional changes in epithelial cells after parasite adhesion. It is 
important to determine adhesiveness of the parasite with enterocytes across 
different Blastocystis strains and investigate its association with parasite 
pathogenicity. In Chapter 5, with two strains exhibiting varied levels of 
enteroadhesion, there was also a variation in the induction of apoptosis and 
barrier compromise. However, it was limited to two strains. To see how the 
ability in attachment would affect their pathogenicity, more strains need to be 
included. 
Aside from adhesion, which is an important measurement of virulence in 
inducing intestinal pathology, it’s also important to compare specific virulence 
factors contributing to pathogenicity. Cysteine proteases are suspected to be 
Blastocystis virulence factors and have been shown to play a role in epithelial 
barrier compromise (Mirza et al., 2012b). Proteases from Entamoeba, 
Acanthamoeba and other pathogens were reported to induce epithelial barrier 
dysfunction (Groeger et al., 2010, Lauwaet et al., 2004a). Both qualitative and 
quantitative differences in cysteine protease profiles have also been reported 
between pathogenic and non-pathogenic strains of E. histolytica (Davis et al., 
2007, Hirata et al., 2007, Reed et al., 1989) and G. intestinalis (DuBois et al., 
2006, Guimaraes et al., 2003). Previously, it was shown that Blastocystis ST-4 
and ST-7 exhibited extensive variations in protease activity (Mirza and Tan, 
2009). But it was limited to two strains from each subtype, moreover, a 
comparison of the cytopathic effects of these strains is still lacking. It’s 
necessary to investigate the differences in protease activity among a wider 
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range of Blastocystis strains and see whether it correlates with the parasites’ 
ability to induce epithelial pathology. 
Another issue complicating the pathogenic potential of Blastocystis is reports 
of treatment failure (Stensvold et al., 2008, Stensvold et al., 2010). Non-
responsiveness to Mz chemotherapy has been frequently reported (Stensvold 
et al., 2009c). Strain-to-strain variation within Blastocystis in susceptibility to 
Mz and other antiparasitic agents is commonly reported and has been 
proposed to be the reason for frequent treatment failures in parasite infections 
(Mirza et al., 2011a). However, from an evolutionary standpoint, mutations 
associated with drug resistance may impair essential biological functions or 
impose energy demands on the organism, leading to decreased microbial 
fitness (Andersson et al., 2010, Ben-Ami et al., 2012). Studies of a variety of 
pathogens including different species of viruses, bacteria, and parasites, 
indicate that antimicrobial resistance places a toll on the organisms’ fitness as 
well as virulence (Muregi et al., 2011). A recent study in an intestinal 
protozoan parasite, Giardia, revealed impaired attachment and decreased 
infectivity in Mz resistant (Mzr) strains compared with parental Mz sensitive 
(Mzs) strains (Tejman-Yarden et al., 2011) and was given as a possible reason 
for the scarcity of treatment failure in people with symptomatic parasite 
infections. The interplay among drug resistance, fitness and virulence in 
Blastocystis has never been studied. Considering the frequent reports of 
treatment failure in symptomatic Blastocystis infections, it will be interesting 
to establish whether drug resistance exerts any effects on the pathogenicity as 
well as other aspects of parasite fitness. 
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In the present study, using seven isolates from Blastocystis ST-4 and ST-7, 
extensive intra- and inter-subtype variability in inducing intestinal barrier 
dysfunction was firstly demonstrated, and the question whether adhesion 
contributed to this variation was investigated. It was found that Mz resistance 
correlated with impairment of parasite adhesion and adhesion-associated 
cytopathic effects. Additionally, Mz resistance also seemed to be associated 
with nitrosative stress tolerance, an important factor assisting parasite survival 





6.2 MATERIALS AND METHODS 
6.2.1 Parasite culture 
Seven axenized isolates of Blastocystis (designated B, C, E, G, H, S-1 and 
WR-1) were used (Figure 6.1). Isolates B, C, E, G and H were originally 
recovered from symptomatic patients at the Singapore General Hospital (Ho et 
al., 1993). All five isolates belonged to ST-7 according to recent classification 
system as B (Stensvold et al, 2007b). ST-4 (WR-1 and S-1) strains were 
isolated from rats during animal survey (Chen et al., 1997a). Isolates were 
subtyped previously by small-subunit rRNA gene analyses (Noel et al, 2005). 
Both ST-4 and ST-7 are well characterized zoonotic Blastocystis isolates 
commonly detected in humans with gastrointestinal symptoms (Stensvold et al, 
2009c). Stock cultures of all seven isolates were maintained as isolate B as 
described in Chapter 2.     
                             





6.2.2 Culture of Caco-2 colonic epithelial cell line 
Caco-2 stock cultures were maintained as previously described in Chapter 2. 
For Western blot analysis, Caco-2 monolayers were grown on 6-well cell 
culture plates (corning) until 100% confluency. For immunofluorescence and 
confocal microscopy experiments, Caco-2 monolayers were cultured on Poly-
L-lysine-treated 15mm glass coverslips placed in standard 24-well culture 
plates. For epithelial permeability experiments cells were grown on Millipore 
transwell filters with PET membranes of 3μm pore-size, placed in 24-well 
tissue culture plates. In order to synchronize cells before experiments, all 
cultures were serum-starved overnight in antibiotic-free and serum-free 
DMEM.    
6.2.3 Parasite viability assay 
The optimized Blastocystis viability assay was used to measure 50%  
inhibitory concentrations (IC50s) of different drugs for the Blastocystis strains 
(Mirza et al., 2011a). Briefly, stock solutions of drugs were prepared in 
dimethyl sulfoxide (DMSO), diluted in pre-reduced Blastocystis culture 
medium, transferred to 96-well plates and pre-reduced in anaerobic jar for 4 h  
at 37°C. Parasites were counted and 0.5×106 cells were incubated in each well 
of a standard 96-well plate with dilutions of different drugs ranging between 0 
and 100 μg/ml. The drug concentration range was reduced or increased 
depending on the results of the first test. A range of parasite counts between 
zero and 0.5×106 per well were used for viability control. The final DMSO 
concentration was kept constant at 0.5% in each well. Since the parasite redox 
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activity varies with volume, the final total volume of each well was kept 
constant at 200 µl. After 24 h of drug exposure, resazurin solution (Sigma) 
was added to each well at a final concentration of 10% (v/v); 3 h after 
incubation under anaerobic condition at 37°C, fluorescence readings of 
resazurin were taken at 550-nm excitation and 580-nm emission wave lengths 
using a Tecan Infinite M200 reader. Values were imported into GraphPad 
Prism5 software and IC50s were calculated.  
6.2.4 Growth curve 
The growth curve of each of the seven isolates was made by culturing over a 
period of 96h. Briefly, 5×106 parasites of each isolate were inoculated into 
IMDM and cultured under anaerobic conditions at 37°C. At each of the five 
time points (0, 24, 48, 72 and 96 h), parasite pellets were resuspended and cell 
numbers were counted using appropriate dilutions in a hemocytometer.  
6.2.5 Azocasein assay for cysteine protease activity 
Parasite protease activity was determined using an azocasein assay as 
described previously (Sio et al., 2006). Briefly, lysates of 4×106 parasites were 
co-incubated with 2 mM dithiothreitol (DTT) (Sigma) at 37°C for 10 min to 
activate protease activity. Azocasein (Sigma), 100 μl of 5 mg/ml, solution was 
prepared in PBS (pH 7.4) and incubated with 100 μl of parasite lysate for 1 h 
at 37°C. The reaction was stopped by adding 300 μl of 10% trichloroacetic 
acid (TCA) and samples were incubated on ice for 30 min. Undigested 
azocasein was removed by centrifugation (5,000 × g for 5 min) and the 
resultant supernatant was transferred to a clean tube containing 500 μl of 525 
mM NaOH. Absorbance was measured using a spectrophotometer at 442 nm 
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(Tecan Magellan). PBS was used as a negative control. For inhibition 
experiment, 2 mM iodoacetamide (IA) were added to the parasite lysate and 
incubated for 1 h at room temperature (22°C-24°C) to inhibit the cysteine 
proteases (Puthia et al., 2005).  
6.2.6 Adhesion assay 
Adhesion assay with all Blastocystis isolates were performed as described in 
Chapter 3.  
6.2.7 Epithelial permeability 
Caco-2 monolayers were co-incubated with parasite live cells of all 
Blastocystis isolates for 24 h. Epithelial permeability was then measured as 
described in Chapter 4. 
6.2.8 Western blot  
Western blot analysis for ZO-1, Occludin were performed as described in 
Chapter 4. MLC and MLCp were done with primary antibody (mouse anti-
MLC, rabbit anti-MLCp; Sigma).  
6.2.9 Confocal microscopy  
Nitric oxide cytotoxicity against Blastocystis was investigated by confocal 
microscopy (Annexin-FITC/PI staining). Live Blastocystis were treated for 3 h 
with a 50 μg/ml concentration of GSNO (S-Nitrosoglutathione), a nitric oxide 
donor. After drug exposure, the parasites were washed and re-suspended in 
Annexin V binding buffer (BioVision). Fluorescein isothiocyanate (FITC)-
labeled annexin V and propidium iodide (PI) (BioVision) were then added to 
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the cell suspension at the ratio of 1:100. Imaging of cell suspensions was 
conducted using an Olympus Fluoview FV1000 (Japan). Images were 
captured using Olympus Fluoview v. 1.6b.  
Visualization of tight junction proteins in Caco-2 cells were performed as 
described in Chapter 4.  
To explore the spatial relationship between Blastocystis and Caco-2 
monolayers after attachment, immunofluorescence was performed as 
described in Chapter 2.  
6.2.10 Drug preparation  
Stock solutions of each compound to be tested were prepared fresh in dimethyl 
sulfoxide (DMSO). For drug sensitivity determination, stock solutions were 
diluted in pre-reduced Blastocystis medium and transferred to 96-well plates 
and pre-reduced again for 4 h. The final DMSO concentration was kept 
constant at 0.5%. 
6.2.11 Statistical analysis 
The ANOVA test was used to confirm the statistical significance of the 
results. Correlation analyses between Mz resistance and fitness parameters (i. 
e. attachment, permeability increase and nitric oxide tolerance) were 
performed using the Pearson correlation method in GraphPad Prism 6 





6.3.1 Blastocystis exhibits intra-and inter- subtype variation in ability to 
induce epithelial permeability increase in human epithelium 
It has been previously reported that Blastocystis induces human intestinal 
barrier dysfunction in an in vitro model (Mirza et al., 2012b). Chapter 4 also 
identified the barier-disruptiong effects of Blastocystis, the study investigated 
the variability in the ability of different parasite isolates to breach the 
epithelial barrier. Live parasites of all Blastocystis isolates used in the study 
were applied apically on to Caco-2 cell monolayers differentiated on transwell 
inserts. Permeability changes caused by the parasites were analyzed by 
measuring the flux of Dextran–fluorescein isothiocyanate (FITC) probe across 
the intestinal epithelial barrier from the apical to the basolateral compartment. 
Exposure to ST-4 isolates WR-1 and S-1 did not change permeability 
significantly compared with that of the control (Fig. 6.2). In contrast, all five 
ST-7 strains of Blastocystis could induce significant increase in epithelial 
permeability compared with the control and ST-4-treated monolayers 
(p<0.01). Within ST-7, extensive variations in the ability to induce 
permeability increase were observed (Fig. 6.2). Compared with the negative 
control monolayers, the fold increase in permeability to FITC-dextran in ST-7-
infected monolayers were 16, 11.8, 14.5, 5.5, 4.2, respectively, for isolates H, 
G, C, B and E (Table 6.1). Among them, C, G and H induced a significantly 
higher permeability increase compared with isolates B and E (p<0.01) (Fig. 
6.2). The permeability change caused by isolate H was the most prominent and 
was more than three times higher than that by isolate E (Table 6.1). 
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Altogether, it suggested intra- and inter-subtype variation in barrier disruptive 
activity of different Blastocystis isolates.   
 
 
Fig. 6.2 Intra-and inter- subtype variation in Blastocystis in inducing 
permeability increase. Graph representing epithelial permeability of Caco-2 
monolayers after co-incubation with live cells of Blastocystis ST-7 and ST-4 
for 24h. All strains in ST-7 induced significant increase in flux of Dextran–
FITC across epithelial monolayer of Caco-2 cells compared to control 
monolayers (p<0.01). No significant change in permeability was observed in 
Blastocystis ST-4 -infected Caco-2.Within ST-7, an intra-subtype variation in 
the capability of inducing permeability change was observed. Isolates C, G 
and H induced much higher permeability increase compared with isolates B 
and E within the same subtype (p<0.01). **, p<0.01 vs. ST-7 (B, E)-infected 
cells; ##, p<0.01 vs. ST-4-infected cells; ‡, p<0.01 vs. non-infected cells. Each 
value represents mean of twelve samples, taken from three independent 




Table 6.1 Comparisons of effects of luminal pathogens/ toxins on intestinal 
permeability increase  



















ST-7 (G) 11.8 
ST-7 (C) 14.5 
ST-7 (B) 5.5 









































SCBN NF strain 
2×107 
/ml 
24h >4 Chin et al., 
(2002) 48h 9 
SCBN S2 isolate 107 /ml 24h >40 
Buret et 
al., (2002) 
SCBN S2 isolate 106 /ml 2h 5.6 







6.3.2 Blastocystis exhibits intra-and inter-subtype variability in ability to 
disrupt epithelial tight junction proteins 
As in Chapter 4, we proceeded to conduct an analysis of the changes in Caco-
2 tight junction proteins Occludin and ZO-1 after exposure to all the seven 
strains of Blastocystis. Consistent with the permeability results, the profile of 
tight junction degradation shown by Western blot analysis differed from strain 
to strain and correlated with the degree of permeability increase caused by 
each strain (Fig. 6.3). ST-4 treatments did not alter the two tight junction 
proteins significantly which might explain the insignificant permeability 
increase seen above (Fig. 6.2).  
Expression of occludin, was significantly decreased compared with the control 
and ST-4 treatments by exposure to ST-7 isolates C, G, and H (p<0.01) (Fig. 
6.3). But no changes in occludin were observed in ST-7 isolates B- and E-
treated cells, which might contribute to the less pronounced permeability 
increase by B and E compared with C, G and H. The other tight junction 
protein ZO-1, a multi-domain scaffold protein localized at the tight junction, 
however, showed a different pattern of disruption from that of occludin. All 
ST-7 strains induced a significant decrease in ZO-1 band intensity compared 
with the negative control, which might explain the prominent permeability 
increase in B-, E-treated cells compared with control monolayers; nevertheless, 
the degree of ZO-1 degradation by B and E was again significantly less than C, 
G and H (p<0.01) (Fig. 6.3), suggesting a more potent ability in disrupting 
ZO-1 by C, G and H among ST-7 isolates. 
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In addition, immunofluorescence was performed to observe the distribution 
and integrity of the tight junction proteins. Indirect immunolabelling of 
occludin in control monolayers showed a bright and continuous band lining 
cell-to-cell contact (Fig. 6.3C). The staining pattern in cells treated by ST-4 
(WR-1 and S-1) and ST-7 (B and E) isolates did not differ from that of the 
controls. In contrast, infection of Caco-2 cell monolayers with ST-7 (C and G) 
led to focal disruptions and punctate concentration along pericellular 
junctions, while there was almost a complete loss of Occludin in H-treated 
cells. As expected, ZO-1 proteins in cells after ST-4 infection appeared to be 
similar to those of control monolayers, where they showed a typical, 
continuous pericellular organization. Treatments with ST-7 (B and E), 
however, resulted in both a reduction in ZO-1 intensity and reorganization of 
ZO-1 (Fig. 6.3D), as reported previously for ST-7 (B)-treated Caco-2 cells 
(Mirza et al., 2012b)，whereas exposure to ST-7 (C, G and H) isolates led to 





Fig. 6.3 Differential effects on tight junction protein degradation in Caco-
2 cell monolayers by different strains of Blastocystis. (A) Representative 
Western blot analysis of Occludin and ZO-1 level in Caco-2 epithelium. 
Monolayers were harvested after infection with Blastocystis ST-4 and ST-7 
isolates; normal culture media was used as a negative control. No obvious 
change in Occludin and ZO-1 could be noticed in ST-4-treated samples. 
Within ST-7, a more prominent decrease or loss of Occludin band could be 
seen in cells treated by C, G and H strains, while the changes in B, E-treated 
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cells were not obvious; for ZO-1 tight junction protein, loss of band was 
observed in Caco-2 cells after coincubation with ST-7 (C, G and H), whereras 
a decrease in band intensity was also noticed in B, E-treated cells. (B) 
Quantification of tight junction levels through densitometry analysis of 
Western blot radiographs. Densitometric values of Occludin and ZO-1 signals 
were quantified and expressed as the ratio to α-Tubulin. ST-4-treated samples 
did not differ significantly from control in Occludin and ZO-1 level; ST-7 (C, 
G and H) induced significant Occludin and ZO-1 degradation compared with 
ST-4 and ST-7(B, E) isolates (p<0.01). ST-7 (B, E), however, were able to 
induce significant ZO-1 degradation compared with control and ST-4-treated 
samples, but not for Occludin. **, p<0.01 vs. ST-7 (B, E)-infected cells; #, 
p<0.05 vs. ST-4-infected cells; ##, p<0.01 vs. ST-4-infected cells; ‡, p<0.01 
vs. non-infected cells. Results were from three independent experiments. Error 
bars represent the standard errors. (C) Representative confocal micrographs 
illustrating Occludin integrity in Caco-2 monolayers. Caco-2 cells are labelled 
with DAPI (Blue) and an antibody targeting tight junction protein Occludin 
and Cy3® goat anti-mouse IgG (Red). Corresponding with Western blot 
results, in ST-4 and ST-7 (B, E)-treated samples, no obvious change in 
Occludin was observed. Infection with ST-7 (C, G, H), however, induced focal 
disruptions and degradation in Occludin, as shown by the decreased Occludin 
staining intensity in Caco-2 cell line. Scale bar= 10 μm. (D) Representative 
confocal micrographs illustrating ZO-1 integrity in Caco-2 monolayers. Caco-
2 cells are labelled with DAPI (Blue) and an antibody targeting tight junction 
protein ZO-1 and Cy3® goat anti-mouse IgG (Red). Compared with the 
negative control and ST-4-treated samples, where ZO-1 appeared as 
continuous with sharp pericellular staining patterns, all ST-7 isolates resulted 
in focal disruption as well as degradation of ZO-1 in Caco-2 cells. In ST-7 (C, 
G, H)-treated samples, ZO-1 staining almost became invisible, indicating more 
degradation of the protein, which corresponded with the Western blot results. 
Notably, treatments with ST-7 (B, E) resulted in both focal disruptions (green 




6.3.3 Blastocystis isolates exhibit strain-to-strain variation in attachment 
to human enterocytes 
In many parasites and other pathogens, adhesion is directly associated with the 
virulence properties of the strains (Brooks et al., 2013, Rojas et al., 2004). The 
study therefore tested whether there was a difference in the adhesion 
properties of different isolates and whether it correlated with the ability of the 
parasites to induce a permeability increase in intestinal monolayers. To detect 
and quantify adhesion of different Blastocystis isolates to host cells, an 
adhesion assay was developed using Caco-2 cell line. Both of the ST-4 strains 
WR-1 and S-1, showed negligible adhesion (Fig. 6.4). Within ST-7, isolates B 
and E adhered to host cells in a significantly lower number than C, G and H 
(p<0.05) (Fig. 6.5). From the merged image, it was clear that C, G and H 
parasites attached in large numbers (Fig. 6.4). Isolate H, which induced 
highest epithelial permeability increase, was also the most adhesive to host 
cells (Fig. 6.5). The results suggested an association between the level of 
attachment and the ability to induce permeability increase. An analysis of 
these two phenotypes showed a significant positive correlation, suggesting that 
adherence might play a role in virulence (R2=0.8506, p<0.01) (Fig. 6.5). Even 
though isolates S-1 and E exhibited similar level of attachment (Fig. 6.4), the 
former failed to induce a permeability increase in Caco-2 monolayers (Figure 
6.2), suggesting that additional factors of isolate E might contribute to the 
permeability increase. Furthermore, the study also provided visual evidence of 
association between Blastocystis-induced host-cell pathology with parasite-
enterocyte contact (Fig. 6.6). Blastocystis ST-7 (H) preferentially adhered at 
the apical junction region (Fig. 6.6A), as seen previously in Chapter 2 for 
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isolate ST-7 (H). The percentage of parasites preferentially attached to the 
intercellular junctions was 80% ± 3.8% of all attached cells (values are means 
± SE). Parasites adhered intimately with host cells at the cell-cell junction site 
and induced increase in actin polymerization (Fig. 6.6B and C). Besides, loss 
of cellular symmetry could be noticed in the host cells compared to negative 
control which displayed a properly organized epithelium (Fig. 6.6B), 





Fig. 6.4 Blastocystis exhibits intra- and inter-subtype variation in 
attachment to Caco-2 cells. (A) Representative confocal micrographs 
illustrating intra- and inter-subtype variation in Blastocystis attachment to 
Caco-2 cells. Caco-2 monolayers were grown to confluency on glass 
converslips and were then co-incubated with the same number of parasites of 
different strains of Blastocystis pre-stained with CFSE (green). Normal culture 
media was used as a negative control. After co-incubation, the non-attached 
parasites were washed away. The Caco-2 monolayers were then stained with 
DAPI and then were viewed using confocal microscope (Olympus 
FLUOVIEW-FV100; Olympus, Japan). More green in the field represents 
more parasites attached to the monolayer. Both ST-4 strains adhere with a 
negligible number. An intra-subtype variation in the number of attachment 
within ST-7 is obvious. Isolates C, G, H appeared to attach at a much higher 
level than B and E to Caco-2 cells. Scale bar= 100 μm. (B) Graph representing 
number of Blastocystis parasites attached to host cells. ST-7strains C, G and H 
exhibited a significantly higher number of attached parasites than ST-4 strains 
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and ST-7 isolates B and E. *, p<0.05 vs. ST-7 (B, E); **, p<0.01 vs. ST-7 (B, 
E); ##, p<0.01 vs. ST-4. Each value represents a mean of six readings derived 




Fig. 6.5 Relationship between attachment and permeability increase by 
Blastocystis ST-4 and ST-7 parasites. The data points indicate individual 
strains. x and y error bars indicate the standard error for the respective 
measurements (n=3). The R2 for the trend line shown is 0.8506, and the p 
value is 0.0031. There is a positive correlation between the level of attachment 







Fig. 6.6 Blastocystis ST-7 (H) attaches to an intestinal monolayer. Caco-2 
monolayers were grown to confluency on glass coverslips and were then 
coincubated with Blastocystis ST-7 isolate H. Normal culture media was used 
as a negative control. (A) Representative confocal micrographs illustrating 
attachment of Blastocystis ST-7 (H) to Caco-2 monolayers. Blastocysis ST-7 
was labelled with legumain antibody-mAb1D5and secondary Alexa Fluro® 
594 goat anti-mouse IgM (red). Phalloidin-FITC (green) was used to label F-
actin of Caco-2 cells and DAPI (blue) for nuclei. Compared with the negative 
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control, attachment of Blastocystis ST-7 to Caco-2 apical side could be seen 
clearly. (B) Expanded section views of epithelium of control and ST-7 (H)-
treated-monolayers. Parasites could be seen intimately adhering to the 
epithelium and it could also be noted that the parasites adhered preferentially 
to the cell-cell junction site (yellow arrows) and induced an increase in actin 
polymerization. Compared with the negative control which displayed a 
properly organized epithelium, there was loss of cellular symmetry in the cells 
treated by ST-7 (H) (black arrowheads). Scale bar =20 μm. (C) Quantification 
of F-actin staining in Blastocystis-infected Caco-2 monolayers. Each cell slice 
(1–25) corresponds to series of images from Z-stack sections taken at 1μm 
thickness through the cell monolayer. X-axis illustrates cell layers from 
basolateral to apical. Y-axis illustrates the number of pixels present over the 
entire area of image. Monolayers treated with ST-7 (H) resulted in marked 





6.3.4 Blastocystis exhibits extensive intra- and inter-subtype variation in 
cysteine protease activity 
As cysteine proteases (CPs) have been suspected to be virulence factors in 
Blastocystis and have been shown to play a role in inducing barrier 
compromise (Mirza et al., 2012b), hence the study compared the cysteine 
protease activity of all the seven Blastocystis isolates. CP activities in 
respective parasite lysates were determined using azocasein assay. All strains 
tested showed significantly higher protease activity than the PBS control. 
Variation in protease activity was observed among different Blastocystis 
isolates (Fig. 6.7). ST-4 isolates WR-1 and S-1 showed protease activity of 
13.86±2.5 and 13.25±4.2 azocasein units. Except isolate G, most of the ST-7 
strains showed significantly higher protease activity than ST-4 isolates 
(p<0.01), with 30.41±0.94, 34.99±3.04, 26.03±2.10, 26.83±4.17 azocasein 
units for B, E, C, and H respectively. Lysate of G isolate showed activity of 
16.77±3.98 units, which was not significantly different from ST-4 strains. 
There was no correlation between the total CP activities and the virulence of 
each strain, suggesting that total cellular cysteine protease is not responsible 
for the variation in pathogenicity within ST-7 isolates in inducing intestinal 












Fig. 6.7 Intra- and inter-subtype variations in protease activity in 
Blastocystis. Protease activity of Blastocystis ST-4 and ST-7 isolates was 
determined by azocasein assays. Except isolate G, most of ST-7 strains 
exhibited significantly higher protease activities than the two ST-4 isolates 
(p<0.01). PBS showed activity that was significantly lower when compared to 
protease activities of all the isolates (p<0.01). Note that cysteine protease 
inhibitor iodoacetamide (IA) abolished protease activity of all the isolates, 
which is comparable to PBS. ##, p<0.01 vs. ST-4; ‡, p<0.01 vs. PBS control. 
Each value represents mean of six samples, taken from three independent 




6.3.5 Blastocystis ST-7 isolates exhibit extensive variation in resistance to 
Mz, and the level of Mz resistance is inversely correlated with an ability to 
attach and induce a permeability increase 
It was previously reported that isolates B and E belonging to ST-7 were Mz 
resistant (Mirza et al., 2011a). As both of them also exhibited impaired ability 
to adhere to host cells compared with other ST-7 isolates, the study tested 
whether there was an association between attachment and Mz resistance in 
ST-7 as seen in Giardia (Tejman-Yarden et al., 2011). IC-50s of C, G, H 
isolates (2.98±0.97, 3.63±0.96, 1.05±0.32 µg/ml, respectively; Table 6.2) were 
significantly lower than the previously reported IC50s of isolates B, E 
(p<0.01; Fig. 6.8), indicating an intra-subtype variation in Mz resistance in 
Blastocystis ST-7 parasites. Correlation analysis showed a significant negative 
correlation between the level of drug resistance of an isolate and its ability to 
adhere to host cells (R2=0.8908, p=0.0158) (Fig. 6.9A and Table 6.3). The 
results suggested Mz resistance might entail an attachment defect in 
Blastocystis ST-7 strains. 
As the result above showed that the level of attachment was correlated with 
the ability to induce permeability increase (Fig. 6.5), the impaired attachment 
in Mzr strains might indicate a less potent ability in inducing permeability 
increase. Indeed, the correlation analysis between drug resistance and 
permeability increase showed a significant negative correlation (R2=0.9644, 
p<0.01) (Fig. 6.9B and Table 6.3). The results suggested Mz resistance might 






Fig. 6.8 Blastocystis exhibits intra-subtype variation in susceptibility and 
resistance to Mz. Graph representing IC50s of Mz against Blastocystis ST-4 
and ST-7 isolates tested in the study using the resazurin assay. Y axis was 
presented on a logarithmic scale in base 5. The IC50s of Mz against ST-7 
isolates C, G and H were found to be significantly lower than those of isolates 
B, E within the same subtype (p<0.01). **, p<0.01 vs. ST-7 (B, E). Each point 
represents a mean of nine readings derived from three independent 
experiments, triplicate each. Error bars represent the standard errors. 
 
Table 6.2 IC50s of Mz and nitric oxide donors against Blastocystis isolates 
(µg/ml) 
 
  ST-4   ST-7 




H G C 
 
B E 
Mz 5.5±2.89a 0.75±0.04a 
 
1.05±0.32 3.63±0.96 2.98±0.97 
 
32.5±3.4a 115.6±21.6 
GSNO 83.3±2.5b 98.29±0.73 
 
121.73±8.2 75.24±3.99 61.79±4.03 
 
30.63±1.67b 30.92±1.74 
NaNO2 233±9.2 240.6±10.4   217.45±16 162.15±34 199.75±5.8   86.47±12.8 106.35±4.8 
a,  See Reference (Mirza et al., 2011a) 




Fig. 6.9 Correlation analyses between Mz resistance and (A) attachment, 
as well as (B) permeability increase in Blastocystis ST-7 parasites. (A) 
Relationship between Mz resistance and attachment for Blastocystis ST-7 
parasites. The data points indicate individual strains. Error bars indicate the 
standard error for the respective measurements (n=3). There was a negative 
correlation between the level of resistance and attachment (p<0.05, 
R2=0.8908). (B) Relationship between Mz resistance of Blastocystis ST-7 
parasites and their ability in inducing permeability increase. The data points 
indicate individual strains. Error bars indicate standard errors for the 
respective measurements (n=3). There was a negative correlation between the 
level of resistance and permeability increase (p< 0.01, R2=0.9644). 
 
Table 6.3 Correlation of Mz resistance with attachment, permeability increase 
and nitric oxide IC-50 in Blastocystis ST-7 
 
  Pearson 
Correlation (R) 
R2 P value 
Attachment -0.9438 0.8908 0.0158a 
Permeability Increase -0.9821 0.9644 0.0029a 
Nitric Oxide IC-50 -0.8929 0.7972 0.0414a 
   a. Correlation is significant at the 0.05 level (2-tailed). 
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6.3.6 Mz resistance in Blastocystis does not lead to decrease in cell 
proliferation in Blastocystis ST-7 
Most drug resistance mechanisms are associated with a fitness cost that is 
typically observed as a reduced growth rate (Andersson et al., 2010, 
Andersson, 2006). To investigate the functional consequences of Mz 
resistance in Blastocystis, the study examined the proliferative potential of Mzr 
and Mzs strains from growth curves assayed over 96 h. The growth rates of 
Mzr isolates were not always lower than Mzs isolates (Fig. 6.10). Isolate E, 
being highly resistant to Mz, consistently grew more rapidly than Mzs isolates 
C and G, suggesting that drug resistance in Blastocystis ST-7 might not 
necessarily result in slower growth.  
 
Fig. 6.10 Mz resistance in Blastocystis does not lead to decreased growth 
in Blastocystis ST-7. Graph representing growth curve of Blastocystis ST-7 
isolates tested in the study over a period of 96h. The growth rates of Mzr 
isolates B, E were not significantly different from that of Mzs isolates C, G 
and H within the same subtype. Each point represents a mean of 6 readings 
derived from two independent experiments, triplicate each. The error bar 
represents standard errors.  
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6.3.7 Blastocystis ST-7 isolates exhibit extensive variations in resistance to 
nitrosative stress 
Aside from adhesion, microorganisms also need to evolve means to counter 
the host immune system for effective colonization in the intestinal lumen (Tan 
and Mirza, 2012). Nitric oxide (NO) is a potent innate immune response 
against a range of pathogens and nitrosative stress prevents colonization of 
host tissues by parasites and bacteria susceptible to NO (Eckmann et al., 2000, 
Lewis et al., 2010). Previous studies have already suggested NO induces cell 
death in Blastocystis (Eida et al., 2008, Mirza et al., 2011b). Thus, the ability 
of Blastocystis to tolerate nitrosative stress is likely to be important for its 
survival in the gut lumen. It was previously observed that a Mzr strain of 
Blastocystis exhibited lower tolerance to nitric oxide toxicity compared with a 
Mzs strain (Mirza et al., 2011b). In this study, the IC50s of NO donors against 
the Mzr and Mzs strains were tested to examine their ability to tolerate 
nitrosative stress. Interestingly, Mzs isolates C, G and H of Blastocystis ST-7, 
all exhibited significantly higher IC-50s of GSNO (61.79±4.03, 75.24±3.99, 
121.73±8.17µg/ml, respectively; p<0.01; Fig. 6.11A and Table 6.2) than Mzr 
B and E isolates (30.63±1.67, 30.92±1.73 µg/ml, respectively). Therefore, Mzr 
strains B and E were more susceptible to GSNO. An analysis again showed a 
significant negative correlation between the level of Mz resistance of an 
isolate and its ability to tolerate GSNO toxicity (R2=0.7972, p<0.05) (Fig. 
6.11B and Table 6.3). IC50s with another NO donor NaNO2 for all these 
strains exhibited similar trends to those with GSNO (Table 6.2). Taken 
together, the results suggested that, although Mz resistance helps Blastocystis 
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survive stress from chemotherapy, it makes Mzr strains less capable of coping 
with nitrosative stress. 
Concomitantly, to determine the morphological changes resulting from 
nitrosative stress, isolates H and B were stained with propidium iodide and 
annexin V-FITC after exposure to NO. Necrotic cells incorporated both PI and 
annexin V-FITC stain and cells undergoing programmed cell death bind 
annexin V-FITC alone. After treatment with 50 μg /ml concentration of 
GSNO, features of both necrosis and apoptosis were observed in the Mzr 
isolate B, whereas the Mzs isolate H were less affected (Fig. 6.11C). 
Compared with cultures of C, G and H, Mzr isolate B and E exhibited a 
significantly higher percentage of cells undergoing cell death (37.54% and 
32.93% 7.21% for B and E respectively; 12.38%, 10.2%, 7.21% for isolates C, 
G and H respectively; p<0.01) (Fig. 6.11D), which also indicates that the 
parasite cell death induced by NO was predominantly by necrosis with a 





Fig. 6.11 Mz resistant isolates in Blastocystis ST-7 exhibit susceptibility to 
nitric oxide. (A) Graph representing IC50s of NO donor GSNO against 
Blastocystis ST-7 strains tested. ST-7 isolates C, G and H showed significantly 
higher tolerance to GSNO (p<0.01) than Mzr strains B and E. **, p<0.01 vs. 
ST-7 (B, E). Each point represents a mean of nine readings derived from three 
independent experiments, triplicate each. The error bar represents standard 
errors. (B) Relationship between Mz resistance and GSNO resistance in 
Blastocystis ST-7 parasites. The data points indicate individual strains. Error 
bars indicate the standard error for the respective measurements (n=3). There 
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was a negative correlation between level of Mz resistance and tolerance of 
nitric oxide toxicity (p<0.05, R2=0.7972). (C) Confocal micrographs 
illustrating cell death features of Blastocystis H and B isolates under 
nitrosative stress. Blastocystis were cultured under anearobic culture 
conditions, in the presence of 50μg/ml of GSNO. The cells were then stained 
with Annexin-V-FITC and PI to identify cells undergoing cell death. Features 
of necrosis (yellow arrows) and programmed cell death (red arrows) were 
observed. Blastocystis cells undergoing necrosis incorporated both PI and 
annexin V-FITC stain, cells undergoing programmed cell death, on the other 
hand bind annexin V-FITC alone. A significantly higher number of dying cells 
were observed in cultures of ST-7 (B) compared with ST-7 (H) cultures. Scale 
bar= 10 μm. The micrographs are representative of 15 pictures taken in three 
separate experiments (five from each). (D) Graph representing percentage of 
cell death in Blastocystis ST-7 strains after treatment with NO donor GSNO. 
Compared with Mzs ST-7 isolates (C, G, H), percentages of dead cells in ST-7 
(B, E) are significantly higher (p<0.01).**, p<0.01 vs. ST-7 (B, E). Each value 
represents a mean of nine readings derived from three independent 









Although it is one of the commonest eukaryotic organisms present in the 
alimentary tract of human and nonhuman hosts worldwide (Stensvold et al., 
2009d), the debate about the pathogenicity of Blastocystis continues (Garcia, 
1984, Waghorn et al., 1991, Barry, 2004, Tan et al., 2010, Clark et al., 2013) 
and arguments for and against its pathogenicity both abound (Stensvold et al., 
2009d). The enigmatic role of Blastocystis has mainly been due to a lack of  
basic knowledge about its biology and convincing evidence of its 
pathogenicity (Stensvold et al., 2009d). A major obstacle or challenge is the 
potential for intra- and inter-subtype variation in Blastocystis pathogenicity 
(Scanlan, 2012, Clark et al., 2013). Although previous research attempted to 
validate this argument by using animal models (Iguchi et al., 2007), the 
number of strains used were limited and no consensus on the appropriate 
infection model was reached for Blastocystis, thus the infection outcomes 
might be reflective of infectivity rather than pathogenicity. The current study, 
using a well-established in-vitro system mimicking the host-pathogen 
interplay, provides, for the first time, a comprehensive analysis of different 
strains from two clinically relevant subtypes, and gives evidence that 
Blastocystis exhibited not only inter- but also intra-subtype variability in 
causing barrier dysfunction. Disturbances in epithelial barrier function are 
commonly associated with intestinal inflammatory disorders and have been 
reported in symptomatic cases of Blastocystis infection (Turner, 2009, Tan, 
2008, Dagci et al., 2002, Poirier et al., 2012). Thus the findings from the 
current study might help explain the conflicting data concerning the 
168 
 
inconsistency in reports of Blastocystis-induced intestinal inflammatory 
disorders. 
Paracellular permeability was regulated by tight junctions, which seal the 
space between neighboring cells, generating an impermeable barrier between 
the epithelium and the extracellular environment, protecting deeper tissues 
from external aggressions including microbial infections (Bonazzi et al., 
2011). However, this first line of defense against infection has become one of 
the most exploited gates for pathogens to access and colonize the host 
organism (Bonazzi et al., 2011). Enteric pathogens have developed a broad 
and complex range of mechanisms to subvert host tight junction (O'Hara et al., 
2008). As discussed in Chapter 4, key mechanisms identified to date include 
direct rearrangement or degradation of specific tight junction proteins, 
reorganization of the cell cytoskeleton, and activation of host cell signaling 
events (Sears, 2000, Berkes et al., 2003, Fasano et al., 2004). The study 
revealed disruption of tight junctions (TJs) which mainly resulted from 
degradation in at least two TJ proteins: ZO-1 protein, which is linked to the 
cytoskeleton and plays a pivotal role in the TJ architecture (Peiffer et al., 
2001); and occludin, which is important in maintaining the integrity and 
barrier function (Furuse et al., 1993, McCarthy et al., 1996). Previously, it was 
reported that Blastocystis phophorylates MLC and leads to cytoskeletal and 
ZO-1 rearrangement (Mirza et al., 2012b). Indeed, the study also observed 
myosin light chain phosphorylation and TJ rearrangement in B and E-treated 
Caco-2 cells besides degradation of ZO-1 protein (Fig. 6.12). However, for 
Blastocystis isolates C, G, and H, although MLC was phosphorylated, 
degradation of TJs appeared to be the main mechanism, indicating the 
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strategies utilized by Blastocystis to induce permeability increase are likely to 
be diverse and different isolates may have developed different major 
mechanism to compromise barrier function. In a recent study, the observation 
that ROCK inhibition did not completely rescue the increase in the epithelial 
permeability induced by the parasite (Mirza et al., 2012b) also suggested that 
Blastocystis uitilizes more than one mechanism to breach the epithelial barrier. 
 
Fig. 6.12 Differential effects on myosin light chain phosphorylation in 
Caco-2 cell monolayers by different strains of Blastocystis. (A) 
Representative Western blots exhibiting level of MLCp after incubation with 
Blastocystis ST-4 and ST-7 parasites. Total MLC was used as a loading 
control. An obvious increase in MLCp could be noticed in ST-7-treated 
samples. (B) Graph represents MLCp/MLC ratio normalized to the negative 
control in Caco-2 cells calculated through densitometry analysis of Western 
blot radiographs. A significant increase in was observed in all ST-7-treated 
Caco-2 epithelium compared with the negative control and ST-4-treated 
samples (p<0.01). ‡, p<0.01 vs. control. Error bars represent the standard error 




Epithelial attachment is an important factor determining the persistence and 
virulence of luminal pathogens (Elmendorf et al., 2003, Tavares et al., 2005). 
The study for the first time showed Blastocystis isolates exhibits strain-to-
strain variation in attachment to human enterocytes. Differential production of 
the adhesins or other factors could modulate the parasite–cell surface 
interaction (Gilbert et al. 2000). Results in Chapter 3 suggested a galactose-
binding protein as an important element involved in cell surface recognition 
and attachment to host cells. It would be interesting to investigate whether 
similar proteins could be found on other isolates and compare the expression. 
More importantly, the results showed for the first time pathogenicity of 
Blastocystis was correlated with their ability to attach to epithelial cells. How 
adhesion leads to intestinal barrier dysfunction needs to be investigated 
further. Giardia intestinalis was shown to produce harmful substances as a 
result of the host-pathogen contact (Maia-Brigagao et al., 2012). Several 
enzymes from the secreted products have been identified in G. intestinalis, 
which are suggested to facilitate effective parasite adhesion and colonization 
of the human small intestine (Ringqvist et al., 2011, Rodriguez-Fuentes et al., 
2006). Whether the adhesion of Blastocystis with host cells also enables 
particular enzymes to be released and to participate in pathogenesis would be 
interesting to investigate. The Blastocystis genome has been available and in 
silico analysis of the ST-7 secretome predicted 75 putative secreted proteins, 
some of which may have a direct connection with pathogenicity (Denoeud et 
al., 2011). Recently, two cysteine proteases (legumain and cathepsin B) have 
been characterized in the ST-7 culture supernatant. The enzymes showed 
proteolytic activities by gelatin zymograms (Wawrzyniak et al., 2012). 
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However, whether these secreted proteins act on intestinal cells and disturb gut 
function has not been studied. It would be interesting to investigate whether 
adhesion of Blastocystis to the epithelium might trigger the parasite to actively 
produce virulence factors that possibly activate signaling cascade leading to 
tight junction disruption. Preferential adherence of cytopathic Blastocystis 
strains to intercellular junctions leading to tight junction degradation observed 
in this chapter as well as in Chapter 2 also supports this idea.  
Parasites such as Giardia intestinalis and Entamoeba histolytica have distinct 
virulent and non-virulent strains that may be attributable to qualitative and 
quantitative variation in their cysteine proteases activity (Reed et al., 1989, 
Guimaraes et al., 2003, Puthia et al., 2005) and are also implicated in the 
activation of NF-kB in colonic epithelium, leading to proinflammatory 
cytokine IL-8 upregulation (Puthia et al., 2008). It was shown that cysteine 
proteases could cause human epithelial barrier compromise (Mirza et al., 
2012b). Indeed, isolate E, being the least adhesive in ST-7, has the highest 
cysteine protease activity, which might explain the permeability increase 
observed in E-infected epithelium; while isolate S-1, with equivalent level of 
attachment to E, and at the same time the lowest CP activity, failed to induce 
any increase in intestinal permeability. Interestingly, the highly adhesive G 
isolate, though with similar CP activity to ST-4 isolates, could induce 
prominent epithelial barrier disruption, highlighting the important role of 
adhesion in mediating intestinal pathology. Taken together, both adhesion and 
CP activity might contribute to Blastocystis–induced barrier dysfunction. ST-4 
isolates, low in both adhesion and CP activity, appeared to be avirulent for 
human intestinal monolayer; whereas all ST-7 isolates studied are capable of 
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infection because of being either adhesive or exhibiting high CP activity, or 
both. Moreover, adhesion is a major determinant in the pathogenicity of a 
strain. The results provided evidence that the pathogenesis of blastocystosis is 
complex and parasite adhesion and cysteine proteinases might be important 
virulence factors. Specific virulence factors and their mechanisms remain to 
be explored in depth. 
Besides the observation that Blastocystis ST-7 exhibited intra-subtype 
variation in epithelial attachment, the association between epithelial 
attachment and Mz susceptibility was also observed. Mzr isolates in ST-7 
exhibited a defect in epithelial attachment. How Mz resistance would affect 
Blastocystis adhesion to host cells remains to be addressed. Drug resistance 
has been shown to modulate adhesion in some bacterial and parasitic agents 
such as Escherichia coli, Giardia, and Stenotrophomonas (Deneke et al., 
1985, Klein et al., 1985, Carlone et al., 1987, Li Pira et al., 1987, Gismondo et 
al., 1994, Nilsson et al., 2003, Pompilio et al., 2010, Tejman-Yarden et al., 
2011). Tejman-Yarden et al. showed that in Giardia lamblia, epithelial 
attachment was linked to glucose metabolism (Tejman-Yarden et al., 2011). 
Glucose promoted parasite attachment and Mzr lines were shown to consume 
less glucose than their parental Mzs lines, providing a possible explanation for 
the attachment defect observed in Mzr lines. In Blastocystis, the glucose 
consumption of all seven strains used in the study was also measured. 
However, their respective rate did not correlate with the level of Mz resistance 
(Fig. 6. 13), suggesting that glucose metabolism may play a different role in 
Blastocystis from that in Giardia. In Chapter 3, a galactose-binding protein 
was suggested to play a role in Blastocystis adhesion. Whether the synthesis or 
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Fig. 6.13 Differential consumption rate of glucose by Blastocystis ST-4 and 
ST-7 strains. Different strains of Blastocystis from ST-4 and ST-7 were 
cultured in medium containing 5 mM glucose and incubated under anaerobic 
conditions, and levels of glucose remaining in the medium were measured 
after a 24-h incubation period. Glucose consumption was expressed as the 
mean glucose consumption for 106 cells over the period (mmol/day). No 
correlation was found between the rate of glucose consumption and the level 
of attachment or Mz resistance. 
 
Mzr strains not only exhibited a defect in attachment, they also showed 
impaired NO tolerance in Blastocystis ST-7. NO secretion is an important 
aspect in human innate immunity and limits microbial persistence in the gut by 
inducing cell death and preventing their growth and encystations (Eckmann et 
al., 2000). Therefore, the ability to tolerate nitrosative stress would be an 
important aspect for parasite survival. The results suggested Mz resistance 
might limit its survivability to host innate immune response such as coping 
with nitrosative stress. How Mz resistance affects the susceptibility to NO 
needs to be investigated further. Development of Mz resistance in 
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microorganisms is a multifactorial process and the mechanisms are diverse 
(Leitsch et al., 2011). In Giardia and Trichomonas, Mz resistance usually 
develops due to impairment of Mz activation enzymes in the parasite. For 
example, resistance to Mz has been associated with down-regulation or 
decreased activity of pyruvate: ferredoxin oxidoreductase (PFOR), which 
activates the 5-nitroimidazole (5-NI) pro-drugs to the toxic radical states 
inside the parasite in conjunction with the electron acceptor ferredoxin 
(Tejman-Yarden et al., 2011, Leitsch et al., 2010, Upcroft et al., 2001). These 
Mz activation enzymes are oxygen sensitive and are also important 
components of parasite anaerobic respiratory system. Anaerobic respiratory 
enzymes also play an essential role in free radical (e.g. H2O2 or NO) 
scavenging and if these enzymes are impaired, as expected in metronidazole 
resistant parasite strains, it would lead to decreased free radical tolerance in 
these isolates (Ellis et al., 1993, Rasoloson et al., 2001). However, the 
mechanism of Mz activation has not been studied in Blastocystis, although 
PFOR and other oxidoreductase enzymes are present in the organism 
(Denoeud et al., 2011, Wawrzyniak et al., 2008). Further investigation of Mz 
activation and/or resistance mechanisms as well as NO-scavenging 
mechanisms in Blastocystis would be necessary to elucidate the association 
between NO susceptibility and Mz resistance. Recent studies of Giardia and 
Trichomonas suggested that Mz was activated by the nitroreductase activity of 
flavin-dependent thioredoxin reductase and Mz resistance was associated with 
decreased NADPH oxidase activity (Leitsch et al., 2011, Leitsch et al., 2009). 
A flavohemoglobin (FlavoHb) which plays a pivotal role in NO detoxification 
has been characterized recently in Giardia intestinalis (Mastronicola et al., 
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2010). Interestingly, other studies have suggested flavoHb also demonstrates 
NADPH oxidase activity (Rafferty et al., 2010). Furthermore, flavoHb seems 
to be important in the pathogenesis of disease (Sebbane et al., 2006, Roos et 
al., 2006). It would be intriguing to explore whether flavoHb or its homolog 
exists in Blastocystis and whether it plays any function in Mz resistance, NO-
scavenging or pathogenesis.  
In conclusion, this chapter showed the molecular and cellular basis for 
extensive intra- and inter- subtype variability in pathogenicity in Blastocystis 
ST-4 and ST-7 in vitro. The existence of both pathogenic and apathogenic 
isolates might help explain the disparity in symptoms among patients with 
Blastocystis infections. The modes of pathogenesis of blastocystosis are 
diverse and the range of clinical symptoms observed is unlikely to be 
attributed to a single virulence factor or pathogenic mechanism. Moreover, the 
study indicates that adhesion is an important biomarker for the pathogenicity 
of the parasite and subsequent outcome of infection/disease and that adhesion 
can be impaired by Mz resistance. The proposed model for Blastocystis 
pathogenesis based on findings from this chapter is summarized in Fig. 6.14. 
Interestingly, the five ST-7 strains tested here were morphologically 
indistinguishable from each other, but varied significantly in many aspects of 
their pathobiology, including attachment and drug resistance. A deeper 
analysis and systematic comparison of the genome and protein expression 
profiles among these Blastocystis strains could aid in the identification and 







Fig. 6.14 Summary model illustrating pathogenesis and fitness cost in 
Blastocystis. Both adhesion and cysteine proteases contribute to Blastocystis–
induced barrier dysfunction. Adhesion leads to degradation of TJ proteins 
possibly by triggering release of virulence factors. The factors may also 
contribute to cysteine protease activity. CP induces intestinal barrier function 
by rearranging TJ proteins, but might also cause degradation of TJ. 
Development of Mz resistance entails impairment in adhesion as well as 
tolerance to nitrosative stress. TJ, tight junction; MLCp, myosin light 













APPLICATION OF THE ADHESION 
MODULATOR IN BLASTOCYSTIS 




Chapters 2 and 4 demonstrated that Blastocystis isolate ST-7 (B) is capable of 
adhering to human intestinal epithelium and causing epithelial barrier 
compromise. This isolate also displays metronidazole resistance as seen in 
Chapter 6. Patients infected with antibiotic resistant virulent Blastocystis 
strains might be difficult to manage (Mirza et al., 2012b). There is a need to 
develop alternative or adjunctive treatment options for such infections. 
Currently too few drugs are available to treat parasitic infections, and most of 
these were developed over 50 years ago (Sibley et al., 2003). Some still retain 
efficacy, but these are frequently so toxic that the treatment itself is life-
threatening (Jackson et al., 2010, Marino et al., 1990). Prudent use and 
appropriate management can slow the selection of resistant microbial 
populations, but in all cases, the development of new therapeutic strategies is 
necessary. Because adhesion to host cells is the key first step in causing 
microbial infections and Chapter 6 highlights its important role in Blastocystis 
pathogenesis, it should be possible to prevent such infections by blocking 
adhesion. The current study aims to address this issue by evaluating a 
treatment strategy targeting Blastocystis adhesion to host cells. 
Anti-adhesion therapy is meant to reduce the contact between host tissues and 
pathogens, either by prevention or reversal of adhesion of the infectious agent 
(Ofek et al., 2003). The adherent state is not only a key step in pathogenesis, 
but also advantageous for pathogen survival. After adhering to host cells, 
pathogens are able to initiate certain biological processes like proliferation, 
toxin secretion and cell invasion and assume a significantly greater resistance 
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to clearance by normal cleansing mechanisms and to killing by normal 
immune factors, and antibiotics (Dai et al., 2000). Pathogens may be better 
able to acquire nutrients, further enhancing their ability to survive and infect 
the host (Ofek et al., 2003). Therefore, prevention of adhesion at an early 
stage following the exposure of the host to pathogens would be a good 
strategy to reduce the infection and disease.  
It was found that a large number of bacterial, viral, and protozoan pathogens 
bind in vitro to carbohydrate structures of glycoconjugates present on the 
intestinal cell surface (Table 6.1) and that this binding can be readily inhibited 
by suitable mono-or oligosaccharides (Dai et al., 2000), which compete with 
the host-cell glycoproteins or glycolipids on the carbohydrate binding domain 
of the pathogen adhesin lectin. Inhibition of adhesion by suitable 
carbohydrates could lead to the development of anti-adhesion therapy as a 
novel approach against pathogen infections. In Chapter 3, galactose was 
identified as an effective modulator for ST-7 (B) adhesion to Caco-2 cells. The 
current chapter would evaluate the therapeutic potential of galactose by testing 
its displacing effects on adhered parasites and also investigate whether 
application of galactose in the host-pathogen interaction system could 
ameliorate the pathogenic effects exerted by the parasite. Chapter 6 revealed 
that Blastocystis parasites of the same subtype exhibited extensive variations 
in the level of attachment. It would be interesting to test whether the same 
modulator galactose, which interfered with the adhesion of one strain ST-7 (B), 
could also be applied to another strain of the same subtype, to see whether 
similar molecules are involved in the host-pathogen recognition process across 
different strains. Therefore, another important goal of the current study was to 
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apply galactose in the highly adhesive strain H, identified in Chapter 6, and 
evaluate whether it could also work for H in displacement and rescue of tight 
junction degradation.  
It’s described here for the first time that addition of galactose could dislodge 
parasites which already adhered to host cells, and that disruption of 
Blastocystis adhesion by galactose treatment leads to the abolition of the 
Blastocystis-induced tight junction degradation in Caco-2 cells. Importantly, 
the results showed galactose was also effective for the most adhesive and 
virulent H strain within Blastocystis ST-7. 
Table 7.1 Microbial carbohydrate receptors on the intestinal microvillus 
membrane  
 




7.2 MATERIALS AND METHODS 
7.2.1 Parasite culture 
Axenized isolates of Blastocystis B and H were maintained as previously 
described in Chapter 2. 1-day-old healthy Blastocystis parasites were used in 
all experiment. 
7.2.2 Culture of Caco-2 colonic epithelial cell line 
Caco-2 stock cultures were maintained as previously described in Chapter 2. 
For Western blot analysis, Caco-2 monolayers were grown on standard 24-
well cell culture plates (Corning) until 100% confluency. 
7.2.3 Attachment assay 
Attachment assay was performed as previously described in Chapter 3.   
To define the possible role of surface galactose glycoproteins in attachment, 
assays were done in the presence of monosaccharides (D-galactose) (50 and 
100 mM). 
To see whether monosaccharides have a displacing effect for parasites already 
adhered to the host cells. Parasites were incubated with Caco-2 for 1 hour at 
37°C to adhere first, then monosaccharides or PBS control were added to the 
coculture, then continue to incubate for another 1 hour. At the end of 
incubation, unbound parasites were washed as previously described.  
7.2.4 Western blot  
Monolayers were treated with 1.25 × 107 parasites/ well in the presence or 
absence of sugar at different concentrations and co-incubated for 1 h at 37°C. 
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ZO-1 Western blot analysis was then performed as previously described in 
Chapter 4.  
7.2.5 Statistical analysis 
Results are expressed as mean ± SEM. Differences between means were 
compared using Student's t tests or analysis of variance where appropriate. 





7.3.1 Displacing effect of galactose on Blastocystis adhesion to Caco-2 cells 
To examine the ability of galactose to displace already adhered Blastocystis 
parasites, galactose was applied to the medium of Blastocystis-epithelial cell 
interaction after the parasites have established adhesion with Caco-2 cells. The 
results showed that addition of galactose significantly interfered with the 
parasite-cell attachment and displaced adhered parasites to 13.9% ± 4.2% of 
the control (p<0.01) (Fig. 7.1), while no obvious change was observed with 




Fig. 7.1 Displacement of Blastocystis from Caco-2 cells by galactose. 
Blastocystis ST-7 (B) were incubated with Caco-2 for 1 hour at 37°C to allow 
parasites to adhere first, then galacose (100mM), glucose (100mM) or PBS 
control were added to the coculture medium, then continue to incubate for 
another hour at 37°C. The number of parasites attached with addition of PBS 
control was assigned as 100%. The numbers of attached parasites with 
saccharides addition were normalized to control. *, p<0.01 versus control. 
Values are the means ± standard errors from data of three experiments. Error 
bars represent standard errors. Glu, glucoe; Gal, Galactose. 
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7.3.2 Effect of the cytadherence inhibitor galactose on prevention of 
Blastocystis–induced tight junction degradation in Caco-2 cell monolayers  
In Chapter 6, it was proposed adhesive capacity of a Blastocystis strain might 
be an important determining factor of its pathogenicity. Inhibition of parasite 
adhesion to host cells, therefore, might be expected to concomitantly diminish 
the pathogenic effects. For these reasons, it would be good to test the effect of 
galactose on Blastocystis-induced barrier dysfunction. Degradation of tight 
junction protein ZO-1 was prevented by addition of galactose in a dose-
dependent manner (Fig. 7.2). In contrast, glucose with no inhibitory effects for 
Blastocystis cytadherence was unable to ameliorate the tight junction changes, 
supporting the view that adhesion was an important prerequisite for 
Blastocystis–induced cytopathogenicity. Galactose and glucose alone 
(saccharide control) did not change the expression of ZO-1 tight junction 




Fig. 7.2 Galactose prevented Blastocystis–induced ZO-1 tight junction 
degradation in a dose-dependent manner. (A) Representative Western blot 
analysis of ZO-1 level in Caco-2 epithelium. Caco-2 monolayers were infected 
with Blastocystis ST-7 (B) in the presence of saccharides at different 
concentrations (25, 50 and 100mM) and incubated for 1 hour. Monolayers 
were washed and prepared for Western blot. Normal culture media with no 
sugar addtion was used as a negative control. (B) Quantification of ZO-1 
levels through densitometry analysis of Western blot radiographs. 
Densitometric values of ZO-1 signals were quantified and expressed as the 
ratio to β-actin*, p<0.01 versus control. Values are the means ± standard 
errors from data of three experiments. Error bars represent standard errors. Glu, 
glucoe; Gal, Galactose. 
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7.3.3 Evaluation of galactose on the adhesion of the highly adhesive 
Blastocystis ST-7 (H) isolate to Caco-2 cells: interference with adhesion, 
displacing effects as well as rescue of tight junction degradation   
It was important to test the efficacy of galactose in other representative 
isolates of Blastocystis with known differences in cytadherence levels. ST-7 
(H) has been been shown to be highly adhesive among ST-7 in Chapter 6. The 
results showed that galactose did effectively decrease H adhesion in a dose-
dependent manner (67.7% ± 14.1%, 33% ± 0.3% of control at 50 and 100mM, 
respectively) (Fig. 7.3) (p<0.01 for both values), suggesting there might be 
common receptor-ligand mediating parasite-host adhesion among different 
isolates. Displacement effect of galactose on ST-7 (H) adhesion was also 
significant (reduced by 51% ± 14%) (p=0.012) (Fig. 7.4), albeit to a lesser 
extent than that on ST-7 (B) as indicated above (inhibited by 86.1% ± 4.2% 
compared to control) (Fig. 7.1). Also, the ZO-1 tight junction protein was 
prevented from degradation by ST-7 (H) in the presence of galactose at 






Fig. 7.3 Dose-dependent inhibiton of galactose on Blastocystis ST-7 (H) 
adhesion to Caco-2 monolayers. Blastocystis ST-7 (H) were incubated with 
epithelial cells in the presence of different concentrations of galactose (50 and 
100mM, respectively). A value of 100% was assigned to number of binding 
parasites without addition of sugars. The numbers of attached parasites with 









Fig. 7.4 Displacement of Blastocystis ST-7 (H) from Caco-2 cells by 
galactose. Blastocystis ST-7 (H) were incubated with Caco-2 for 1 hour at 
37°C to allow parasites to adhere first, then galacose, glucose or PBS control 
were added to the coculture medium, then continue to incubate for another 
hour. The number of parasites attached with addition of PBS control was 
assigned as 100%. The numbers of attached parasites with saccharides 






Fig. 7.5 Galactose rescued Blastocystis ST-7 (H) –induced ZO-1 tight 
junction degradation. (A) Representative Western blot analysis of ZO-1 level 
in Caco-2 epithelium. Caco-2 monolayers were infected with Blastocystis ST-
7 (H) in the presence of saccharides galactose and glucose at 100mM and 
incubated for 1 hour. Monolayers were washed and prepared for Western blot. 
Normal culture media with no sugar addtion was used as a negative control. (B) 
Quantification of ZO-1 levels through densitometry analysis of Western blot 
radiographs. Densitometric values of Occludin and ZO-1 signals were 
quantified and expressed as the ratio to β-actin. *, p<0.01 versus control. #, 
p<0.05 versus control. Values are the means ± standard errors from data of 





The results in Chapter 3 showed galactose was able to greatly inhibit the 
binding of Blastocystis ST-7 (B) to Caco-2 cell. This chapter highlights its 
ability to displace adhered parasites. Eradication has been challenging in 
Blastocystis infections (Scanlan et al., 2013). In the presence of galactose, 
rather than binding to host cell surface and initiating the infection process, the 
parasites would be detached and then flushed from the gastrointestinal tract. 
Because of its displacing effects, galactosewould probably help with this 
difficult problem. Cytadherence inhibition by galactose also significantly 
reduced disruption of tight junction protein caused by Blastocystis. This 
observation not only confirmed the important role of adhesion in initiating 
pathogenesis, but also pointed towards potential application of galactose-based 
antiadhesives in Blastocystis infections.  
Altogether, the results provided a rationale for developing therapeutic agents 
that act by either prevention of attachment or induction of detachment of 
Blastocystis from intestinal epithelial cells to ameliorate the harmful effects of 
Blastocystis infections. There have been frequent reports of treatment failures 
using common anti-protozoals (Roberts et al., 2013). With the identification of 
antibiotic resistant strains, alternative therapies against infectious diseases are 
urgently needed (Mirza et al., 2011a, Mirza et al., 2012b). Chapter 6 
highlights that adherence to host cells might be an important determining 
factor in its pathogenesis and thus might serve as a good therapeutic target. 
Because the action of antiadhesives does not require the blocking of any 
fundamental metabolic processes of micro-organisms, emergence of resistance 
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is unlikely (Dai et al., 2000). Antiadhesives represent a viable alternative for 
antibiotic-resistant Blastocystis infections. 
A number of anti-adhesion strategies have been suggested (Dai et al., 2000), 
including mucosal immunity (to induce secretory immunoglobulin A (SIgA) 
antiadhesin antibodies), metabolic inhibitors of the expression of adhesions 
(e.g., sublethal concentration of antibiotics), dietary inhibitors (e.g., human 
milk), lectin drugs (consisting of lectin-like molecules that can block 
attachment by competitively occupying the receptor), and receptor analogues 
(oligosaccharides and glycoconjugates) (Dai et al., 2000). Among these, the 
key role of lectin-carbohydrate interactions in microbial adhesion has been 
increasingly recognized (Ofek et al., 2003, Sharon et al., 2000). Inhibition of 
bacterial adhesion by suitable carbohydrates could lead to an anti-adhesion 
therapy as a novel approach against pathogen infections.  Entamoeba 
histolytica employs a Gal/GalNAc lectin that is involved in parasite 
attachment and host cell toxicity (Saffer et al., 1991). Gal, GalNAc and lactose 
have been shown to inhibit trophozoite attachment and host cell cytotoxicity in 
vitro (Ravdin et al., 1981). The results suggested the possible role of galactose 
in reducing Blastocystis infections. However, it should be noted that mono- 
and disaccharides are mostly digested and absorbed in the small intestine and 
are usually not found in the colon (Jantscher-Krenn et al., 2012), the site of 
Blastocystis colonisation. Recent studies have suggested the use of 
oligosaccharides as antiadhesives against parasitic and bacterial infections. For 
example, it has been shown that Human milk oligosaccharides (HMO) reduce 
Entamoeba histolytica attachment and cytotoxicity in vitro (Jantscher-Krenn et 
al., 2012), with the major role played by galacto-oligosaccharides (GOS). Also, 
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studies indicate that GOS and perhaps other galactose-containing prebiotic 
oligosaccharides can act as antiadhesives against EPEC adherence to intestinal 
epithelial cells (Shoaf et al., 2006). It is suggested that certain exogenous 
oligosaccharides structurally resemble the receptor sites coating the intestinal 
epithelial cells to which intestinal pathogens recognize and adhere (Kunz et al., 
2000). Thus, these oligosaccharides may act as molecular receptor decoys or 
antiadhesives that can competitively inhibit adherence and prevent infection. 
Moreover, HMO and GOS, resist digestion and reach the colon (Albrecht et 
al., 2011), and thus might be more clinically useful. Another alternative is 
glycomimetics (Hartmann et al., 2012), compounds that structurally mimic the 
inhibitory carbohydrates but that may be more readily obtainable and could be 
designed to resist digestion. It would be interesting to test some these 
compounds in Blastocystis adhesion and barrier function studies. 
More interestingly, the reduction in Blastocystis parasitism of epithelial cells 
by galactose was observed in a highly adhesive ST-7 isolate H. The fact that 
the two isolates belonging to the same subtype are affected by the same 
inhibitor in a key step during infection suggests that the attachment of the 
different isolates of parasite belonging to the same subtype to the host may be 
mediated by the same or similar galactose-binding proteins. The reasons for 
the apparently great difference in attachment and virulence of the strains 
within the same subtype as seen in Chapter 6 are still unknown. It would be 
interesting to characterize the galactose-binding protein and compare among 
strains to see whether it is equally present or expressed in adhesive and non-
adhesive Blastocystis strains. Further exploration of the functional 
consequences of the antigenic differences for the protein may lead to a better 
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understanding of its role in pathogenesis. More importantly, in view of the 
potential for pharmacologic intervention, the observation also points out the 
possibility of applying the same or structurally similar modulator in infections 
with different Blastocystis isolates.  
Despite the efficacy of galactose in ST-7 (H), the inhibitory activity of 
galactose at the same concentration was much lower in ST-7 (H) than in ST-7 
(B), suggesting there might be other unknown mechanisms important for 
mediating the contact between ST-7 (H) and Caco-2 cells. It indicates that 
pathogens may express more than one adhesin during the infectious process. 
Other than just adhesin-receptor interactions, adhesion may also involve 
factors such as hydrophobic and other non-specific interactions under different 
shear-forces (Dai et al., 2000). Therefore, for anti-adhesion therapy to be 
effective, it will probably be necessary to use multiple agents specifically 
inhibiting each type of adhesin of the infecting pathogen or by interfering with 
other interactions involved in adhesion. Preparation of suitable cocktails of 
inhibitory sugars have been used for the treatment of bacterial infections 
(Sharon et al., 2000). More detailed information is needed about the molecular 
mechanisms mediating in adhesion of Blastocystis H strain to host cells. 
Results from the current study indicated antiadhesives as a novel approach for 
treatment of metronidazole-resistant Blastocystis infections.  More detailed 
information about the specificity of Blastocystis surface lectins and the 
elucidation of the structure of their receptors will certainly be of benefit in the 
design of such drugs. It would be interesting to clinically investigate whether 
















As one of the most frequently encountered protist in human and animal fecal 
samples, the controversy over the pathogenic potential of Blastocystis has 
never ceased since it was firstly described (Barry, 2004). With the use of a 
variety of classic and modern molecular methods as well as the establishment 
of in vitro infection models during the last decade, there have been great 
advancements in the area of its molecular and cellular biology (Clark et al., 
2013, Denoeud et al., 2011, Tan et al., 2010, Wu et al., 2010), as well as 
pathogenic mechanisms (Mirza et al., 2011b, Mirza et al., 2012b). However, 
many important aspects of Blastocystis pathogenesis remain unidentified. 
Adhesion is a crucial step in initiating and maintaining infections, yet nothing 
is known about the molecules mediating this initial interaction of Blastocystis 
and host. The chain of events leading to parasite-induced pathology after 
Blastocystis-enterocyte contact is largely unknown. The overall aim of this 
thesis was to study the pathobiology of Blastocystis adhesion. This study 
identified a strain capable of adhering to host cells and causing pathological 
changes. It also provided an in-depth analysis of the factors involved in 
adhesion. The study also characterized events in the host cells in response to 
parasite adhesion in barrier functional disturbances. It also provided analysis 
of adhesion properties across different strains from two subtypes and 
compared their pathogenic potential. Furthermore, the study not only selected 
galactose as an effective inhibitor for adhesion, but also evaluated its efficacy 
in attenuating the pathogenic effects produced by Blastocystis.  
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The uptake of Blastocystis may occur by faecal-oral route from contaminated 
drinking water or food supplies (Tan, 2008). Once ingested, the parasite then 
enter the lumen of the large intestine where parasite replication and 
colonization occur. The ability of Blastocystis to attach itself to the epithelial 
lining of the large intestine would be critical for its survival in an environment 
where peristaltic flow and shear stress are constant. To initiate an infection 
and induce epithelial pathology, a microorganism must be able to effectively 
adhere to and colonize the intestinal lumen. Failure to do such would result in 
parasite clearance by peristalsis, and consequently a reduction of both 
infection and transmission. Results in Chapter 2 for the first time showed that 
Blastocystis avidly bound to human intestinal epithelium and induced direct 
pathological changes. Importantly, by establishing an easily manipulated 
adhesion assay, the study was the first to investigate the physiochemical 
factors involved in Blastocystis adhesion. This model served as a valuable tool 
in elucidating potential mechanisms involved in parasite-host cell attachment. 
A comprehensive investigation of the attachment process would help us 
understand clinically relevant questions. Blastocystis has been remarkable in 
establishing chronic as well as persistent infections, either symptomatic or 
asymptomatic, for which there is no known eradication strategy (Scanlan et 
al., 2013). Understanding the basis of persistent infections will aid the 
development of new treatments. Many factors contribute to the ability of 
pathogens to establish persistent infections, including both host and pathogen 
factors, among which one important characteristic is adhesion of the 
microorganism (Rhen et al., 2003). Our results showing the high affinity in the 
host-parasite attachment indicates that adhesion might impede clearance of the 
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parasite, which explains why eradication has been a long-term problem in 
Blastocystis treatment. It was previously shown that Blastocystis was able to 
suppress of the innate immune response of human enterocytes by 
downregulating enterocyte NO production (Mirza et al., 2011b). Altogether, 
these findings suggest that the parasite may have evolved several strategies to 
survive and reproduce in the colon, which might contribute to the recurrent 
infections commonly seen in the clinical setting. 
Our results revealed that adhesion was temperature-dependent and increased 
as the temperature was slightly elevated. The dependence of Blastocystis 
attachment on temperature also has its clinical relevance. Blastocystis is 
regarded as an opportunistic pathogen associated with a number of 
inflammatory disorders such as IBS and was more prevalent especially when 
there are other infections occurring (Dogruman-Al et al., 2010, Llibre et al., 
1989, Poirier et al., 2012). It was also suggested that even if Blastocystis is 
primarily a commensal, it could become pathogenic under certain conditions 
such as immunosuprression, poor nutrition or concurrent infections (Boreham 
et al., 1993). It might be because under such conditions of low-grade 
inflammation, the local temperature of infected sites might increase and thus 
the local microenvironment might facilitate the attachment of Blastocystis and 
leading to more severe pathology. Further understanding whether attachment 
might have contributed to the higher prevalence of Blastocystis in 
inflammatory disorders would provide insights into the implication of 
attachment in clinical management. 
Following adhesion and colonization, Blastocystis produced pathogenic effects 
on the host cells. Chapter 4 conducted for the first time a comprehensive 
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analysis of molecular and cellular basis for the epithelial functional 
disturbance, including molecular alterations in the tight junction complex and 
enterocyte apoptosis and Interestingly, Blastocystis–induced apoptosis was 
shown to contribute to the alterations in epithelial permeability. Understanding 
the molecular and cellular basis for Blastocystis–induced defect in barrier 
function will enable us to devise therapies targeting these changes. In addition, 
Chapter 4 also revealed an interesting redistribution of Claudin-1 tight 
junction protein, and pointed towards a possible association of the parasite 
with host cell proteins. Future exploration needs to focus on identification of 
molecules involved in the interaction of the parasite and host, which will 
reveal new insights into the molecular pathogenesis of this emerging 
protozoan microorganism. 
One reason for the controversial pathogenic potential of Blastocystis is the 
diverse clinical presentations. The duration and severity of symptoms vary 
from acute enteritis to chronic mild diarrhea (Nagel et al., 2012, Stensvold et 
al., 2009c). There is no consensus on the possible reasons for variation in 
intestinal symptoms, but strain-to-strain variations in pathogenicity have been 
implicated. Similar variations have been observed in Giardia, and it was 
proposed that different isolates of G. duodenalis were shown to differ in their 
abilities to trigger pathological changes in vitro (Solaymani-Mohammadi et al., 
2011). Chapter 6 revealed that there are wide intra- and inter-subtype 
variations in the ability to induce intestinal permeability, which is largely 
related to their attachment capability, suggesting that the diverse symptoms 
seen in the clinical setting might be ascribed to the attachment features of 
various Blastocystis strains. Therefore, attachment could be a biomarker for 
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the virulence of a particular strain and is an important virulence factor in 
establishing infection as well as determining the diverse infection outcomes of 
Blastocystis. This is the first study highlighting the cellular basis for strain-to-
strain variations in pathogenicity, providing a possible explanation for the 
diverse clinical outcomes of Blastocystis infections. The study may also 
explain why some strains were more likely to be isolated in infections. It 
would be interesting to characterize more clinically important strains and 
conduct comparative study on their attachment capability. 
Epithelial attachment is generally regarded as an important factor determining 
the persistence and virulence of luminal pathogens (Elmendorf et al., 2003, 
Tavares et al., 2005). We showed for the first time pathogenicity of 
Blastocystis was correlated with their ability to attach to epithelial cells. How 
adhesion leads to intestinal barrier dysfunction needs to be investigated 
further. Whether the adhesion of Blastocystis with host cells also enables 
certain enzymes to be released and thus participate in pathogenesis would be 
interesting to investigate. Recently the Blastocystis genome has been available 
and in silico analysis of the Blastocystis ST-7 secretome predicted 75 putative 
secreted proteins, some of which may have a direct connection with 
pathogenicity (Denoeud et al., 2011). Two cysteine proteases (legumain and 
cathepsin B) have recently been characterized in the ST-7 culture supernatant, 
which showed proteolytic activities by gelatin zymograms (Wawrzyniak et al., 
2012). However, whether these secreted proteins act on intestinal cells and 
disturb gut function have not been studied. It is reasonable to speculate that 
adhering to the epithelium might trigger Blastocystis to actively produce 
virulence factors which possibly activate signaling cascade leading to tight 
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junction disruption. Preferential adherence of cytopathic Blastocystis strains to 
intercellular junctions observed in this study also supports this idea.  
In addition, in this study, using two clinically relevant Blastocystis subtypes, 
it’s shown that ST-7 Blastocystis isolates recovered from symptomatic human 
patients attached and induced epithelial barrier dysfunction in Caco-2 human 
epithelial cell-line; while ST-4 isolates, recovered from rats, did not induce 
enterocyte pathology. The results with ST-4 strains suggested that the 
interaction between Blastocystis and host cells is species specific. The isolates 
may have adapted to their hosts for survival. However, clinical reports of ST-4 
infections are also very common. Regarding the contrasting results, it might 
probably be due to the different isolates from ST-4. It would be important to 
characterize more clinical strains from ST-4 and test their host cell specificity 
in adhesion and inducing pathological changes.  
Understanding the physiochemical factors and molecular mechanisms 
involved in adhesion not only enabled us to know the clinical relevance of 
adhesion, but also lent us insights into devising anti-adhesion therapy. Recent 
studies have highlighted the lack of efficacy of several commonly used 
antimicrobial regimens in the treatment of Blastocystis infections, as well as 
the chronic nature of the infections, pointing out the need for further research 
into treatment options for Blastocystis infection. It’s necessary to design 
alternative or adjunctive treatment options against antibiotic resistant 
Blastocystis infections. As attachment is crucial for Blastocystis survival and 
important for its pathogenicity, and thus would be an appealing drug target. 
Modulators that prevent robust attachment may allow Blastocystis to be 
flushed from the intestinal lumen by host peristalsis, and ultimately result in 
202 
 
reduction in infection. Chapter 3 revealed that galactose was an effective 
inhibitor for attachment of the metronidazole-resistant isolate ST-7 (B). With 
addition of galactose, the results showed that the ZO-1 tight junction 
degradation by ST-7 (B) was prevented, pointing towards the possible 
application of adhesion inhibitors. Interestingly, the adhesion of the highly 
adhesive strain ST-7 (H) was also significantly prevented and the pathogenic 
effects of H on Caco-2 cells were also ameliorated, suggesting galactose 
therapy might have broader applications for Blastocystis infections by 
different strains. The result also suggested that similar proteins involved in 
adhesion and other processes related to pathophysiology of Blastocystis. It 
would be interesting to perform comparative genome sequencing and compare 
the genomic or expression variations within the same ST or between STs, 
which would yield insights into the identification and analysis of the key 
factors associated with the pathobiology of blastocystosis. 
Altogether, these investigations have revealed fresh insight into the molecular 
mechanisms of Blastocystis pathogenesis, reiterating the pathogenic potential 
of the parasite, as well as providing an impetus for therapeutic targets. The 
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